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Résumé  
 
L’autophagie est une voie hautement conservée de dégradation lysosomale des 
constituants cellulaires qui est essentiel à l’homéostasie cellulaire et contribue à 
l’apprêtement et à la présentation des antigènes. Les rôles relativement récents de 
l'autophagie dans l'immunité innée et acquise sous-tendent de nouveaux paradigmes 
immunologiques pouvant faciliter le développement de nouvelles thérapies où la 
dérégulation de l’autophagie est associée à des maladies auto-immunes. Cependant, 
l'étude in vivo de la réponse autophagique est difficile en raison du nombre limité de 
méthodes d'analyse pouvant fournir une définition dynamique des protéines clés 
impliquées dans cette voie. En conséquence, nous avons développé un programme de 
recherche en protéomique intégrée afin d’identifier et de quantifier les proteines 
associées à l'autophagie et de déterminer les mécanismes moléculaires régissant les 
fonctions de l’autophagosome dans la présentation antigénique en utilisant une approche 
de biologie des systèmes. Pour étudier comment l'autophagie et la présentation 
antigénique sont activement régulés dans les macrophages, nous avons d'abord 
procédé à une étude protéomique à grande échelle sous différentes conditions connues 
pour stimuler l'autophagie, tels l’activation par les cytokines et l’infection virale.  
La cytokine tumor necrosis factor-alpha (TNF-α) est l'une des principales cytokines pro-
inflammatoires qui intervient dans les réactions locales et systémiques afin de 
développer une réponse immune adaptative. La protéomique quantitative d'extraits 
membranaires de macrophages contrôles et stimulés avec le TNF-α a révélé que 
l'activation des macrophages a entrainé la dégradation de protéines mitochondriales et 
des changements d’abondance de plusieurs protéines impliquées dans le trafic 
vésiculaire et la réponse immunitaire. Nous avons constaté que la dégradation des 
protéines mitochondriales était sous le contrôle de la voie ATG5, et était spécifique au 
TNF-α. En outre, l’utilisation d’un nouveau système de présentation antigènique, nous a 
permi de constater que l'induction de la mitophagie par le TNF-α, a entrainée 
l’apprêtement et la présentation d’antigènes mitochondriaux par des molécules du CMH 
de classe I, contribuant ainsi la variation du répertoire immunopeptidomique à la surface 
cellulaire. Ces résultats mettent en évidence un rôle insoupçonné du TNF-α dans la 
mitophagie et permet une meilleure compréhension des mécanismes responsables de 
la présentation d’auto-antigènes par les molécules du CMH de classe I.
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Une interaction complexe existe également entre infection virale et l'autophagie. 
Récemment, notre laboratoire a fourni une première preuve suggérant que la 
macroautophagie peut contribuer à la présentation de protéines virales par les molécules 
du CMH de classe I lors de l’infection virale par l'herpès simplex virus de type 1 (HSV-
1). Le virus HSV1 fait parti des virus humains les plus complexes et les plus répandues. 
Bien que la composition des particules virales a été étudiée précédemment, on connaît 
moins bien l'expression de l'ensemble du protéome viral lors de l’infection des cellules 
hôtes. Afin de caractériser les changements dynamiques de l’expression des protéines 
virales lors de l’infection, nous avons analysé par LC-MS/MS le protéome du HSV1 dans 
les macrophages infectés. Ces analyses nous ont permis d’identifier un total de 67 
protéines virales structurales et non structurales (82% du protéome HSV1) en utilisant le 
spectromètre de masse LTQ-Orbitrap. Nous avons également identifié 90 nouveaux sites 
de phosphorylation et de dix nouveaux sites d’ubiquitylation sur différentes protéines 
virales. Suite à l’ubiquitylation, les protéines virales peuvent se localiser au noyau ou 
participer à des événements de fusion avec la membrane nucléaire, suggérant ainsi que 
cette modification pourrait influer le trafic vésiculaire des protéines virales. Le traitement 
avec des inhibiteurs de la réplication de l'ADN induit des changements sur l'abondance 
et la modification des protéines virales, mettant en évidence l'interdépendance des 
protéines virales au cours du cycle de vie du virus. Compte tenu de l'importance de la 
dynamique d'expression, de l’ubiquitylation et la phosphorylation sur la fonction des 
proteines virales, ces résultats ouvriront la voie vers de nouvelles études sur la biologie 
des virus de l'herpès.  
Fait intéressant, l'infection HSV1 dans les macrophages déclenche une nouvelle forme 
d'autophagie qui diffère remarquablement de la macroautophagie. Ce processus, appelé 
autophagie associée à l’enveloppe nucléaire (nuclear envelope derived autophagy, 
NEDA), conduit à la formation de vésicules membranaires contenant 4 couches 
lipidiques provenant de l'enveloppe nucléaire où on retrouve une grande proportion de 
certaines protéines virales, telle la glycoprotéine B. Les mécanismes régissant NEDA et 
leur importance lors de l’infection virale sont encore méconnus. En utilisant un essai de 
présentation antigénique, nous avons pu montrer que la voie NEDA est indépendante 
d’ATG5 et participe à l’apprêtement et la présentation d’antigènes viraux par le CMH de 
classe I. Pour comprendre l'implication de NEDA dans la présentation des antigènes, il 
est essentiel de caractériser le protéome des autophagosomes isolés à partir de 
macrophages infectés par HSV1. Aussi, nous avons développé une nouvelle approche 
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de fractionnement basé sur l’isolation de lysosomes chargés de billes de latex, nous 
permettant ainsi d’obtenir des extraits cellulaires enrichis en autophagosomes. Le 
transfert des antigènes HSV1 dans les autophagosomes a été determine par 
protéomique quantitative. Les protéines provenant de l’enveloppe nucléaire ont été 
préférentiellement transférées dans les autophagosome lors de l'infection des 
macrophages par le HSV1. Les analyses protéomiques d’autophagosomes impliquant 
NEDA ou la macroautophagie ont permis de decouvrir des mécanismes jouant un rôle 
clé dans l’immunodominance de la glycoprotéine B lors de l'infection HSV1. Ces 
analyses ont également révélées que diverses voies autophagiques peuvent être 
induites pour favoriser la capture sélective de protéines virales, façonnant de façon 
dynamique la nature de la réponse immunitaire lors d'une infection.  
En conclusion, l'application des méthodes de protéomique quantitative a joué un rôle clé 
dans l'identification et la quantification des protéines ayant des rôles importants dans la 
régulation de l'autophagie chez les macrophages, et nous a permis d'identifier les 
changements qui se produisent lors de la formation des autophagosomes lors de 
maladies inflammatoires ou d’infection virale. En outre, notre approche de biologie des 
systèmes, qui combine la protéomique quantitative basée sur la spectrométrie de masse 
avec des essais fonctionnels tels la présentation antigénique, nous a permis d’acquérir 
de nouvelles connaissances sur les mécanismes moléculaires régissant les fonctions de 
l'autophagie lors de la présentation antigénique. Une meilleure compréhension de ces 
mécanismes permettra de réduire les effets nuisibles de l'immunodominance suite à 
l'infection virale ou lors du développement du cancer en mettant en place une réponse 
immunitaire appropriée.  
Mots-clés: Autophagie, présentation antigénique, protéomique quantitative, 
spectrométrie de masse, TNF-α, macrophages, Herpès Simplex Virus 
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 Abstract 
 
Autophagy is a highly conserved lysosomal-mediated protein degradation pathway that 
plays a crucial role in maintaining cellular homeostasis and contributes to antigen 
processing and presentation. The emerging roles of autophagy in both innate and 
adaptive immunity underpin novel immunological paradigms that may provide 
opportunities for the development of new therapies where impaired autophagy is 
associated with autoimmune diseases. However, the in vivo study of autophagic 
response is challenging in view of the limited number of analytical approaches that can 
provide a dynamic definition of the key proteins involved in this pathway. Accordingly, we 
developed an integrated proteomics research program to unravel the molecular 
machines associated with autophagy and to decipher the fine details of the molecular 
mechanisms governing the functions of the autophagosome in antigen presentation 
using a systems biology approach. To study how autophagy and antigen presentation 
are actively modulated in macrophages, we first conducted comprehensive, global 
proteomics studies under different conditions known to stimulate autophagy. Autophagy 
is modulated by cytokines as well as by viral infection in various ways. 
TNF-α is one of the major proinflammatory cytokines that mediate local and systemic 
responses and direct the development of adaptive immunity. Label-free quantitative 
proteomics analysis of membrane extracts from TNF-α activated and resting 
macrophages revealed that TNF-α activation led to the downregulation of mitochondrial 
proteins and the differential regulation of several proteins involved in vesicle trafficking 
and immune response. Importantly, we found that the downregulation of mitochondria 
proteins occurred through Atg5-dependent mitophagy, and was specific to TNF-α. 
Furthermore, using a novel antigen presentation system, we observed that the induction 
of mitophagy by TNF-α enabled the processing and presentation of mitochondrial 
antigens at the cell surface by MHC class I molecules, suggesting that TNF-α induced 
mitophagy contributes to the modification of the MHC class I peptide repertoire. These 
findings highlight an unsuspected role of TNF-α in mitophagy and expanded our 
understanding of the mechanisms responsible for MHC class I presentation of self-
antigens.
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A complex interplay also exists between viral infection and autophagy. Recently, our lab 
provided the first evidence that macroautophagy can contribute to the presentation of 
viral proteins on MHC class I molecules during Herpes Simplex Virus type 1 (HSV1) 
infection. HSV1 are among the most complex and widespread human viruses. While the 
composition of viral particles has been studied, less is known about the expression of the 
whole viral proteome in infected cells. To comprehensively characterize the system, we 
analyzed the proteome of the prototypical HSV1 in infected macrophages by LC-MS/MS. 
We achieved a very high level of protein coverage and identified a total of 67 structural 
and non-structural viral proteins (82% of the HSV1 proteome) using LC-MS/MS on a 
LTQ-Orbitrap instrument. We also obtained a comprehensive map of 90 novel 
phosphorylation sites and ten novel ubiquitylation sites on different viral proteins. 
Interestingly all ubiquitylated proteins could either localize to the nucleus or participate in 
membrane fusion events, suggesting that ubiquitylation of viral proteins might affect their 
trafficking. Treatment with inhibitors of DNA replication induced changes of both viral 
protein abundance and modifications, highlighting the interdependence of viral proteins 
during the life cycle of the virus. Given the importance of expression dynamics, 
ubiquitylation and phosphorylation for protein function, these findings will serve as 
important tools for future studies on herpes virus biology. 
Interestingly, HSV1 infection in macrophages triggers a novel form of autophagy which 
remarkably differs in many ways from macroautophagy. This process, referred to as 
nuclear envelope-derived autophagy (NEDA), leads to the formation of 4-membrane 
layered vesicles originating from the nuclear envelope where some viral protein such as 
glycoprotein B are highly enriched. To which extent this process differs from 
macroautophagy and participates in the pathogenesis of HSV infection is still largely 
unknown. Using a novel antigen presentation assay we could show that NEDA is an 
Atg5-independent pathway that participates in the capture of viral proteins, and their 
processing and presentation on MHC class I molecules. To understand the involvement 
of NEDA in antigen presentation it is crucial to characterize the autophagosomal 
proteome in HSV1 infected macrophages. We developed a novel isolation method based 
on the loading of the lysosomal compartment with latex beads, a unique tool to obtain 
very pure cell extracts, upon autophagy induction. The transfer of HSV1 antigens into 
autophagosomes was monitored using quantitative proteomics. Nuclear enveloped-
derived proteins were preferentially transferred to the autophagosome during HSV1 
infection. Detailed proteomics characterization of autophagosomes formed during NEDA 
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and macroautophagy led to the discovery of mechanisms that play a key role in 
glycoprotein B immunodominance during HSV1 infection. These analyses also revealed 
that various autophagic pathways can be induced to promote the capture of selective 
sets of viral proteins, thus actively shaping the nature of the immune response during 
infection.    
In conclusion, the application of quantitative proteomics methods played a key role in 
identifying and quantifying important regulators of autophagy in macrophages and 
allowed us to identify changes occurring during the remodeling of autophagosomes in 
response to disease and inflammatory conditions such as viral infections. Furthermore, 
our systems biology approach that combined mass spectrometry-based quantitative 
proteomics with functional screens such as antigen presentation assays revealed novel 
biological insights on the molecular mechanisms governing the functions of autophagy in 
antigen presentation. Harnessing the contribution of autophagy in antigen presentation 
has the potential to minimize the deleterious effects of immunodominance in viral 
infection and cancer by shaping an appropriate immune response. 
 
Keywords: Autophagy, antigen presentation, quantitative proteomics, mass 
spectrometry, TNF-α, macrophages, Herpes Simplex Virus  
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1.1. The immune system 
 
The immune system is composed of structures and mechanisms that allow an organism 
to discriminate between ”self” and ”non-self” 1. These defense mechanisms provide the 
body with protection against foreign pathogens such as bacteria, viruses, parasites or 
fungi and it also prevents autoreactive damage causing autoimmune disease, an 
immunosurveillance mechanisms referred to as self tolerance2. Furthermore, the immune 
system is also able to recognize an “altered- self" as in the case of cancer cells. The 
immune system is broadly divided into two main systems composed of innate immunity 
(or nonspecific immunity) and acquired/adaptive immunity (or specific immunity). 
Although these two subsystems were often seen as completely separate, the current 
opinion is that innate immunity and adaptive immunity systems are functionally 
interconnected and complement each other to contain infectious diseases3. 
 
1.1.1 Innate immunity 
 
The innate immune system represents an excellent and rapid first line of defense against 
microbes. It is composed of physical barriers, antimicrobial substances, inflammatory 
mechanisms, complement system, leukocytes and fever, which are very effective against 
a variety of pathogens. The innate immune system recognizes molecular patterns 
common to various pathogens via a restricted number of receptors on phagocytic cells 
such as Toll-like receptors and is hence not specific2. This initial response is very rapid 
(in a time frame of hours) as these pathogen receptors are widely expressed on many 
cells. However, due to the lack of specificity the system rapidly fails when attacked by a 
pathogen that has evolved to evade the defense mechanisms. The presence of a 
constant synergizing interaction between innate and adaptive immunity allows the rapid 
establishment of specific defense mechanisms targeted at the pathogen. For example, 
phagocytosis and autophagy, two non-specific defense mechanisms for degradation of 
pathogens that are intra-or extracellular, are now recognized as part of the specific 
immune response1, 4. 
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1.1.2. Adaptive immunity 
 
Adaptive immunity, which has been acquired later in evolution, comprises a limited 
number of cells with very specific recognition capabilities for any pathogen. The adaptive 
immune system uses two types of responses, the cell-mediated response and the 
humoral response. For each of these responses, specialized cells have evolved that 
express antigen-specific receptors on their surface to exclusively recognize antigens 
associated with different pathogens2. The antigen receptor, if linked with a specific 
antigen, generates a clonal expansion of the latter, necessary to obtain enough immune 
cells to elucidate an efficient immune response. The adaptive immune response is hence 
slower (in a timeframe of days). In the case of cell-mediated immunity, the main actors 
are T lymphocytes, previously activated by professional antigen-presenting cells (APCs). 
To provide humoral immunity and perform the role of APCs, B cells actively produce 
antibodies after activation by antigen interaction. In addition to the development of 
effector cells, the adaptive response also enables the development of memory cells, thus 
providing a more rapid immune response if re-infected with the same pathogen4, a 
mechanism used in vaccination strategies3. 
 
1.1.2.1. T cells – important effector cells of adaptive immunity 
 
Adaptive immune cells that cause cell-mediated immunity originate from pluripotent 
hematopoietic stem cells in the bone marrow. These pluripotent cells generate 
multipotent stem cells that give rise to lymphoid and myeloid precursors. These 
precursors generate all cells comprising the immune system; T cells (derived from 
lymphoid precursors) and monocytes/macrophages and dendritic cells (formed from 
myeloid precursors)5. 
Bone marrow derived T cells undergo a ''selection'' in the thymus. Thymic selection 
comprises positive and negative selection4. During positive selection only T cells able to 
bind major histocompatibility (MHC) molecules expressed by the epithelial cells of the 
thymus cortex with sufficient affinity survive, while others are eliminated by apoptosis6. 
Thereafter, the cells having passed the positive selection, migrate to the thymus to 
undergo negative selection (or clonal deletion). Here the lack of affinity with peptide-MHC 
complexes ensures the survival of lymphocytes, since T cells that interact too strongly 
with “self”-peptide-MHC complexes are eliminated7. This last step is crucial to avoid auto-
reactive lymphocytes causing autoimmune diseases and plays an important role in 
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central tolerance8. After the thymic selection, “naïve” T cells enter the blood and 
lymphatic circulation, where they can get activated as “effector” T lymphocytes and / or 
"memory" T lymphocytes following recognition of specific antigens. The differentiation of 
naive T cells into effector T lymphocytes is executed by professional antigen presenting 
cells, including dendritic cells and macrophages, regulated by co-stimulatory molecules 
and cytokines, and allows T effector cells to eliminate infected cells4. 
There are different subgroups of effector T cells. Cluster of differentiation (CD) 4+ T 
lymphocytes play a central role in the development of the humoral response and cell 
mediated immune response. CD4+ T cells can differentiate into type I T helper (TH1) cells 
or type II T helper (TH2) cells, following binding of a peptide antigen on MHC class II 
complex from macrophages or dendritic cells and T cell receptor (TCR). TH1 and TH2 
cells differ based on their subsequent production of cytokines. TH1 cells modulate cell-
mediated immunity by secreting cytokines such as interferon and interleukin-2 (IL-2), 
whereas TH2 cells modulate humoral immunity by secreting IL-4, IL-10 and IL-139. 
Naïve CD8 + T cells differentiate into cytotoxic T lymphocytes (CTL) following activation 
through the interaction of their TCR with peptide-MHC class I and strong co-stimulatory 
activity on the surface of an APC. The co-stimulatory activity is promoted by the cytokine 
production of CD4+ T cells, resulting in the increased expression of co-stimulatory 
molecules. CD8+ T lymphocytes are particularly effective in eliminating virus-infected 
cells10. CD8+ T cells can destroy infected cells directly via the release of serine proteases 
called granzymes and the protein perforin11, which allows granzymes to enter into 
infected cells. 
 
 
1.2. Macrophages – key players in innate and adaptive 
immunity 
 
Macrophages are innate immune cells with well-established roles in the primary response 
to pathogens, but also in the coordination of the adaptive immune response, 
inflammation, tissue homeostasis, and repair. Macrophages were initially recognized by 
Elli Metchnikoff as phagocytic cells responsible for pathogen elimination and 
housekeeping functions in a wide range of organisms, from invertebrates to vertebrates. 
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Ellie Metchnikoff, who won the Nobel Prize in Physiology or Medicine in 1908 for his 
description of phagocytosis, proposed that the key to immunity was to “stimulate the 
phagocytes”12. 
Macrophages evolved in simple multicellular organisms to phagocyte and clear dying 
cells during development, and to protect the host through innate immunity, both as 
resident tissue macrophages and monocyte-derived cells mobilized during inflammation. 
Macrophages are very plastic and can change their functional phenotype depending on 
the environmental stimuli they receive. These cells have a vital role in protecting the host 
through their ability to kill pathogens and instruct other immune cells, but also contribute 
to the pathogenesis of inflammatory and degenerative diseases. 
Macrophages are present in essentially all tissues. They differentiate from circulating 
peripheral-blood mononuclear cells (PBMCs), which migrate into tissue in the steady 
state or in response to inflammation13. PBMCs develop from a common myeloid 
progenitor cell in the bone marrow. This myeloid progenitor cell is the precursor of many 
different cell types, including, eosinophils, basophils, neutrophils, macrophages, dendritic 
cells and mast cells. During monocyte development, myeloid progenitor cells (termed 
granulocyte/macrophage colony-forming units) successively generate monoblasts, pro-
monocytes and finally monocytes, which are sent from the bone marrow into the 
bloodstream13. Monocytes travel from the blood into tissue to form long-lived tissue- 
specific macrophages of the bone (osteoclasts), alveoli, central nervous system 
(microglial cells), gastrointestinal tract, liver (Kupffer cells), connective tissue 
(histiocytes), skin (Langerhans cells), peritoneum and spleen. Resident macrophage 
populations in different organs adjust to their local microenvironment. The stimuli that 
regulate tissue-specific phenotypes of macrophages include surface and secretory 
products of neighboring cells and extracellular matrix. Macrophages can respond to 
endogenous cues that are quickly generated following infection or injury. These early 
stimuli are typically produced by innate immune cells and can result in a distinct, though 
usually transient, effect on the physiology of macrophages14. Macrophages can also 
respond to stimuli produced by antigen-specific immune cells. These signals are more 
specific and prolonged than innate immune stimuli and generally exert longer term 
alterations in macrophages15. 
Macrophages are professional phagocytes that internalize large particles like dead cells 
or pathogens, and play crucial roles in immunity by the initiation of microbicidal 
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mechanisms as a part of innate immunity14. In mammals, the internalization of 
microorganisms at sites of infection by macrophages proceeds via the internalization of 
pathogens in phagosomes, where they are killed and degraded by hydrolytic enzymes. 
Phagosomes obtained these functional properties relatively recently during the evolution 
of multicellular organisms through the acquisition of molecular machineries that 
transformed phagosomes from a lytic vacuole into an organelle fully competent for 
antigen presentation16. Indeed, the processing of proteins from internalized pathogens to 
derive antigens for presentation at the cell surface on major histocompatibility complex 
(MHC) class I and class II molecules is a key mechanism of adaptive immunity to initiate 
specific defense mechanisms17. Importantly, the initiation of an efficient immune 
response depends on the capability of APCs such as macrophages to display peptide 
MHC complexes on their cell surface. 
 
1.2.1. Macrophage activation 
 
Cytokines produced by immune cells can activate macrophages to convey different 
responses. Classically macrophages are activated in response to interferon-γ (IFN-γ), 
which can be produced during an adaptive immune response by T helper 1 (TH1) cells or 
CD8+ T cells or during an innate immune response by natural killer cells, and tumor 
necrosis factor (TNF), which is produced by antigen presenting cells (Figure 1.1). The 
term classically activated has been used to refer to the effector macrophages that are 
produced during cell-mediated immune responses14, 15, 18. 
IFN-γ activation results in the transcriptional regulation of several genes including nitric 
oxide synthase-2 and phagocyte oxidase that are associated with reactive oxygen 
species (ROS) production. ROS are an established feature of the macrophage’s 
microbicidal activity and improve the killing abilities of macrophages19. IFN-γ transforms 
resting macrophages into potent cells with increased antigen presenting capacity, 
increased synthesis of proinflammatory cytokines and toxic mediators, and enhanced 
complement mediated phagocytosis. Thus, macrophages obtain the capacity to kill 
bacteria, especially intracellular pathogens. IFN-γ also mediates phagosome maturation 
and antigen loading on MHC class I and class II molecules20-22 and regulates the 
upregulation of MHC class I as well as co-stimulatory molecules on macrophages14. 
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Classically activated macrophages secrete pro-inflammatory cytokines such as IL-1, IL-
6 and IL-23, a hallmark of the macrophage’s microbicidal activity14. Proinflammatory 
cytokines produced by classically activated macrophages are an important feature of the 
host defense, but they can also cause extensive damage to the host. The expansion of 
TH17 cells has been linked to IL-1, IL-6 and IL-2323, 24. These cells produce IL-17, a 
cytokine that can contribute to inflammatory autoimmune diseases14. Interestingly, 
macrophages activated through Toll-like receptor (TLR) ligand stimulation produce tumor 
necrosis factor α (TNF-α), another important cytokine that synergizes with INF-γ to 
enhance macrophage activation. Macrophages can also be stimulated exogenously from 
the secretion of this cytokine by antigen presenting cells. TNF-α stimulation is particularly 
important in Leishmania infections as macrophages stimulated with IFN-γ alone are less 
efficient at killing this parasite due to lack of TLR ligands expression. TNF-α also has a 
central role in inflammatory cell activation and recruitment, and is associated with the 
development of various chronic inflammatory diseases such as Crohn’s disease25. 
Taken together, classically activated macrophages are products of a cell-mediated 
immune response. They can also be transiently generated in response to innate stimuli 
following viral infections or stress. Some pathogens have acquired the ability to interfere 
with IFN-γ signaling and inhibit efficient macrophage activation. Classically activated 
macrophages are vital components of the host defense, but their activation must be 
tightly controlled, because the cytokines and mediators they produce can lead to host 
tissue damage. Indeed classically activated macrophages are key mediators of the 
immunopathology that occurs during several autoimmune diseases, including 
rheumatoid arthritis26 and inflammatory bowel disease27. 
Similarly to classically activated macrophages, wound healing or alternatively activated 
macrophages can arise in response to innate or adaptive signals (Figure 1.1). 
Macrophages are alternatively activated by IL-4 and IL-1328, which trigger a distinct 
phenotype that accounts for allergic, cellular and humoral responses to parasitic and 
extracellular pathogens28. Basophils and mast cells are important early sources of innate 
IL-4 production, while other granulocytes might also contribute. It is well established that 
IL-4 and IL-13 are associated with TH2 type responses. IL-4- and IL-13 can promote the 
development of wound-healing macrophages, though this activation yields poor antigen-
presenting cells that are less efficient at producing ROS or at clearing intra cellular 
pathogens than classically activated macrophages29. 
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Figure 1.1. Cytokine mediated macrophage activation.  
Classically activated macrophages are generated from IFN-γ and TNF-α stimulation. IL-4 
stimulation results in wound-healing (alternatively) activated macrophages. Regulatory 
macrophages are formed in response to various stimuli including glucocorticoids and IL-10. From 
reference14. 
 
Due to the role of TH1-derived interferon-γ in cell-mediated immunity to intracellular 
infection and of IL-4 (TH2) in extracellular parasitic infection, macrophages were 
designated analogously as M1 (classic) and M2 (alternative) macrophages. This concept 
was recently extended to a wider range of immune modulatory mediators and functions30. 
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In addition to classically and alternatively activated macrophages, regulatory 
macrophages develop in response to various stimuli, including immune complexes, 
glucocorticoids, apoptotic cells, prostaglandins, G-protein coupled receptor ligands or IL-
10 (Figure 1.1). This innate or acquired deactivation of macrophages causes the 
production of IL-10, which suppresses immune responses and is the most important and 
reliable characteristic of regulatory macrophages14. 
Taken together, both innate and adaptive signals can influence macrophage physiology 
and these alteration allow macrophages to participate in homeostatic processes such as 
tissue remodeling and wound healing as well as in host defense. However, each of these 
alterations can have potentially dangerous consequences and must be appropriately 
regulated. 
 
1.3. Antigen processing and presentation 
 
The efficiency of T cell-mediated adaptive immune responses depends on the ability of 
antigen presenting cells, such as macrophages, to display peptide and MHC complexes 
on their surface31. MHC molecules are divided into MHC class I and MHC class II, where 
the former presents peptides at the cell surface to CD8+ and the latter to CD4+ T cells. 
MHC class I and II also differ by the structure of the groove where antigenic peptides are 
bound. The antigen-binding groove of MHC class I molecules is closed at each end, 
resulting in the binding of peptides with a defined length (8-10 amino acids)32. In contrast, 
the antigen binding groove of MHC class II molecules has open ends, permitting the 
loading of peptides of a more variable length (13-25 amino acids).33. 
While MHC I complexes are expressed ubiquitously by all nucleated cells and recognized 
by CD8+ T cells, MHC II molecules are limited to professional APCs such as B cells, 
macrophages and dendritic cells, and are then recognized by CD4+ T cells.34 However, 
MHC class II expression can be induced by IFN-γ and other stimuli in non-APCs. Non-
APCs can express MHC class II molecules in the absence of co-stimulatory molecules 
to maintain peripheral tolerance34.  
Membrane trafficking plays a key role in both endogenous and exogenous antigen 
processing and presentation (see Figure 1.2). Initially, two segregated pathways of 
antigen presentation were proposed. Endogenous antigens, including viral proteins 
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synthesized by infected cells, are degraded in the cytoplasm by the proteasome. The 
resulting peptides are translocated into the endoplasmic reticulum (ER) lumen by the 
MHC locus-encoded peptide transporter associated with antigen processing (TAP), 
where they can be further trimmed and are loaded onto nascent MHC class I molecules35. 
The constitutive 26S proteasome is composed of a 20S core barrel that has protease 
activity36 and two 19S caps. It generates the bulk peptides for MHC class I molecules. 
Two alternative proteasomes exist: the immunoproteasome, which is expressed by many 
immune cells and the thymus specific proteasome, which is expressed in thymic epithelial 
cells37. Immune cell-specific variants of the proteolytic core are incorporated into the 20S 
barrel altering the degradation pattern of the proteasome38. 
 
 
Figure 1.2. MHC class I and MHC class II antigen processing and presentation pathways. 
Endogenous antigens are degraded in the cytoplasm by the proteasome. The resulting peptides 
are translocated into the endoplasmic reticulum (ER), where they are loaded on MHC class I 
molecules and transported to the cell surface to be presented to CD8+ T cells. Exogenous 
antigens are internalized by endocytosis or phagocytosis, processed by hydrolases, and then 
loaded onto MHC class II molecules before translocation to the cell surface and presentation to 
CD4+ T cells. Exogenous antigens can also be presented on MHC class I molecules, a process 
referred to as cross-presentation. Autophagy contributes to endogenous and exogenous MHC 
class II antigen processing and presentation by delivering endogenous antigens to MHC class II-
containing compartments (MIICs) for lysosomal antigen processing and MHC class II loading of 
antigens. Autophagy can also contribute to the presentation of endogenous antigens by MHC 
class I molecules. Endogenous antigens may be transported from the autophagosome to the 
cytosol to enter the classical pathway, or peptides may be loaded onto MHC class I molecules in 
the autophagolysosome compartment. Adapted from reference39. 
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In the ER, the MHC class I heterodimer is assembled from a polymorphic heavy chain 
and a light chain called β2-microglobulin (β2m). In order to be stable a peptide in the 
MHC I binding groove is required. Without peptides, MHC class I molecules are stabilized 
by ER chaperone proteins such as calreticulin, ERp57, protein disulfide isomerase and 
the chaperone tapasin. Tapasin interacts with TAP, thus coupling peptide translocation 
into the ER with peptide delivery to MHC class I molecules. The complex of TAP, tapasin, 
MHC class I, ERp57 and calreticulin is known as the peptide loading complex (PLC)34. 
Peptides may bind to MHC class I molecules directly or may need further trimming by ER 
aminopeptidase associated with antigen processing (ERAAP). When peptides bind to 
MHC class I molecules, the chaperones are released and fully assembled peptide-MHC 
class I complexes leave the ER and are transported to the cell surface through the 
secretory pathway (Figure 1.2) for presentation to CD8+ T cells35, 40. Peptides and MHC 
class I molecules that fail to bind are transported back into the cytosol and degraded by 
the ER-associated protein degradation system (ERAD)41. 
In contrast, exogenous antigens are internalized by endocytosis or phagocytosis, 
processed by hydrolases in lytic endovacuolar compartments and the resulting peptides 
loaded onto MHC class II molecules. The transmembrane α – and β chains of MHC class 
II are assembled in the ER and associate with the invariant chain (Ii). The resulting Ii-
MHC class II complex is transported to a late endosomal compartment termed the MHC 
class II compartment (MIIC). Here Ii is cleaved, leaving a residual class II associated Ii 
peptide (CLIP) in the peptide binding groove of the MHC class II heterodimer. In the MIIC, 
MHC class II molecules require HLA DM (H2-M in mice) to enable the exchange of the 
CLIP fragment for a specific peptide derived from the degradation of exogenous proteins 
in the endosomal pathway. MHC class II molecules are then translocated to the cell 
surface for presentation of their cargo to CD4+ T cells (Figure 1.2).34 
Although initially thought to be strictly segregated, these two pathways were revisited to 
account for the cells’ ability to present exogenous antigens on MHC class I molecules, a 
process referred to as cross-presentation (Figure 1.2)42. Different models have been 
proposed for the cross-presentation pathway. In the phagosome to cytosol model, 
antigens internalized by phagocytosis are transported across the phagosome membrane 
into the cytosol, where they can be further processed by the proteasome and enter the 
classical processing pathway for MHC class I presentation43. In the phagosome to cytosol 
to phagosome model, peptides are loaded on MHC class I molecules in the phagosome 
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itself. This model involves two transmembrane transport steps of the phagocytosed 
antigens44, 45. The first step transports peptides into the cytoplasm where antigens are 
further trimmed by the proteasome. The second step enables the re-entry of the 
processed antigens in the phagosome lumen through TAP44-46. It was recently shown 
that antigenic peptides that bind to MHC class I molecules can also be generated by 
proteases in the lumen of vacuolar organelles hence avoiding the detour to the 
proteasome in the cytosol. These peptides are directly loaded on the MHC class I 
complexes in the ”vacuolar pathway”47. While the contribution of the endo-phagocytic 
pathway to the processing of exogenous antigen for MHC class I and II antigen 
presentation has been recognized for several years, it has been shown only very recently 
that endogenous and exogenous antigens can also be taken up by autophagosomes and 
presented on both MHC class I and MHC class II molecules, thus making autophagy an 
emerging immunological paradigm (see chapter 1.4.6.2 for more details)48. 
 
 
1.4. Autophagy 
 
A constant balance between biosynthetic and catabolic processes is crucial for cellular 
homeostasis. Eukaryotic cells primarily use two distinct mechanisms for large-scale 
degradation, the ubiquitin dependent proteasome system (UPS) and autophagy. 
Proteasome-mediated degradation requires previous ubiquitylation of the cargo, which is 
then recognized by ubiquitin receptors directing it to the 26S proteasome. The UPS 
rapidly eliminates proteins to regulate many cellular processes, including signal 
transduction, cell division and gene expression and is considered to be highly selective. 
Conversely, autophagy, a highly conserved lysosomal degradation pathway, can 
degrade almost any cargo including whole organelles. Half a century ago, Christian de 
Duve coined the term “autophagy” (literally, “self-eating”) to describe a process whereby 
cells digest their cytoplasmic materials within lysosomes49, 50. This was based on his 
discovery of lysosomes in 195551, for which he won the Nobel Prize in Physiology or 
Medicine in 197452.  
Half a decade of research has helped to understand that there is not one autophagic 
pathway, but at least three primary types of autophagy: macroautophagy, 
microautophagy and chaperone-mediated autophagy (CMA), which share a common 
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destiny of lysosomal degradation, but are mechanistically different from one another53, 54. 
Both micro and macroautophagy can be selective or non-selective. During 
microautophagy, lysosomes engulf cytoplasmic materials by inward invagination of the 
lysosomal membrane. Chaperone-mediated autophagy, mediated by the chaperone 
hsc70, co-chaperones, and the lysosomal-associated membrane protein type 2A 
(LAMP2A), transports proteins across the lysosomal membrane without membrane 
rearrangements55, 56. During classical macroautophagy a phagophore is formed at the 
phagophore assembly site (PAS). The phagophore subsequently engulfes cytosolic 
components such as organelles and packages them in a two-membrane–bound 
compartment called the autophagosome. The autophagosome subsequently fuses with 
the lysosome to form the autophagolysosome in which the content is completely 
degraded and the resulting macromolecules are released back into the cytosol for reuse 
(Figure 1.3)56. 
 
Figure 1.3. Autophagy pathway.  
Mammalian autophagy proceeds through a series of steps. Upon several, yet unknown signals 
the phagophore is formed. The phagophore subsequently engulfes cytosolic components such as 
organelles and packages them in a double-membrane autophagosome. Autophagosome 
maturation proceeds via fusion with an endosome and/or lysosome, followed by breakdown and 
degradation of the autophagosome inner membrane and cargo, and recycling of the resulting 
macromolecules. The core molecular machinery is also shown. Adapted from reference56. 
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1.4.1. Molecular regulation of autophagy and the autophagy pathway 
 
Although autophagy was first identified in mammalian cells approximately half a century 
ago, the transition from morphology to molecular mechanisms only started in the last 
decade mainly based on the discovery of autophagy related (ATG) genes initially 
identified in yeast57. Mammalian homologs were found soon after58. Among these ATG 
genes, one subgroup comprised of approximately 18 genes is common to the various 
types of autophagy including non-selective macroautophagy and mitophagy. The 
corresponding gene products of this subgroup are crucial for autophagosome formation 
and are thus referred to as the core autophagy machinery59, 60. There are four different 
functional subgroups: (1) the Atg1/unc-51-like kinase (ULK) complex (Atg1, Atg11, 
Atg13, Atg13, Atg17, Atg29 and Atg31), which plays a role in the initial induction of 
autophagosome formation; (2) the transmembrane protein Atg9 and associated proteins 
(Atg2, Atg9 and Atg18), which regulates membrane recruitment to the elongating 
phagophore after the association of the Atg1 complex at the PAS; (3) the class II 
phosphatidylinositol 3-kinase (PtdIns3K) complex (Vps (vacuolar protein sorting) 34, 
Vps15, Vps30/Atg6, and Atg14), which plays a role during vesicle nucleation and is 
implicated in the targeting of phosphatidylinositol-3-phosphate (PtdIns3P)-binding 
proteins to the PAS; and (4) two ubiquitin like (UBL) conjugation systems: the Atg12 
(Atg5, Atg7, Atg10, Atg12 and Atg16) and Atg8/LC3 (Atg3, Atg4,Atg7 and Atg8) 
conjugation system, which function in vesicle expansion61, 62. 
Mammalian autophagy is regulated by the serine/threonine protein kinases ULK1 and 
ULK2 (mammalian homologues of the yeast autophagy-related protein (Atg1)) and the 
lipid kinase activity of PtIns3K Vps34 (Vps-34 in yeast) associated to Beclin 1 
(mammalian orthologue of yeast Atg6) and Atg14-like protein (Atg14L). ULK1, ULK2 and 
the Vps34-Beclin 1-ATG14L complex integrate upstream signaling pathways (see 
chapter 1.4.4.) and activate the downstream Atg conjugation cascade62, 63. Two ubiquitin-
like systems regulate autophagosome formation and closure, conjugating three UBL 
proteins (Atg12, Atg5 and Atg8) to target proteins or membranes64. Atg7 and Atg10 exert 
the conjugation of Atg12 to Atg5 respectively, which forms a complex with Atg16. A 
complex of Atg12-Atg5-Atg16 together with Atg3 controls conjugation of Atg8 (processed 
by Atg4) to phosphatidylethanolamine (PE) on the isolation membrane64. Although these 
two UBL systems are dependent on each other, they have distinct functions. The Atg12-
Atg5-Atg16 complex localizes transiently to the outer membrane of the PAS. However, 
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Atg8-PE (also called microtubule-associated protein 1A/1B-light chain 3 (LC3)-II) persists 
throughout the early phase of formation, cargo sequestration and fusion to the lysosome 
and is thus often used as marker of autophagic flux65.   
Together with other components lipidated mammalian homologs of Atg8 serve to 
assemble, elongate and close the autophagosome. The UBL protein conjugation 
systems are highly conserved from yeast to mammals. One of the main differences is the 
existence of multiple homologs of yeast Atg8 in mammals. Two subfamilies of at least 
seven Atg8 proteins exist: the LC3 proteins LC3a, LC3b, and LC3c, and GABARAP (γ-
amino butyric acid receptor-associated protein), GABARAPL1 and GABARAPL2. LC3 
plays an important role during phagophore elongation, while GABARAP proteins act at a 
later stage of maturation. In mammals LC3b is the most prevalent and well-established 
autophagosome marker66. 
 
1.4.2. Signaling pathways regulating autophagy 
 
Autophagy is regulated by a complex signaling network of diverse stimulatory and 
inhibitory signals (Figure 1.4). The target of rapamycin (TOR), a highly conserved 
serine/threonine protein kinase that senses growth factors, nutrients and energy levels, 
acts as a ‘master regulator’ of autophagy67. TOR occurs in two distinct complexes, 
TORC1 (target of rapamycin complex 1) and TORC2 that are conserved from yeast to 
mammals. TORC1 is mainly implicated in autophagy regulation. mTORC1 (mammalian 
TORC1) is sensitive to rapamycin, which in many conditions induces autophagy. 
mTORC1/TOR plays a central role in autophagy by integrating the class I PtdIns3K 
signaling and amino acid-dependent signaling pathways. Activation of growth factor 
receptors activates the class I PtdIns3K complex and small GTPase Ras, leading to 
activation of the PtdIns3K-PKB (PtIns3K-protein kinase B)-TOR pathway and the Raf-1-
MEK (Dual specificity mitogen activated protein kinase kinase) 1/2-ERK (extracellular 
signal-regulated kinase) 1/2 pathway, respectively. PKB and ERK1/2 cause the 
phosphorylation and inhibition of the tuberous sclerosis complex 1/2 (TSC1-TSC2), 
resulting in the stabilization of Rheb GTPase, which subsequently activates mTORC1, 
hence inhibiting autophagy. Activated ERK1/2 also induces autophagy. Amino acids 
inhibit the Raf-1-MEK1/2-ERK1/2 signaling cascade, hence antagonizing autophagy. 
High adenosine monophosphate (AMP):adenosine triphosphate (ATP) ratios caused by 
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metabolic stress and low energy levels, cytokines or increased cytosolic Ca2+ 
concentrations, lead to the phosphorylation of  the AMP-activated protein kinase (AMPK) 
and activation by LKB1 (Liver kinase B1). AMPK phosphorylates and activates 
TSC1/TSC2, causing inactivation of mTORC1/TOR and autophagy induction56, 60.  
 
Figure 1.4. Signaling pathways regulating autophagy.  
Complex signaling events are involved in autophagy regulation including stimulatory (blue arrows) 
and inibitory signals (red bars). Blue elements in the figure stimulate autophagy, whereas red 
elements inhibit autophagy. TOR is a key regulator of autophagy induction. From reference68. 
 
TOR-independent autophagy pathways do also exist. Phosphorylation and interruption 
of the interaction of anti-apoptotic proteins, Bcl-2 (B-celllymphoma-2) and Bcl-XL with 
Beclin 1 by the stress-responsive c-Jun amino terminal kinase (JNK1) and death-
associated protein kinase (DAPK) stimulates the phagophore-bound Beclin 1-associated 
class III PtIns3K complex and induces autophagy69, 70. Pharmacological stimulation of 
autophagy can be achieved by inhibiting negative regulators such as TOR with 
rapamycin71. Targeting the class III PI3K implicated in autophagosome formation with 3-
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methyladenine (3-MA) or Wortmannin inhibits autophagy. Inhibition can also be executed 
by targeting autophagosome maturation, using inhibitors of the lysosomal proton pump 
inhibitors such as bafilomycin A1 or lysosomal alkalines such as chloroquine and 3-
hydroxychloroquine71. It is noteworthy that all these pharmacological treatments are not 
specific for the autophagy pathway. Consequently, genetic inhibition of autophagy via 
knockout of ATG genes or knockdown by shRNA (short hairpin ribonucleic acid) resulted 
in more conclusive information about the biological functions of autophagy in health and 
disease72. 
 
1.4.3. Origin of the autophagosomal membrane 
 
The source of the isolation membrane that forms the autophagosome has been eagerly 
debated39. The endoplasmic reticulum (ER), mitochondria, the Golgi apparatus, and the 
plasma membrane represent potential candidates (Figure 1.5)73-78. Recent research 
indicates that several more or less different autophagy pathways exist, using a different 
source of membrane. While Atg5-dependent macroautophagy might recruit its 
membrane from the ER75, a novel pathway that employs Rab9 but not Atg5, Atg7 or LC3 
might originate from the trans-Golgi network79. Another LC3b- and LC3a-positive 
autophagic pathway that is induced in Herpes Simplex Virus type-1 infected cells even 
uses the nuclear envelope80, 81. Taken together, these data indicate that 
autophagosomes can be formed by very different molecular pathways. However, 
regardless of their origin, these vesicles ultimately have to reach a lytic vacuole such as 
a late endosome or a lysosome in order to degrade their cargo. The different ways 
autophagosomes can form might reflect a finely tuned and differentially controlled 
machinery that can react to distinct stimuli and fulfill multiple functions. 
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Figure 1.5. Autophagy mechanisms and potential sources of membrane.  
Distinct mechanisms of autophagy are known. Atg5-dependent macroautophagy might receive its 
membrane from the ER, while a novel Rab9-dependent pathway might originate from the trans-
Golgi network. Another LC3b- and LC3a-positive autophagic pathway that occurs in cells infected 
with Herpes Simplex Virus type 1 uses the nuclear envelope. Several different cellular 
compartments contribute to the isolation membrane formed during macroautophagy (red) under 
different conditions, hence macroautophagy is likely not one uniform pathway. This diversity is 
further highlighted by differences in the contributing cellular machinery. Adapted from reference39. 
 
1.4.4. Selective autophagy 
 
Autophagy was traditionally regarded as a non-selective, bulk degradation process acting 
as a supplier of energy during starvation. This view has changed strongly during the last 
decade as several studies suggested that autophagy can be highly selective. The key 
element of this selectivity is the LC3-interacting motif (LIR), which targets autophagy 
receptors to LC3 (or other Atg8 family proteins) anchored in the phagophore 
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membrane66. In addition, it emerged that ubiquitin as well as ubiquitin binding proteins 
(UBPs) play a role in the regulation of selective autophagy 82. This process refers to the 
selective degradation of, for example, bacteria (xenophagy), organelles (mitophagy and 
pexophagy), ribosomes, macromolecular structures, specific proteins and protein 
aggregates (aggrephagy) by autophagy. During selective autophagy the cargo is 
recruited to the membrane of the growing phagophore by autophagy receptors that 
associate with the cargo and with lipidated Atg8/LC3-II via the LIR motif. The phagophore 
elongates and sequesters the selective cargo to form the double-membrane 
autophagosome. Fusion of the autophagosome with lysosomes (maturation) forms 
autolysosomes where the cargo is degraded66. 
Atg8 family proteins are the only UBL proteins that have been found to be conjugated to 
lipids. All Atg8 homologues impact autophagosome formation and fusion; however their 
individual role as cargo receptors is still not clear. Similarly to the UPS, ubiquitylation also 
plays a crucial role in selective autophagy. Ubiquitin can form multiple ubiquitin chain 
types that can be recognized by ubiquitin-binding domains (UBDs). p62 or sequestosome 
(SQSTM1) was identified as the first selective autophagy receptor 83-85. It was shown that 
p62 acts as both a selective autophagy substrate and a cargoreceptor for autophagic 
degradation of ubiquitylated proteins. Subsequently, the related neighbor of BRCA1 gene 
1 (NBR1) was discovered as an aggrephagy receptor86 and nuclear dot protein 52kDa 
(NDP52) was found to be a xenophagy receptor87 together with optineurin88. These 
autophagy receptors target their cargo for autophagic degradation using LIR-motif 
dependent interactions. The LIR motif has also been called Atg8-family interacting motif 
(AIM)89. 
The LIR motif of p62 was revealed by detailed deletion mapping and point mutation 
analysis together with X-ray crystallography and nuclear magnetic resonance (NMR). All 
LIR motifs contain a core consensus sequence [W/F/Y]xx[L/I/V]66. Acidic or hydroxylated 
residues (E, D, S or T), either N- or C-terminal to the conserved aromatic residue are 
also important. Interestingly, LIR-independent interaction involving Atg8 proteins also 
exist. Behrends et al. identified several LIR-independent Atg8-interacting proteins. 90. 
Importantly, most identified cargo receptors also contain UBDs such as p62, which 
contains a carboxy-terminal ubiquitin associated (UBA) domain. This suggests that cargo 
receptors function as adaptors between ubiquitylated proteins and the autophagic 
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machinery. Taken together, there are basically three types of selective autophagy those 
dependent on ubiquitin, the LIR motif or both. 
 
1.4.5. Mitophagy 
 
Selective autophagy of mitochondria, known as mitophagy, is an important mitochondrial 
quality control mechanism that eliminates damaged or superfluous mitochondria91. The 
mitochondrion plays an important role in eukaryotic cells. While this organelle provides 
critical metabolic functions in fatty acid oxidation, the citric acid cycle, and oxidative 
phosphorylation, it can also cause cell damage92. Reactive oxygen species (ROS) are 
formed as a toxic byproduct of oxidative phosphorylation93. ROS result in oxidative 
damage to mitochondrial lipids, DNA (deoxyribonucleic acid), and proteins, which makes 
mitochondria even more susceptible to ROS production. Damaged mitochondria hence 
release high levels of Ca2+ and cytochrome c to the cytosol inducing apoptosis94. 
Consequently, ensuring proper mitochondrial quality control is critical to cellular survival, 
and mitochondrial damage has been associated to diabetes, aging95, and 
neurodegenerative diseases93. Several mechanisms to eliminate dysfunctional 
mitochondria and prevent cellular damage have evolved in order to preserve a population 
of healthy mitochondria. The mitochondria’s own proteolytic system can degrade 
misfolded mitochondrial membrane proteins96. In addition to proteolytic and proteasomal 
degradation, a recent study suggests that a lysosomal pathway exists in which vesicles 
bud from mitochondria, sequester selected mitochondrial cargo and target those 
mitochondrial components for lysosomal degradation97. These mentioned pathways 
degrade only a subset of mitochondrial proteins, while during mitophagy an entire 
mitochondrion is sequestered within a double membrane vesicle, the autophagosome, 
followed by fusion with the lysosome91. 
Although mitochondrial turnover and clearance of damaged mitochondria may be the 
primary function of mitophagy, specialized forms of mitophagy exist. During erythrozyte 
maturation98 mitophagy completely degrades mitochondria and mitophagy also 
selectively removes sperm-derived mitochondria after oocyte fertilization99, 100. Although 
mitochondria can be engulfed non-selectively along with other cytosolic components 
during bulk autophagy101, mitophagy represents a selective autophagy pathways 
selectively degrading damaged or superfluous mitochondria. Depolarization of 
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mitochondria with the uncoupler carbonyl cyanide m-chlorophenylhydrazone (CCCP)102 
or photoirradiation103 causes autophagic clearance of mammalian mitochondria, while 
other organelles are unaffected.  
The selectivity of mitophagy is brought about by several factors. In yeast, the 
mitochondrial outer membrane protein Atg32104 targets the core autophagic machinery 
to mitochondria for their selective removal via binding to Atg8 through the adapter protein 
Atg1191. Atg11 and Atg32 do not have homologs in higher eukaryotes105, however 
functional homologues might exist in mammals. The ubiquitin-binding adapter 
p62(SQSTM1) for example, is enriched on damaged mitochondria and has been reported 
to target mitochondria to the autophagosome by binding to Atg8/LC3106. Nix (BNIP3L; 
BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like), a Bcl-2 related 
mitochondria outer membrane protein enables the elimination of mitochondria in 
reticulocytes by mitophagy. Nix is necessary for the sequestration of mitochondria into 
autophagosomes98, 107. Nix contains a LIR motif and might thus function as a receptor to 
recruit mitochondria to autophagosome108. Nix and another BH3-only protein BNIP3 
(BCL2/adenovirus E1B 19 kDa protein-interacting protein 3), also play a role in hypoxia 
induced mitophagy in mammalian fibroblasts108. 
Recently a pathway mediated by PTEN (phosphatase and tensin homolog)-induced 
putative protein kinase 1 (PINK1) and the E3 ubiquitin ligase Parkin has emerged as a 
paradigm for mammalian mitophagy.91. PINK1 is a serine/threonine kinase that localizes 
to mitochondria due to its mitochondrial targeting sequence109. In healthy mitochondria, 
PINK1 is imported to the inner mitochondrial membrane, cleaved by several proteases 
including the mitochondrial processing protease, the TIM (transporter inner membrane) 
complex-associated protease and the inner membrane presenilin-associated rhomboid-
like protease PARL, and finally proteolytically degraded110-112. In damaged mitochondria 
the loss of membrane potential inhibits the import of PINK1 causing the accumulation of 
intact PINK1 on the mitochondrial outer membrane, where it interacts with the TOM 
(transporter outer membrane) complex113. This functions as a sensor for mitochondrial 
damage and recruits Parkin from the cytosol to damaged mitochondria114. Parkin 
stimulates mitophagy of damaged mitochondria in several ways. Parkin, causes the 
degradation of its substrates such as Miro and Mitofusins115, 116, which results in 
mitochondrial fragmentation and arrest of motility promoting the autophagosomal 
sequestration of mitochondria. Parkin also mediates hyper-ubiquitylation of the 
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mitochondrial outer membrane, which is recognized by ubiquitin binding adapters such 
as p62, HDAC6 (Histone deacetylase 6) and unknown others. Their interaction with the 
autophagosomal protein LC3 might target damaged mitochondria to the isolation 
membrane91. Importantly, parkin-mediated mitophagy is dependent on core components 
of the autophagic machinery. InhibitingAtg3, Atg5, Atg7 and class III PI3K prevents 
degradation of CCCP treated mitochondria102. 
There are still several open questions with regard to the initiation of mitophagy and 
autophagosome formation. It also still needs to be elucidated how different stimuli initiate 
the mitophagy cascade and how distinct the mitophagy pathways induced by different 
stimuli or conditions are. The existence of multiple mitophagy pathways likely represents 
distinct control mechanisms for the regulation of fast responses to damaged 
mitochondria, constitutive turnover of mitochondria, changes to mitochondrial status with 
nutrient accessibility, and highly specialized developmental requirements91. 
 
1.4.6. Autophagy in infection and immunity 
 
Autophagy contributes to both innate and adaptive immunity against many pathogens. 
Different bacteria and viruses interact in various ways with the autophagic machinery, 
both to elicit an immune response as well as to evade it. Autophagy contributes to 
antimicrobial immunity in direct ways by the xenophagic degradation of intracellular 
pathogens as well as in indirect ways by the modulation of effector cell activation in 
adaptive immunity39. 
 
1.4.6.1. Xenophagy 
 
Probably the most direct way to fight microbial infection is by degradation of the invading 
pathogen itself. Xenophagy, an autophagic pathway that specifically targets invading 
microorganisms and facilitates their lysosomal degradation can exert this defensive 
strategy. There are various mechanisms of xenophagy and they depend mostly on the 
subcellular localization of the pathogen117. Cytosolic pathogens can be taken up by a 
phagophore similar to macroautophagy. Pathogens that are internalized via 
phagocytosis and remain inside the phagosome can be degraded once autophagic 
proteins (e.g. LC3 or Atg5) are targeted to their phagosomal membrane. These 
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components then facilitate fusion of the phagosome with lysosomes, without the 
formation of a new vesicle.118 However, the life cycle of many pathogens includes both 
vacuolar and cytosolic stages, hence these autophagic processes are not mutually 
exclusive.119 In addition to eliminating invading pathogens, xenophagy might contribute 
to the adaptive immune response by generating peptides for antigen presentation, and 
perhaps also by limiting tissue damage caused by a strong pro-inflammatory response117, 
119-121. 
In contrast to some other forms of autophagy, xenophagy is highly selective. The 
substrate specificity is achieved by at least three different mechanisms: (A) selective 
ubiquitylation of pathogens is followed by binding to an adaptor protein like 
p62/sequestosome, NDP52 or optineurin that in turn links the ubiquitylated pathogens to 
LC3 and thus the nascent xenophagic vesicle; (B) a direct interaction between 
pathogenic proteins and the autophagic machinery, as is the case for Shigella IcsA 
binding to Atg5; and (C) an interaction between the autophagic machinery and pathogens 
is mediated by pattern recognition receptor signaling, such as TLR or cytosolic pattern 
recognition receptor signalling39, 119, 120. 
 
1.4.6.2. Autophagy and antigen presentation 
 
The first indication that autophagy contributes to antigen presentation was derived from 
studies of endogenous MHC II antigen presentation (Figure 1.2)122-124. MHC II 
presentation of cytosolic neomycin phosphotransferase antigen in Epstein Barr virus 
transformed cell lines was found to be greatly reduced when autophagy was inhibited.122 
The nuclear antigen 1 of Epstein Barr virus was also degraded in the lysosome, and 
inhibition of autophagy decreased the presentation of this antigen on MHC II 
complexes123. An analysis of the MHC class II immunopeptidome in different culture 
conditions revealed that starvation-induced autophagy shifts the pool of MHC II ligands 
towards a more frequent display of intracellular peptides, including the autophagy protein 
LC3125. This enrichment for cytosolic epitopes suggests that enhancing autophagy or 
targeting of antigens to autophagosomes by LC3 could increase MHC II antigen 
presentation. In addition to macroautophagy, a recent study has shown that chaperone-
mediated autophagy can also lead to MHC class II presentation of cytosolic self 
antigens126. 
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In addition to contributing to endogenous MHC II antigen presentation, autophagy is also 
implicated in MHC II presentation of exogenous antigens (Figure 1.2). Several studies 
showed that macroautophagy or particular components of its molecular machinery 
contribute to efficient delivery of extracellular viral or bacterial antigens to lysosomes for 
their processing. Cells may capture exogenous antigens either by forming 
autophagosomes de novo or by recruiting components of the macroautophagy 
machinery directly to the phagosomal membrane127-129. TLR signaling also links the 
autophagy pathway to phagocytosis via LC3-associated phagocytosis (LAP)130. While 
the link between autophagy and antigen presentation on MHC II is well established, the 
contribution of autophagy to MHC I presentation is much less understood. Autophagy 
does contribute to MHC class I presentation of endogenous viral peptides in infected 
macrophages (Figure 1.2)80. Macroautophagy is also required for the TAP -independent 
antigen processing of another endogenous viral protein that is presented on MHC class 
I molecules131.  
The contribution of autophagy to MHC class I cross presentation is complex. One report 
showed that autophagy does not affect MHC I cross-presentation in dendritic cells129, 
whereas two other studies show enhanced cross presentation of viral and tumor antigens 
upon macroautophagy induction in antigen donor cells132, 133. The latter observations 
suggest that autophagosomes serve as effective vehicles for the delivery of exogenous 
antigens to the cross-presentation pathway in antigen donor cells. In addition, a recent 
study suggests that autophagy participates in the cross presentation of nanoparticle-
associated OVA antigen and proposed that cross presentation occurs in the 
autophagosome itself134. In addition to antigen delivery and processing, autophagy may 
also traffic MHC I complexes between the plasma membrane and intracellular 
compartments. In particular, inhibition of autophagy enhances the surface expression of 
MHC I molecules135.  
In conclusion, autophagy modulates both MHC class I and class II antigen processing 
and presentation (Figure 1.2) as well as MHC I shuttling. Furthermore, macroautophagy 
can promote antigen processing not only by directly enhancing phagosome maturation, 
but also by delivering hydrolases to the lysosome136. Thus, autophagy plays a key role 
for the regulation of a dynamic adaptive immune response against both intracellular and 
extracellular pathogens39. 
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1.4.6.3. Cross-talk between autophagy and cytokines 
 
Most of our current knowledge of the impact of cytokines on autophagy / xenophagy 
comes from studies of the macrophage response to Mycobacterium tuberculosis. 
Xenophagy aids macrophages to overcome the phagosome maturation block induced by 
mycobacteria and to clear the vacuolar pathogen137, 138. Macrophage activation with IFN-
γ promotes maturation of mycobacteria-containing phagosomes, and the IFN-γ inducible 
GTPase Irgm1 is essential for this protective response139, 140. Moreover, IFN-γ induces 
autophagy in macrophages in an Irgm1-dependent manner (Figure 1.6)137, 138. The 
mechanism by which autophagy contributes to IFN-γ-induced phagosome maturation in 
macrophages infected with M. tuberculosis is not yet fully understood and needs further 
research. 
 
Figure 1.6. Cross-talk between autophagy and cytokines.  
While cytokines such as IFN-γ, TNF-α and IL-1β promote autophagy, IL-4, IL-13 and IL-10 inhibit 
it. In turn, autophagy also antagonizes the secretion of IL-1β and IL-18 and positively regulates 
the secretion of TNF-α. From reference39. 
 
Remarkably, IFN-γ does not stimulate autophagy in all conditions. For example, IL-1β 
treatment of macrophages infected with Herpes Simplex Virus type 1 increases 
autophagy and enhances the CD8+ T cell response to a viral antigen, but IFN-γ treatment 
does not80.  
TNF-α, another major pro-inflammatory cytokine, plays an important role in the protective 
immune response to M. tuberculosis. In particular, TNF-α is central for the formation and 
maintenance of granulomas, organized structures of macrophages and highly 
differentiated cells comprised of foamy cells surrounded by a rim of lymphocytes that are 
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a hallmark of tuberculosis infection141. TNF-α stimulates autophagy in several cell types 
(Figure 1.6)142-147. In turn, autophagy arms these host cells to clear Toxoplasma gondii142, 
144.  
While pro-inflammatory cytokines such as IFN-γ and TNF-α induce autophagy, IL-4 and 
IL-13 antagonize it (Figure 1.6)148. For example, IL-13 is a potent inhibitor of starvation-
induced autophagy in HT-29 epithelial cells149, 150. In the context of infection by M. 
tuberculosis, both IL-4 and IL-13 inhibit starvation- or IFN-γ-induced autophagy, hence 
decreasing phagosome maturation and enhancing intracellular survival of the bacteria151. 
Accordingly, modulation of autophagy by cytokines and by pathogens may represent an 
important battleground in the evolutionary arms race between the host and 
mycobacteria152. 
IL-10 also inhibits rapamycin or starvation induced autophagy in murine macrophages 
(Figure 1.6)153, 154. Consequently, since IL-10, IL-4 and IL-13 are mostly secreted by 
macrophages and lymphocyte subsets, cytokine-mediated regulation of autophagy by 
leukocytes might influence the specific immune responses to infectious pathogens. 
Interestingly, autophagy can also directly control the transcription, processing and 
secretion of a number of cytokines148. IL-1β and IL-18 release is increased when 
autophagy is inhibited. It was also shown that autophagy is implicated in the regulation 
of TNF-α secretion by macrophages and dendritic cells (Figure 1.6). In particular, 
inhibition of autophagy with 3-methyl adenine causes a marked decrease of TLR-
dependent secretion of TNF-α155.  
These results illustrate an extensive crosstalk between autophagy and cytokines. A 
variety of mechanisms contribute and the degree of integration between these defense 
pathways depends on multiple factors, including specific receptors and cell types. 
Autophagy hence potentially represents a key therapeutic target for the regulation of 
immune responses and inflammation39. 
 
1.4.6.4.  Autophagy and viral infection 
 
Autophagy plays a crucial role in the host defense against viral infection, coordinating 
pathogen degradation (xenophagy), innate immune signaling and aspects of adaptive 
immunity156. To survive and spread within the host, viruses have developed a variety of 
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strategies to evade autophagy and to exploit the autophagy machinery for their own 
benefit156. During coevolution of viruses and eukaryotes, long-term mutual adaptations 
resulted in a very complex interplay between autophagy and viruses55, 157. 
Herpes simplex virus 1 (HSV1) interacts with autophagy in a complex manner and the 
interactions are discussed in more detail in chapter 1.5.8. Viral infection stimulates 
autophagy158, however the signals that induce autophagy during viral infection are still 
largely unknown. During viral infection autophagy could be induced by viral entry or 
replication, viral components, increased energy requirements, unfolded protein 
responses, and plasma membrane disturbance156. Autophagy can have several antiviral 
effects156. Virophagy can degrade cytoplasmic viral components. Virophagy is a form of 
selective autophagy believed to involve the ubiquitylation of cargo and binding of an 
adaptor protein to both ubiquitin and LC3. However, it is not clear whether virions can be 
selectively targeted for autophagy and if so, is virophagy also ubiquitin dependent156. 
Recent studies have established that Sindbis virus nucleocapsids are selectively 
recruited for autophagic degradation by mechanisms that involve interactions of the 
nucleocapsids with the well-known adaptor protein p62/SQSTM1, as well as a newly 
identified adapter protein SMAD ubiquitination regulatory factor 1 (SMURF), an E3 ligase, 
in an ubiquitin-independent way159. Autophagy may also have an antiviral effect by the 
delivery of viral nucleic acids to endosomal TLRs and hence activate innate immune 
signaling. TLRs that both recognize viral microbial-associated molecular patterns 
(MAMPs) and induce autophagy include TLR3 (polyIC/dsRNA) and TLR7 (ssRNA)160, 161. 
The delivery of cytosolic ligands to TLR-containing vesicles may also play a key role for 
innate recognition of viral pathogens as has been demonstrated for vesicular stomatitis 
virus and TLR7162. Another antiviral function of autophagy is the activation of adaptive 
immunity by presentation of endogenous viral antigens to MHC class I and MHC class II 
molecules (as outlined in more detail in section 1.4.6.2.). Finally, autophagy might be 
antiviral through the regulation of mitochondrial quality control, ROS production and the 
promotion of cell survival156, 163, hence regulating the immune response. 
Autophagy can also exert proviral roles156. Different viruses have developed various 
strategies to evade or suppress autophagy degradation and autophagy-mediated 
immune activation. These viral evasion strategies include the suppression of autophagy 
initiation, the avoidance of autophagic capture, and the inhibition of autophagosomal 
maturation163. The successful evasion of the antiviral effects of autophagy allows viruses 
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to manipulate the autophagy pathway and components of the autophagy machinery to 
facilitate their infection. Dengue virus manipulate lipid metabolism for viral replication via 
lipophagy164. Poliovirus utilize autophagy to promote non-lytic release of virions165. 
Hepatitis C virus (HCV) employ the autophagy machinery to initiate early viral genome 
replication and also to conceal viral RNA in autophagosome-like double membrane 
vesicles166, 167. Moreover, viruses can exploit autophagy related proteins. Two recent 
studies on Coxsackievirus B3168 and Hepatitis B virus (HBV)169 provide in vivo evidence 
that the  Atg5 protein can have proviral functions. Disruption of Atg5 decreases 
Coxsackievirus B3 replication in the pancreas 168 and liver specific knockout of Atg5 
reduces circulating HBV DNA.169. These in vivo studies indicate that for certain viruses 
inhibition of autophagy might have antiviral effects. However it is not clear whether the in 
vivo phenotypes of Atg5 deficiency on Coxsackievirus B and HBV infection are due to 
the inhibition of autophagy or the absence of other Atg5-dependent functions. A recent 
study also proposed that human immunity-related GTPase M (IRGM) and the mouse 
ortholog Irgm1 may be a common target of RNA viruses that evade autophagy170. In this 
study human IRGM was shown to interact with several core autophagy proteins including 
Atg5, Atg10 and LC3b as well as with several viral proteins. The precise mechanisms by 
which viral targeting of IRGM stimulates viral replication remain to be elucidated. 
In conclusion, during co-evolution with their hosts, many viruses have developed diverse 
strategies to evade and manipulate autophagy. Interestingly, even for the same virus, the 
complex interaction with autophagy can varies depending on the specific cellular 
target156. 
 
 
1.5. Characteristics of Herpes simplex virus type 1  
 
Herpes simplex virus (HSV) or Human herpes virus (HHV) is a human pathogen that 
infects orofacial mucosal surfaces (HSV1) and genital mucosal surfaces (HSV2). During 
productive infection, vesicular lesions in the mucosal epithelia are developed, followed 
by the propagation of the virus to sensory neurons and establishment of a latent infection 
persisting for the life of the host. Repeated disease at or next to the site of primary 
infection results from reactivation of dormant virus. Although the common cold sores 
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caused by HSV1 and the genital herpes lesions caused by HSV2 are not fatal conditions, 
infections of the cornea (keratitis) or central nervous system (encephalitis) can cause 
serious pathology, and infection of newborns or immunocompromised individuals can 
result in severe spread disease171, 172. 
 
1.5.1. Virion structure 
 
The International Committee on the Taxonomy of Viruses (ICTV) classified HSV1 and 
HSV2 in the genus Simplexvirus in the subfamily Alphaherpesvirinae of the family 
Herpesviridae171. HSV is a large (150-200nm diameter) enveloped virus173 with a virion 
structure typical for herpes viruses. A mature HSV particle is characterized by four 
structural elements (Figure 1.7)174: 1) a core comprising viral linear dsDNA175-177 
compactly packaged as a torus178, 2) an icosahedral capsid, 3) an intermediate phase or 
‘tegument’ and 4) an outer lipid membrane envelope decorated with viral glycoproteins 
enclosing the structure179. 
 
Figure 1.7. HSV virion structure.  
The HSV1 virion is composed of a tightly packaged viral dsDNA; an icosahedral capsid; a 
tegument layer comprising various viral proteins; and a glycoprotein-studded lipid membrane 
envelope. Adapted from reference171. 
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1.5.2. Genome organization 
 
The HSV-1 genome, sequenced in 1988, comprises a linear, double stranded DNA of 
approximately 150,000 base pairs180, 181. From this large genome the virus encodes at 
least 80 gene products171. The complex genome contains two covalently linked 
segments, called Long (L) or Short (S), according to their relative length. Each segment 
holds unique regions (UL or US) flanked by inverted repeat sequences182. There are only 
single copies of genes present in the unique regions, while genes that are encoded in 
the repeat regions, such as ICP0 or ICP4, exist in the genome in two copies. Viral genes 
(and their protein products) are generally named by their relative position from left to right 
in the UL or US region. From the long segments UL, 65 viral proteins are expressed, 
whereas 14 viral proteins are expressed form the short segments US183. Many viral 
proteins are also referred to by alternative names according to their function or 
properties, for example gB for glycoprotein B, Infected cell protein (ICP) number or Virion 
Protein (VP) number171.  
 
1.5.3. Viral life cycle 
 
Productive infection of a cell by HSV follows several key stages including entry, viral gene 
expression, viral DNA synthesis and assembly and egress of progeny virions171, 173. To 
initiate infection, HSV attaches to at least three different classes of cell-surface receptors 
and fuses its envelope with the plasma membrane. This process involves the function of 
several viral envelope proteins, including at least gB, gC, gD and the gH/gL 
heterodimer171. Following fusion, the viral nucleocapsid and tegument proteins are 
released into the cytoplasm of the host cell. The nucleocapsid and some teguments 
proteins are then transported to the nuclear pore, through which viral DNA is released 
into the nucleus. As soon as the viral DNA is in the nucleus, transcription and translation 
of the viral immediate early (IE) and early (E) genes from the viral DNA begins. In turn, 
viral DNA is synthesized, viral late (L) genes are transcribed and translated, the capsid 
is assembled within the nucleus, DNA packaged and finally progeny virions are 
released.171 
The pathway of virion egress from an infected cell is still debated. Two pathways have 
been suggested. In the re-envelopment model184, 185, enveloped virions fuse with the 
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outer nuclear membrane to release free nucleocapsids into the cytoplasm that re-
envelope by budding into the Golgi compartment and are subsequently secreted from 
the cell by vesicles. In the luminal pathway model186, enveloped virions migrate in 
vesicles from the innernuclear space to the Golgi or within the lumen of the endoplasmic 
reticulum (ER) and are released from the cell via the secretory pathway. 
 
1.5.4. Viral gene expression 
 
DNA viruses exploit the host cell in many ways to express viral proteins necessary to 
replicate and propagate. The virus requires the expression of two types of proteins, non-
structural proteins essential for viral DNA replication and structural proteins that form the 
virion and envelope for viral DNA packaging. All viral mRNAs are synthesized by host 
RNA polymerase II. Herpes viruses are characterized by a temporally regulated gene 
expression cascade187. There are 3 temporal classes of HSV gene expression: 
immediate early (α), early (β) and late (γ) genes. Nevertheless, viral gene expression 
does not take place in distinct stages, but progresses rather gradually. The first genes 
transcribed during viral infection are the immediate early (IE) genes. IE genes initiate 
transcription of early (E) genes, whose gene products perform the replication of the viral 
DNA. Viral DNA replication promotes the expression of the late genes, which encode the 
structural proteins171. IE proteins also promote the transcription of a subset of the late 
genes prior to DNA replication, called early/late, leaky late or γ1 genes. After the initiation 
of viral DNA replication171 a second subgroup of late genes, the true late or γ2 genes, is 
also transcribed. 
During the regulation of gene expression the shutdown of immediate early and early gene 
expression, which is regulated by ICP4188-191 and ICP8192-194 is a key regulatory 
mechanism. HSV also shuts down host cell RNA, DNA and protein synthesis195. HSV 
seizes these cellular components for its own protein synthesis. HSV achieves this using 
several mechanisms including the degradation of existing mRNAs196-198, by inhibiting 
RNA maturation199, 200 or by destabilizing several cellular proteins, especially those 
involved in the regulation of the host cell cycle201, 202. 
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1.5.5. Latent infection 
 
All herpes virus infections are characterized by the development of a latent infection that 
can last the lifetime of the host. In contrast to a persistent infection, where the virus 
constantly replicates, during HSV latency, viral progeny are not produced and gene 
transcription is limited. HSV latent infection is mostly localized in sensory neurons in 
ganglion tissue, either trigeminal ganglia for HSV1 or sacral ganglia for HSV2. Following 
the primary infection at an oral or genital mucosal surface, the virus migrates along the 
innervating neuronal axon to the neuronal cell body171. The virus stays in a quiescent 
state in the neuron and there is no production of lytic gene products. In the latent state, 
the HSV genome exists in the nucleus of the neuron as circular, extra-chromosomal 
DNA203, 204 and only a family of viral RNA transcripts referred to as latency-associated 
transcripts (LATs) is produced. The virus stays in latency for the life of the host, or until 
the virus is resuscitated, through specific physical stresses or exposure to ultraviolet 
radiation171, and new progeny are generated, which migrate along the neuron axis to the 
initial infection site to re-induce a lytic replication cycle205.  
 
1.5.6. Treatment of HSV infections 
 
The standard therapy for HSV infections constitutes drug treatment with acyclovir, a 
synthetic acyclic purine-nucleoside analogue172. Acyclovir is a prodrug that is processed 
only in infected cells by the viral thymidine kinase, which phosphorylates, and hence 
activates the nucleoside analogue drug, which is then incorporated into nascent DNA, 
where it causes DNA strand termination. There are also precursor drugs currently in use, 
valaciclovir (converted to acyclovir) and famciclovir (converted to penciclovir), which have 
better oral bioavailability than acyclovir and penciclovir respectively206. 
Although, prophylactic vaccination might be difficult to establish as HSV recurs in 
individuals with humoral and cell mediated immunity207, two subunit vaccines have been 
investigated for therapy and prevention. gB and gD vaccine subunits did not show any 
prophylactic or therapeutic effect208. Potential vaccines include attenuated HSV 
constructs (γ34.5 deletion) or disabled infectious single-cycle vaccines, however these 
constructs require the ability to attenuate a virus that can cause severe mortality if the 
brain is infected172. 
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1.5.7. Viral infection control- Viral evasion 
 
Although the mechanisms leading to the transition from the latency phase to viral 
reactivation are poorly understood, CD8+ T cells play a key role in maintaining viral 
latency209-212. CD4+ T cells also control the infection by promoting the development of 
cell-mediated immune response carried out by CD8+ T cells213. 
During HSV1 infection, viral proteins are degraded by the proteasome to generate 
peptides that are loaded on MHC class I molecules and presented at the cell surface to 
stimulate a CD8+ T cell response. It has been shown that the cytotoxic T cell response 
to HSV-1 infection in mice is almost entirely directed against a single gB 
immunodominant epitope corresponding to the peptide SSIEFARL214. In fact, more than 
50% of the CD8+ T cells present in infected mice are directed against this single epitope. 
The other reactive viral epitopes in mice are unknown215. A study examining the CD4+ T 
cell repertoire in HSV1 infected human patients also detected gB as the most abundantly 
presented protein, followed by gD, and ICP4216. The cellular processes responsible for 
gB immunodominance are poorly understood, however could represent an immune 
evasive strategy of the virus. Directing the immune response against a single epitope 
might result in a limited, inefficient immune response. 
The HSV1 virus has developed multiple immune evasion mechanisms. The inhibition of 
the peptide transporting molecule TAP by the viral protein ICP47 is one of the most well 
established mechanisms resulting in a strong MHC class I down regulation on the surface 
of infected cells217, 218. HSV1 can also counteract natural killer T (NKT) cell functions by 
suppression of CD1d recycling219. MHC class II presentation can also be blocked by gB, 
which replaces the invariant chain, thereby preventing binding of antigenic peptides220, 
221. In addition to inhibiting the adaptive immune response, HSV1 has developed 
mechanisms to protect itself against the humoral response by bridging the Fc part of 
antibodies, thereby blocking the antibody’s action222. HSV1 also established several 
mechanisms to counteract innate immunity such as the inhibition of the autophagic 
response to avoid degradation of virions223. HSV1 interacts in several additional ways 
with the autophagy pathway (see section 1.5.8. for more details) and it impedes the 
interferon-mediated antiviral response224-226. Improving our knowledge about these viral 
immune evasion mechanisms will help us to understand how HSV1 can persist in the 
body of the host.  
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1.5.8. HSV-1 and autophagy: a complex interplay 
 
The infected cell protein 34.5(ICP34.5), also called γ34.5227 is a neurovirulence factor 
and a potent viral autophagy evasion protein158. ICP34.5 contains a GADD homology 
domain228, 229 that binds protein phosphatase-1α (PP1α) required for eIF2α 
dephosphorylation to reverse host translational shutoff230. In addition ICP34.5 contains a 
Beclin 1 binding domain required for the inhibition of autophagy223. ICP34.5 counteracts 
autophagy by directly targeting Beclin 1 through binding to different regions of Beclin 1223. 
Additionally, ICP34.5 inhibits upstream signals that promote autophagy by reversing 
protein kinase R (PKR)-mediated eIF2α phosphorylation231. Hence, it seems that 
ICP34.5 evolved as a multifunctional virulence factor in HSV1infection. It reverses host 
cell shutoff through its PP1α binding domain to ensure viral protein synthesis, and it 
mediates autophagy evasion through inhibition of PKR signaling and directly antagonizes 
Beclin 1, which may prevent xenophagic degradation of virions or viral proteins158. 
 
1.5.8.1. Nuclear envelope derived autophagy (NEDA) 
 
It was recently described that macroautophagy can contribute to efficient processing and 
presentation of a viral antigen in murine macrophages during late, but not early stages 
of HSV-1 infection.80 Ultrastructural analyses of HSV1 infected macrophages did not only 
show macroautophagosomes, but also a novel type of autophagosomes that formed at 
the nuclear envelope and fused with lysosomes.80  
This novel form of autophagy induced during HSV-1 infection is referred to as nuclear 
envelope-derived autophagy (NEDA). Remarkably, this autophagic response triggered 
during HSV1 infection differs in many ways from macroautophagy. This process occurs 
around 6 hours after infection and leads to the formation of 4-membrane layered 
structures through coiling from the nuclear envelope where some of the viral proteins, 
such as gB, are highly abundant.80 NEDA is characterized by the accumulation of LC3a 
and LC3b around the nuclear rim. LC3a is a marker for the occurrence of NEDA as it is 
only detected during NEDA and not during macroautophagy. 
NEDA is known to depend on the viral protein ICP34.5. Using mutant viruses, it was 
shown that NEDA is regulated differently than macroautophagy as binding of Beclin 1 by 
ICP34.5 had no effect on NEDA. Instead, NEDA is stimulated in response to ICP34.5 
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binding to protein phosphatase 1α (PP1α). NEDA depends on the expression of late viral 
proteins and can be inhibited by acyclovir treatment. This suggests that NEDA might be 
a cellular stress response induced late during HSV-1 infection that compensates for the 
modulation of the macroautophagy by the virus.232 
The role of NEDA in the pathogenesis of viral infection, whether it benefits the host or the 
virus, and how this autophagic process differs from classical macroautophagy is poorly 
understood. Furthermore, the extent to which this autophagic process is involved in the 
processing and presentation of viral proteins and peptides remains to be established. 
 
 
1.6. Mass spectrometry-based proteomics 
 
The field of proteomics, or the study of the full array of proteins expressed by an 
organism, has become a fundamental tool for molecular and cellular biology. The 
proteome, in analogy to the genome, is used to describe the entire collection of proteins 
produced by an organism under a defined set of conditions. In comparison to the 
genome, the proteome is much more dynamic and complex, constantly changing in 
response to environmental alterations. A further level of complexity is introduced by the 
addition of protein post-translational modifications, e.g. phosphorylation or ubiquitylation, 
an important strategy to influence and modulate protein structure and function. Proteomic 
profiles of a particular organism, tissue or cell are affected by various environmental 
stimuli, including those provoked by infectious disease. After the discovery of protein 
ionization techniques, mass spectrometry has become an indispensable tool in protein 
analysis and a key technology for proteomics. The ability of mass spectrometry (MS) to 
identify and quantify thousands of proteins from complex samples impacts broadly on 
biology and medicine. Mass spectrometry-based proteomics has revolutionized system 
biology because of its ability to map thousands of proteins and posttranslational 
modifications (PTMs) in parallel. Systems biology is based on comprehensive data at all 
molecular levels and mass spectrometry-based proteomics has emerged as a powerful 
tool, which changed the way in which biological systems are probed.  
Numerous experimental strategies and schemes have been devised. A generic shotgun 
proteomic workflow shown in Figure 1.8 can be divided into (1) sample preparation, (2) 
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protein and peptide separation, (3) mass spectrometry, and (4) data analysis and allows 
scientists to put together modular workflows incorporating elements that fit best for a 
particular biological question233. 
 
 
 
Figure 1.8. General shotgun proteomics workflow.  
During sample preparation (1),which might include subcellular fractionations or enrichment for 
post-translational modifications, protein extracts are obtained and subsequently digested with 
trypsin to obtain peptides. Pre-fractionation at the protein or peptide level (2) such as SDS-PAGE 
(sodium dodecyl sulfate-polyacrylamide gel electrophoresis) or SCX (strong cation-exchange) 
fractionation can be introduced. Analysis with liquid chromatography (LC)-mass spectrometry 
(MS) (3) then results in large datasets of MS and tandem mass spectrometry (MS/MS) data 
containing quantitative peptide information. Bioinformatics tools (4) such as Mascot are used for 
peptide and protein identification in combination with quantitative analysis softwares to obtain 
peptide and protein profiles. 
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1.6.1. Sample preparation 
 
Proteomics can be used to examine various types of input material from prokaryote or 
eukaryote cells through entire tissues and body fluids. The first step of most sample 
preparation protocols usually comprises protein extraction from cells or tissues, which 
can be performed by cell lysis and biochemical fractionation, such as autophagosome 
isolation, or by affinity selection234. The protein content of these samples can be analyzed 
directly, or depending on the study optional subcellular enrichment, enrichment of PTMs, 
protein fractionation or affinity purification can be performed. In each condition, in 
shotgun bottom-up proteomics proteins are digested into peptides (in top down 
proteomics entire proteins are analyzed)233. 
In mass spectrometry-based proteomics trypsin is the most popular enzyme used for 
digestion of proteins into peptides234. Trypsin has several advantages for MS-based 
proteomics. Trypsin has a high cleavage specificity and cleaves peptides C-terminal to 
arginine or lysine residues. This results in the generation of peptides with a strong-
terminal charge in a mass range suitable for effective fragmentation by tandem mass 
spectrometry (MS/MS). Obtained peptides can be subsequently fractionated to increase 
the coverage of protein identifications as well as the dynamic range as outlined in more 
detail below. 
 
1.6.2. Separation of proteins and peptides 
 
The analysis of a complex protein samples involves the separation of the proteins or 
peptides in a sample followed by the identification of the resolved proteins or peptides. 
There are two main approaches, the gel-based and the gel-free approaches, each 
involving either single- or multi-dimensional separation of protein extracts. In the gel-
based approach one-dimensional sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (1D-(SDS)-PAGE) or two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) followed by mass spectrometry are the most widely used 
methods for protein separation and identification235, 236. Proteins can be separated by 1D-
PAGE according to their molecular weight (MW), while in 2D-PAGE proteins are first 
separated by their isoelectric point (pI) and by their molecular weight in a second 
dimension. Although the resolving power of 2D-PAGE is excellent, the analysis remains 
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tedious in view of the time requirement for all necessary steps including spot excision, 
protein digestion and analysis of the corresponding peptides by mass spectrometry. Also, 
dynamic range and protein solubility issues make the detection and separation of low-
abundance and hydrophobic proteins by 2D-PAGE difficult237-239. Especially, the analysis 
of integral membrane proteins remains challenging. In this context, GeLC-MS is more 
frequently used for the analysis of complex mixtures234. This technique is two-
dimensional based on a combination of 1D-PAGE, where proteins are digested in gel, 
peptides are then extracted and separated in the second dimension by Reversed Phase 
Liquid Chromatography (RPLC). This method is well established and works well with 
many samples. The relatively large amounts of starting material are sometimes 
considered a major disadvantage of this approach. The biggest advantage of the 
approach is the relative ease of use and reduction of the dynamic range of a sample 
since the proteins are concentrated in one lane and not distributed over multiple fractions 
as for shotgun approaches discussed below. 
The techniques employed for gel-free approaches are shotgun proteomics using 1D-, 
2D- or 3D-chromatography coupled online to the MS instrument. The most frequently 
used chromatographic method for protein and peptide separations is RPLC (Reversed 
Phase Liquid Chromatography). Here, the analytes are partitioned between a non-polar 
solid phase, typically made of long alkyl chains chemically bound to silica or polymeric 
particles packed into a column, and a mobile phase typically water, acid, e.g. acetic acid 
or formic acid, and a varying portion of organic solvents, such as acetonitrile or methanol. 
Using C18 bound columns for peptide separations and C3, C4 or C8 for proteins, the 
analytes are separated based on their hydrophobicity. Proteins or peptides are eluted by 
gradually increasing the amount of the organic solvent, which disrupts hydrophobic 
interactions and favors the elution of analytes based on their hydrophobicity. 
As far as LC separations are concerned there are two major tendencies. The first major 
tendency in LC separations concerns the RP chromatography system that is directly 
connected to the mass spectrometer. Long columns (more than 20cm) packed with small 
particles (3μm or less) and long gradient times (2h or more) are becoming more and 
more widespread in order to increase peak capacity240, 241. The peak capacity is a 
theoretical measure of the performance of multidimensional separations. The higher the 
peak capacity, the more peaks can be separated. The second major tendency is the 
increasing popularity of two-dimensional LC separations. One-dimensional separations 
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may lack sufficient resolving power to separate all proteins present in complex biological 
samples or cell preparations. Hence, 2D-chromatography coupled online to MS is often 
used to achieve better separation and thus improve quantitation accuracy. In this method 
two independent chromatography and orthogonal phases are commonly used in 
succession. In addition to a reversed-phase (RP) resin a strong cation-exchange (SCX) 
resin is typically used. The SCX resin typically consists of negatively charged carboxyl- 
or sulfate-groups bound to polymeric particles. Peptides are separated based on their 
charge and fractions are eluted using increasing salt concentrations. Techniques such 
as strong anion exchange chromatography (SAX)242 are also gaining popularity to boost 
the number of identified and quantified proteins in a proteome. 
A very useful technique for proteome analysis that may be specifically applied to 
membrane or organelle proteomics, is the multidimensional protein identification 
technology (MudPIT) developed by Yates and coworkers in 2001243, 244. MudPIT 
combines multidimensional liquid chromatography with electrospray ionization tandem 
mass spectrometry. The multidimensional liquid chromatography method integrates a 
reversed-phase resin, a strong cation-exchange resin and another reversed-phase resin 
in a triphasic column. The complex peptide mixture is loaded onto the system and the 
separated peptides are eluted directly off the column and into the mass spectrometer. In 
the MudPIT approach, the first RP phase guarantees the even application of the sample. 
Then peptides are systematically separated, depending on the charge in the second 
dimension (SCX) and hydrophobicity in the third (RP). MudPIT increases peptide 
separation for mass spectrometry analysis when compared to other techniques. MudPIT 
has a dynamic range of 10000 to 1 between the most abundant and least abundant 
proteins/peptides in a complex mixture and has a peak capacity of 23 000243. MudPIT is 
also well established. The increased sample complexity together with reported and 
experienced reproducibility problems can be considered major disadvantages of the 
technique. In comparison to GeLC-MS, sample consumption is reduced, which must also 
be considered advantageous. Two-dimensional LC separations are currently also often 
used ‘off-line’ rather than online. The physical separation of the two chromatographic 
steps allows more flexibility in terms of matching sample quantities and solvents systems 
between the separation dimensions245. 
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One can summarize that all sample preparation techniques come with advantages and 
disadvantages and must be considered carefully. For this PhD project, gel-based as well 
as gel-free approaches were used. 
 
1.6.3. Mass spectrometry 
 
Mass spectrometric measurements are based on the determination of the mass-to-
charge (m/z) ratio of gas phase ions. All mass spectrometers comprise three main 
components: an ionization source to create the gas-phase ions, mass analyzer(s) that 
measures the mass-to-charge ratio (m/z) of the ionized analytes, and an ion detector that 
records the impact of the individual ions. 
 
1.6.3.1. Ionization techniques – Electrospray Ionization 
 
Electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI), so 
called ‘soft ionization’ methods causing the vaporization and ionization of a sample whilst 
minimizing fragmentation, are the two techniques most frequently used for mass 
spectrometry analysis234. The minimization of fragmentation is especially important for 
labile, biological molecules, and for the study of complex mixtures, where fragments must 
not interfere with the mass spectrum when trying to define the original constituents. ESI 
enables the formation of liquid to gas phase ions and is therefore readily coupled to liquid-
chromatography-based separation tools. MALDI sublimates and ionizes the samples out 
of a dry, crystalline matrix via laser pulses. For the analysis of complex samples 
integrated liquid-chromatography ESI-MS systems (LC-MS) have emerged as the 
principal methods of choice today. Since in the current work ESI was exclusively used, 
this technique will be described in more detail below. 
Electrospray involves the dispersion of a solution into electrically charged droplets with 
subsequent gaseous ion formation. The possibility to create gas phase ions of 
macromolecules by spraying a solution from the tip of an electrically charged capillary 
was first recognized by Dole in the 1960s246. Yet, the first successful experiments using 
ESI as a true interface for mass spectrometry of large biomolecules were described by 
Fenn and co-workers only in 1986247. The efforts that lead to the development of 
electrospray ionization for the analysis of biological macromolecules were awarded with 
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the attribution of the Nobel Prize in Chemistry to John Bennett Fenn in 2002248 (shared 
with Tanaka for his discovery of MALDI249, and Wüthrich, who pioneered NMR 
techniques for biomolecules250). In ESI ions are generated at atmospheric pressure by 
passing a solution-based sample through a small, charged capillary (internal diameter < 
250 μm)251. The small capillary is at a potential difference to a counter electrode at 
voltages between +500 and 4,500 V, which depends on both the inner diameter of the 
needle and the solvents that make up the solution. Generally, higher voltages are 
necessary for capillaries with larger inner diameters and solvents with higher boiling 
points. 
Electrostatic spraying of a sample solution initially creates an aerosol of charged droplets. 
Occasionally, mainly at higher flow rates (>5 μL/min) a concentric flow of gas, such as 
N2 is employed to facilitate this nebulization process. The resulting field at the capillary 
tip results in the accumulation of either positive or negative ions on the surface of the 
emerging liquid. Accordingly, the charged droplets comprising both solvent and analyte 
molecules have a net positive or negative charge depending on the polarity of the applied 
voltage. The aerosol is at least partially generated by a process involving the formation 
of a conical meniscus by the emerging liquid at the tube exit known as a “Taylor Cone”252. 
The “Taylor Cone” is caused by the competition between the surface tension of the liquid 
and forces owing to the interaction of dipoles in the liquid with the applied field. When the 
liquid is electrically conducting, a thin jet merges from the tip of the cone. This fine jet 
breaks up into small, charged droplets, whose diameters are affected by various 
parameters such as the applied potential, the solution flow rate and the solvent 
properties. Solvent evaporation shrinks the droplet thereby bringing the surface charges 
closer together and enhancing the density of charges on the droplet surface to a critical 
value, the so-called “Rayleigh Limit”, at which the Coulombic repulsion of the surface 
charges would overcome the surface tension. As predicted theoretically already by Lord 
Rayleigh in 1882 the resulting instability leads to the disintegration of the droplets into a 
plurality of offspring droplets. 
There are two major competing theories explaining the gas phase ion formation from 
charged droplets: the charged residue model (CRM) and the ion evaporation model 
(IEM). Both models assume that sequential evaporation steps followed by droplet fission 
result in smaller and smaller droplets. In the CRM, which was originally proposed by 
Dole246, this sequence continues until the droplets become so small that each one 
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contains a single solute molecule. The naked molecule would retain some of its droplets 
charge to become a free gas ion upon solvent evaporation. The IEM, developed by 
Iribarne and Thomson253, 254, presumes that before ultimate droplets containing only one 
solute molecule are formed, the field at a droplet´s surface intensifies sufficiently to lift a 
solute ion from the droplet surface into the ambient gas. This means the surface field can 
release ions from the droplet surface. Irrespective of how the ions are formed, once 
desolvated, they make their way - directed by the electric field - in to the mass analyzer, 
where they are separated based on their mass-to-charge-ratio. 
Protonation/deprotonation is the main source of charging for biologically relevant ions in 
ESI. In the positive ion mode (application of a positive capillary potential) the produced 
protein or peptide ions are protonated on the basic sites within the molecule and ions 
with the general formula [M+nH]n+ are formed. The multiplicity of protonation is hence 
correlated to the number of basic amino acid residues in the protein or peptide structure 
resulted from charge accumulation in the droplets. The generation of multiply charged 
ions is a hallmark of ESI enabling the use of mass spectrometers with limited m/z ranges 
to analyze higher-molecular weight molecules. However, with the increase of charge 
state, the m/z becomes lower and the spacing between the isotopomers (peaks due to 
the presence of other isotopes) is reduced, thereby placing higher requirements on mass 
spectrometer resolution for proper peak separation. 
  
1.6.3.2. Tandem mass spectrometry (MS/MS) 
 
The technique of tandem mass spectrometry (MS/MS) is essential for the structural 
analysis of peptides and proteins. As the name implies MS/MS comprises two stages of 
MS. In the first stage ions of a selected m/z are isolated from the rest of the ions 
originating from the ion source. These ions, termed precursor ions are then activated, 
leading to the formation of product ions that are subsequently analyzed by the second 
MS analyzer for sequencing of the peptide. With trap instruments MSn experiments are 
possible, where n is equal to the number of stages of MS performed. 
In discovery proteomics experiments, tandem mass spectrometry (MS/MS) data are 
usually collected on peptides through automated data-dependent acquisition (DDA). With 
DDA, mass information on intact peptides in a full-scan mass spectrum (MS1) is used to 
decide which subset of peptides will be targeted for acquisition of fragmentation (MS/MS) 
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spectra necessary for sequence identification255. Usually “top ten” or “top15” methods are 
employed, where only the 10 or 15 most intense parent ions in the full scan are selected 
for fragmentation. An alternative to DDA is data independent acquisition (DIA)256. In DIA, 
MS/MS scans are collected systematically and independently of precursor information. 
 
1.6.3.2.1. Dissociation methods for MS/MS 
Ion activation is required to increase the internal energy of the precursor ion and favor its 
fragmentation. In practice, ion activation and dissociation cannot be separated, 
consequently ion activation methods are typically referred to as dissociation methods. 
The internal energy of ions can be enhanced in different ways. The dissociation method 
almost universally used across all types of mass spectrometers is collision-induced 
dissociation (CID)257, 258 also referred to as collisionally activated dissociation (CAD). 
Recently, also higher energy collisional induced dissociation (HCD)259, 260 has emerged. 
HCD provides beam type CID MS/MS with detection of fragment ions at high resolution 
in the Orbitrap mass analyzer261. In addition, there are a few other techniques that can 
be used. Electron capture dissociation (ECD)262 and Electron Transfer Dissociation 
(ETD)263 are becoming increasingly more widely available.  
In linear ion trap based CID the precursor ion collides with a neutral target gas, the so-
called collision gas, and a fraction of the kinetic energy of the precursor ion is converted 
into internal energy. The dissociation is an ergodic process, where the weakest bonds 
such as backbone amide bonds and post-translational modifications tend to be cleaved 
off. Low-energy CID (in the range of 1-100 eV) is mostly used in Q-ToF (quadrupole-
time-of-flight), LIT (linear ion trap), FT-ICR (Fourier transform ion cyclotron resonance) 
and Orbitrap instruments264. To enhance the efficiency of low-energy CID, ion activation 
is attained by multiple collisions using heavier gases (N2, Ar) and extended collision cells. 
HCD employs higher energy dissociations than in ion trap CID, enabling a wider range 
of fragmentation pathways. HCD fragmentation is available for the LTQ (linear trap 
quadrupole) Orbitrap, where ions are fragmented in a collision cell rather than an ion trap 
and then transferred back through the C-trap for analysis at high resolution in the 
Orbitrap. Compared with traditional ion trap-based CID, HCD fragmentation with Orbitrap 
detection has several advantages such as no low-mass cutoff, high resolution ion 
detection, and increased ion fragments resulting in higher quality MS/MS spectra. 
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However longer spectral acquisition times, as more ions are required for Fourier 
transform detection in the Orbitrap compared to detection of CID spectra in the ion trap 
via electron multipliers, are a downside. The use of more efficient HCD collision cells as 
in the LTQ Orbitrap Velos and Elite instruments has greatly improved the performance 
of HCD fragmentation, making rapid and routine analysis possible265. 
 
1.6.3.2.2. Nomenclature of fragment ions 
The nomenclature for fragment ions of peptides is illustrated in Figure 1.9. The 
classification of the various peptide fragments was initially proposed by Roepstorff and 
Fohlmann266 and was later modified by Biemann267. The identification of the breakage 
point of the peptide backbone and the determination of the retained charge on the N- or 
C-terminus fragment of the peptide is central to this nomenclature. 
 
 
 
Figure 1.9. Nomenclature for fragment ions.  
The type of ions produced depends on the cleavage site. Adapted from reference268. 
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The ions are referred to as a-, b-, or c-series if the charge is retained on the N-terminus 
of the fragment ion. If the C-terminus of the fragment ion is charged, the ions are called 
x-, y- and z-ion series. The position of the amino acid where fragmentation has occurred 
is designated by a subscript number, which is counted sequentially from the N- or C-
terminus, respectively269. Different activation methods result in the formation of different 
ion series. b-ions (acylium-ions) and y-ions (ammonium ions), which are shown in Figure 
1.9 are formed by low energy collision-induced dissociation typically performed in 
quadrupole ion traps, quadrupole time-of-flight, Fourier transform ion cyclotron 
resonance and Orbitrap instruments. The b-ions can dissociate into a-ions with the 
concomitant loss of CO. Electron Capture dissociation generates c- and z-ions. 
 
1.6.3.3. Mass analyzers 
The different types of mass analyzer measure the mass-to-charge ratio (m/z) of the 
ionized analytes in different ways. Five basic types of mass analyzers are currently 
employed in proteomics that use three different principles: separation on the basis of 
time-of-flight (ToF MS), separation by quadrupole electric fields (quadrupole MS) or 
separation by selective ejection of ions from a three-dimensional trapping field (ion trap, 
FT-ICR, Orbitrap MS)234. For proteomics applications the most important parameters of 
mass analyzers are the m/z limit, sensitivity, resolution, mass accuracy and the ability to 
perform tandem mass spectrometry. 
Resolution (R), which is the ability to resolve two adjacent peaks, refers to the precision 
of the measurement. Resolution is defined by the following equation: 
                                                       Resolution =
m
m
Δ
                                    Equation 1.1 
m is the m/z of the peak of interest and Δm is the peak width at a specified height (typically 
50%). Hence, the higher the value of R, the better the ability of the mass analyzer to 
separate two closely spaced m/z values.  
Mass accuracy, generally reported as parts per million (ppm), is the most important 
parameter in establishing compound identity. Mass accuracy is a measurement of the 
correlation between the observed m/z and the “true value”. It can be determined from the 
following equation: 
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                            Mass accuracy (ppm) = 1000000×−
theory
theoryobserved
m
mm               Equation 1.2 
mobserved is the m/z of the peak of interest obtained in the mass spectrum and mtheory is a 
calculated m/z expected for the species.  
The above mentioned analyzers can be stand-alone or combined in a “hybrid” mass 
spectrometer to take advantage of the strength of each. In this thesis, we have used two 
hybrid mass spectrometry instruments, the LTQ-OrbitrapXL (Thermo Scientific) and the 
more recent generation LTQ Orbitrap Elite. These instruments comprise a linear ion trap 
(LIT) and a high field Orbitrap for high resolution separation of gas phase ions. The LIT, 
the Orbitrap and the respective hybrid instruments will be described in more detail below. 
 
1.6.3.3.1. Linear quadrupole ion traps (LIT) 
The LIT is a close relative of the quadrupole mass analyzer. While a quadrupole has 
electric fields in two dimensions (x and y) and the ions move perpendicular to the field, 
the LIT has the electric field in all three dimensions. It is a quadrupole with an applied 
high potential to the front and the back sections. This generates a trapping potential with 
the ions being trapped in the center section. Ions in a quadrupole field experience 
restoring forces that drive them back toward the center of the trap. The motion of the ions 
in the field is defined by solutions to the Mathieu equation270 and a Mathieu stability 
diagram applies to the ion trap. Ions are confined radially in the center section by radio 
frequency (rf) potentials and axially by DC potentials. Ions are extracted through the ion 
exit slots in the x-rods of the quadrupole. The extraction of ions is important on the one 
hand in order to avoid space charge effects caused by too many ions in the analyzer cell 
that interact through Coulombic repulsion, and on the other hand for the isolation of 
precursor ions in tandem mass spectrometry instruments. To acquire a mass spectrum 
with an ion trap the ion trajectories must be made unstable. Mass analysis is attained by 
making ion trajectories unstable in a mass-selective manner. Different techniques for the 
extraction of ions trapped in a quadrupole field exist. The main principle is to enhance 
the oscillation amplitude of the selected ions by applying a supplemental resonance 
voltage to the trap that causes excitation of the ion with corresponding ion resonance. To 
eject an ion of selected m/z ratio from a quadrupole trap either dipole or quadrupole 
excitation can be performed. Ions of a range of m/z ratios can be ejected in different 
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ways, for example, by applying a fixed trapping rf voltage with a scanning excitation 
frequency or by applying a fixed supplemental excitation voltage and a simultaneous 
change in the main trapping rf voltage. Both options bring ions of a range of m/z into 
resonance for a successive ejection. Another way to eject ions of a range of m/z from a 
quadrupole trap is a frequency scan, using multiple frequencies or a broadband 
waveform. In the case of a broadband waveform all frequencies except for the resonant 
frequency of the ion to be isolated are present and thus all other ions are ejected from 
the trap. This ejection method needs less time and hence increases the duty cycle of the 
instrument. The duty cycle refers to the time the detector in fact is measuring ions. It can 
be determined in this way: (ion detection time/total scan time) x 100%.271 The mass 
accuracy of ion traps is hundreds of ppm. The sensitivity, throughput and ease of use of 
the LIT, combined with its relatively low cost has led to the widespread use of the LIT in 
mass spectrometry labs. 
 
1.6.3.3.2. Orbitrap Mass Analyzer 
An Orbitrap mass analyzer is the most recent addition to the set of tools that can be used 
for the identification, characterization and quantitation of components in biological 
systems. The proof of principle of the Orbitrap was first described by Makarov272 and 
Hardman and Makarov first described the injection of electrosprayed ions into the 
Orbitrap273. With its capacity to deliver low-ppm mass accuracy and extremely high 
resolving power similar to those achievable with FT-ICR instrumentation, all within a time 
scale compatible with nano-LC separations, the Orbitrap has become an instrument of 
choice for many proteomics applications since its commercial introduction in 2005. 
The Orbitrap consists of an inner (central) and an outer electrode that are used to trap 
ions in a quadrologarithmic electrostatic potential272, 273. The electrostatic attraction 
towards the central electrode is compensated by a centrifugal force arising from the initial 
tangential velocity of the ions. Ions revolve about the central electrode and oscillate 
harmonically along its axis (the z-direction) with a frequency characteristic of their m/z 
values. The axial component of these oscillations is independent of initial energy, angles 
and positions. The oscillations of the moving ions induce an image current that is 
detected via a differential amplifier between the two halves of an electrode encapsulating 
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the Orbitrap. The m/z of different ions in the Orbitrap can be determined from respective 
frequencies of oscillation after a Fourier transformation. 
The Orbitrap operates very efficiently as a high resolving accurate mass detector. The 
literature supports claims of routine mass measurements of less than 2 pm for the 
analysis of complex peptide mixtures274 and even intact proteins275. The maximum 
resolving power of the classical Orbitrap is just over 100,000 (referenced to m/z 400)276. 
 
1.6.3.3.3. LTQ Orbitrap 
Fig. 1.10 shows a hybrid LTQ Orbitrap. It comprises three main parts: an LTQ linear ion 
trap mass spectrometer, a C-trap and an Orbitrap mass analyzer. The ions from the 
electrospray ion source are first transmitted via rf-only multipoles into the first section 
after the source in a LTQ Orbitrap, the linear ion trap, which is very fast and capable of 
multiple levels of fragmentation usually referred to as MSn. MS and MSn spectra are 
detected at very high sensitivity but relatively low resolution and mass accuracy. Ions 
stored in the linear ion trap can be released via an rf-only octapole into a C-shaped RF-
only quadrupole, the so-called C-trap. In the C-trap, ions are accumulated and their 
energy is reduced by residual nitrogen gas. Controlling the number of ions transmitted to 
the C-trap, and then injected into the Orbitrap helps to reduce space charge effects, 
which can decrease mass resolution and accuracy through non-ideal behavior of the ions 
in the Orbitrap electrostatic fields. From the C-trap the accumulated ions are filled into 
the Orbitrap by a pulse and their signal is detected in the Orbitrap. On their way from C-
trap, ions pass through three stages of differential pumping until they reach the ultrahigh 
vacuum compartment of the Orbitrap maintained at ≈ 2 x 10-10 mbar274. 
The acquisition of MS/MS spectra in the linear ion trap and a high resolution/mass 
accuracy spectrum of the precursor in the Orbitrap can be done in parallel or series. 
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Figure 1.10. Schematics of the LTQ Orbitrap XL and Orbitrap Elite hybrid mass 
spectrometers. 
(A).The LTQ Orbitrap XL consists of a LTQ linear ion trap mass spectrometer, a C-trap and an 
Orbitrap mass analyzer. (B) The Orbitrap Elite contains novel elements such as a dual pressure 
LIT and a compact high-field Orbitrap analyzer. ETD fragmentation is optional. Adapted from 
Thermo Scientific (http://planetorbitrap.com). 
 
1.6.3.3.4. Obitrap Elite 
The Thermo Scientific Orbitrap Elite mass spectrometer, introduced in 2011 and depicted 
in Figure 1.10, combines a dual-pressure linear ion trap (Velos Pro) with a novel high-
field Orbitrap mass analyzer277. The Orbitrap Elite is characterized with enhanced 
sensitivity and faster scan speed. This was achieved by improvements in several areas. 
A novel dual-pressure linear ion trap278 makes it possible to separate capture and 
fragmentation processes from the mass scanning and detection process with an MS 
acquisition speed to>12 scan/s. A combination of C-trap and HCD collision cell with an 
applied axial field enhances extraction of fragment ions and trapping capacities leading 
to faster MS/MS scans. The injection times required to acquire high resolution, high mass 
accuracy MS/MS spectra are similar to those previously needed for ion trap 
fragmentation (“high-low” mode), making routine proteomics analysis in a “high-high” 
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mode, where not only MS spectra, but also fragmentation spectra have high mass 
accuracy278 possible. Additionally, a more robust ion transfer interface was introduced. 
Most importantly, by employing a compact, high-field Orbitrap analyzer with reduced trap 
dimensions, the resolving power of the Orbitrap analyzer has been increased two fold for 
the same transient length. In addition, enhanced Fourier Transform algorithm, which 
incorporates phase information, increases the resolving power to 240,000 at m/z 400277. 
Enhanced proteome coverage of complex samples can be achieved due to the higher 
resolution and quality of spectra, as well as the faster scan speed. The availability of 
multiple fragmentation techniques (CID, HCD and optional ETD) offers new opportunities 
to approach demanding research objectives277. 
Recently, there have been more additions to the Orbitrap family of hybrid/tribrid 
instruments. The Thermo Scientific Q Exactive hybrid quadrupole-Orbitrap mass 
spectrometer, introduced in 2011 combines quadrupole precursor selection with high-
resolution, accurate-mass Orbitrap detection279. The Thermo Scientific Orbitrap Fusion 
Tribrid mass spectrometer, the newest addition, introduced in 2013, is a combination of 
quadrupole, Orbitrap, and ion trap mass analysis in a Tribrid architecture that delivers 
unparalleled analysis capabilities280. 
In the setup used in this thesis, a precursor scan was performed with the Orbitrap 
followed by the recording of MS/MS spectra in the linear ion trap on LTQ Orbitrap XL or 
Orbitrap Elite instruments respectively. The instruments were operated in data 
dependent acquisition mode using CID as fragmentation. 
 
1.6.4. Quantification in mass spectrometry-based proteomics 
 
Quantification plays a key role in MS-based proteomics. Proteomics can define the 
absolute amount of each protein in a mixture or their relative abundance between 
conditions. Absolute quantification can provide the copy number of proteins in a cell using 
the AQUA (absolute quantification) method, where an isotopically labeled peptide is 
synthesized and spiked in known amounts to the sample to absolutely quantify its 
endogenous counterpart281. 
There are two main approaches used for relative quantitation in proteomics –label-free 
or stable-isotope based methods (Figure 1.11). 
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Figure 1.11. Overview of quantitative proteomics workflows.  
In label-free quantification workflows unlabeled samples are individually analyzed and quantitation 
is performed based on spectral counting or MS1 based approaches (depicted). Metabolic labeling 
is characterized by the isotopic labeling of proteins in vivo (indicated by blue - light and red - 
heavy), after which the samples are combined and processed for quantitative analysis. With 
isobaric tags, protein extraction is performed prior to labeling. Isobaric tags yield peptide fragment 
ion spectra through LC-MS/MS analysis generated in MS1 and the cleaved tag spectra generated 
in MS2, which are used for peptide identification and relative quantitation. Adapted from Thermo 
Scientific (http://www.piercenet.com/method/quantitative-proteomics). 
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1.6.4.1. Stable-isotope based methods 
 
Stable-isotope labeling for peptide and protein quantification is based on the principally 
identical physicochemical properties of labeled and natural peptides. Hence, relative and 
absolute quantification of a sample of interest can be performed by comparing its MS 
intensity with that of a labeled peptide standard present in the same sample245. Stable-
isotope labeling can be performed based on metabolic or chemical labeling. 
 
1.6.4.1.1. Metabolic labeling 
In metabolic labeling strategies, cells are cultured in defined isotope media (Figure 1.11). 
The isotope label is introduced into every protein during cell growth and division, which 
creates labeled standards for every protein in a sample of interest. The introduction of 
the isotope label at the earliest possible step in a proteomic workflow, results in both high 
quantification accuracy and high precision as systematic errors arising from sample 
handling can be eliminated. Stable isotope labeling with amino acids in cell culture 
(SILAC), introduced more than a decade ago, is the method of choice in mammalian 
systems 282. In the classical SILAC experiment, arginine and lysine are provided in light 
and heavy forms (isotopically labelled with 13C and 15N) to two cell populations and are 
incorporated into each protein after several cell doublings. The MS intensities of the 
isotope clusters of the labeled and unlabeled peptides are compared for relative 
quantification. The combination of several conditions is possible, however a maximum of 
three samples is typically compared. A drawback of multiplexing SILAC-labeled samples 
is the likelihood of overlapping isotope clusters, complicating proper quantification245. The 
use of SILAC has recently been extended to entire organisms and even to human tissue. 
In the super SILAC approach, unlabeled tissues from patients or an animal model system 
are compared to a representative mix of different heavy-labeled SILAC cell lines used as 
a common internal standard283.  
 
1.6.4.1.2. Chemical protein and peptide labeling 
Popular implementations of chemical derivatization for quantification are tandem mass 
tags (TMT-tags)284 and iTRAQ (isobaric tags for absolute and relative quantification)285, 
286, both of which chemically derivatize primary amines of the peptides. Differential 
labelling with these reagents generates peptides with identical mass (isobaric), which 
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can be distinguished following fragmentation by the isotope encoded reporter ions in the 
lower mass range region of MS/MS spectra. The intensities of the reporter ions are used 
for the quantification (Figure 1.11). Isobaric labeling has several advantages for the 
multiplexed analysis of different biological samples. TMT reagents, for example, are now 
available in up to 10 different versions, allowing for the comparison of 10 conditions in a 
single experiment. Furthermore, the peptides labeled with isobaric tags co-elute during 
LC separations resulting in no increase of the complexity. Even more the complexity of 
peptide mass spectra is not increased because differentially labelled peptides are 
isobaric245.  
An alternative for the chemical labeling of protein digests is stable-isotope dimethyl 
labeling287, 288. Here, primary amines of peptides are labeled by formaldehyde through 
reductive amination using cyanoborohydride. Different combinations of reagent 
isotopomers result in many possible label combinations with distinct mass shifts. 
Generally, duplex and triplex reactions, which introduce mass differences of a minimum 
of 4 Da are used to avoid overlapping isotope envelopes. Dimethyl labeling has several 
advantages. It is inexpensive and it can be performed in solution or directly in reversed 
phase chromatography columns which avoids sample loss. One limitation is the use of 
deuterium as part of the labels which can lead to small retention time shifts of labeled 
peptides during LC-MS/MS analysis. 
 
1.6.4.2. Label-free quantitation 
 
Label-free quantitative proteomics aims at the quantification of peptides and proteins 
without the use of stable-isotope labels. Label-free quantitation is a rapidly growing area 
in proteomics and it can be roughly divided into spectrum count approaches or MS1-
intensity-based approaches. 
 
1.6.4.2.1. Spectral count based approaches 
Spectral counting is a simple quantification method in which the number of peptide 
fragmentation events is used as a proxy for the protein amount. Spectrum count 
approaches are based on the observation that the number of peptide-to-spectrum 
matches (PSMs; spectrum count), the number of identified distinct peptides, and the 
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protein sequence coverage in an LC-MS/MS experiment correlate with protein 
abundance245. Filtering of PSMs for protein quantification is important as it has been 
demonstrated that considering only high-confidence PSMs allows for the detection of 
smaller abundance changes with statistical significance compared to the application of 
less stringent criteria289. However, including low-scoring PSMs results in a higher 
dynamic range and more accurate quantification of low-abundance proteins289, 290. In 
label free studies samples are analyzed separately by LC-MS/MS. Consequently stable 
and reproducible mass spectrometry analysis has to be guaranteed and is generally best 
achieved by the analysis of all samples in a single sequence in the same instrument245. 
 
1.6.4.2.2. MS1 intensity based approaches 
Intensity-based label-free quantification uses the MS signal response of peptides for 
quantification (Figure 1.11). In bottom-up proteomics this can either be achieved using 
the peak height intensity values or by integrating the area under the curve (AUC) of the 
peptide peak245. Classically, full scan survey spectra are used to obtain extracted ion 
chromatograms (XICs). A robust LC-MS/MS setup is required for accurate quantification. 
Narrow LC peak widths yield better signal-to-noise ratios, hence extending the dynamic 
range of quantification245. In cases where peptides were not identified in all conditions, 
XICs are mapped by the alignment of accurate mass and retention time. Retention time 
stability and reproducibility are thus key in label-free quantitative proteomics.  
When large datasets need to compared the number of conditions that can be compared 
using label-free approaches is not predefined and intensity-based or spectral count 
based relative quantification is hence particularly attractive.  
 
1.6.5. Bioinformatics and data analysis 
 
Proteomic studies generate a lot of data. The analysis and interpretation of the vast 
volumes of proteomics data still remains demanding. Hence, the development of 
transparent tools for proteomic data analysis using statistical principles is a fundamental 
challenge291. A key breakthrough was the development of algorithms for protein 
identification from mass spectrometric data. Peptides matching to the spectra are 
identified. Proteins are inferred from the identified peptides. Nowadays MS/MS data of 
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individual peptides are commonly used. MS/MS data provides information about the 
peptide sequence and important additional structural information in addition to the 
peptide mass. Thus, database searching with tandem mass spectrometry data is more 
specific and discriminating. 
For protein identifications, spectra acquired by MS/MS are scanned against 
comprehensive protein sequence databases e.g. NCBI292 or Uniprot293 using one of 
various algorithms. There are three main approaches234. In the “peptide sequence tag” 
approach a short, unambiguous amino acid sequence from the peak pattern is extracted 
and combined with the mass information. Together, this represents a specific probe to 
define the origin of the peptide294. The cross-correlation method utilizes theoretical 
constructed mass spectra corresponding to peptide sequences from the database under 
certain fragmentation conditions. The best match is established by the overlap or “cross-
correlation” of these predicted spectra with the measured mass spectra295. In the third 
approach, “probability based matching”, which is implemented in the Mascot search 
engine296, 297, calculated fragments from peptide sequences in the database are 
compared to observed experimental peaks starting with the most intense ions in the 
spectra in order to find the best matching peptide. From this comparison an identification 
score is calculated: 
                                                 Identification Score )log(10 P−=                      Equation 1.3 
P represents the probability that the number of fragment matches is a random event. The 
identification score reveals the statistical significance of the match between the 
experimental spectrum and the sequences in a database. All these approaches produce 
a compilation of the identified peptides into a protein “hit list”. 
Database search engines like Mascot297 or SEQUEST295 are known to generate a 
significant number of incorrect peptide assignments298, because protein hits might just 
be randomly assigned hits. These data analyses limitations can be significantly 
decreased by adopting statistical models for validation of peptide assignments291. Usually 
target decoy database search strategies are used to discriminate correct from incorrect 
peptide assignments299 as implemented in the proteoconnections software300 used in this 
study. This allows filtering of large-scale proteomics data sets with predictable sensitivity 
and False Discovery Rates (FDR). Determining the False Discovery Rate (FDR) is an 
important statistical parameter employed in proteomics analysis to estimate error rates 
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of protein or peptide identifications. In addition, a false-positive rate (FPR) exists, which 
is widely used (and sometimes confused with FDR) in the proteomics community as well 
and it is important to note the difference between the FPR and the FDR as it applies to 
protein identifications. Figure 1.12 shows the analytical outcome of a proteomics 
experiment. The search engine, for example Mascot, returns protein hits, which can be 
true protein identifications present in the analyzed sample, so-called True Positives (TP) 
or they can be just random hits, which are not true protein identifications, namely False 
Positives (FP). Besides this, there are protein identifications, which are true proteins in 
the analyzed sample, but which are not returned as a protein hit in the output of the 
search engine, so-called False Negatives (FN). Those proteins that are not returned by 
the search engine and also are not present, are called True Negatives (TN). Ideally, a 
proteomics experiment should only result in TP. In reality, FP are regularly detected and 
cannot necessarily be discriminated from TP based on their scores alone. 
 
 
Figure 1.12. Analytical outcome of a proteomics experiment.  
TP – True Positives, FP – False Positives, FN – False Negatives, TN – True Negatives. From 
reference268. 
 
False Discovery Rate and False Positive Rate are defined in Equations 1.4 and 1.5. 
                                                     
TPFP
FPFDR
+
=                                            Equation 1.4 
                                                    
TNFP
FPFPR
+
=                                             Equation 1.5 
The FDR is the rate of random protein assignments to true protein assignments, whereas 
the FPR is the fraction of proteins not present in the analyzed sample that appear in the 
final protein list. In a proteomics experiment the FDR is required to be around 1-2% 
percent. 
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Quantitative proteomics involves additional data extraction and processing. Intensity-
based label-free quantification procedures typically require mass calibration, noise and 
data reduction steps, followed by feature detection and generation of peptide elution 
profiles or peptide maps. In turn, peptide features from different LC-MS/MS experiments 
are aligned in the time and mass dimensions, and intensities are normalized. Finally, 
relative quantification is achieved by clustering the intensities of the individual peptide 
features across all experiments in the dataset245. For this purpose in this study our in 
house developed label-free quantitation software ‘Proteoprofile’, which quantified 
peptides and proteins based on the peptide ion peak heights was used. There are also 
public, free tools available including OpenMS301, Census302, and Superhirn303. For stable 
isotope based labelling MaxQuant304 is the most established software and it is especially 
optimized for SILAC-based quantitation.  
Finally, it is important to integrate the proteomics dataset with several bioinformatics tools 
such as Gene ontology305 term enrichment analysis, pathway analysis306 or protein 
interaction307 network analysis data in a biologically meaningful way, so that hypotheses 
about specific biological phenomenon can be generated and ultimately tested.  
 
1.6.6. Proteomics of post-translational modifications 
 
Mass spectrometry is the tool of choice for the analysis of posttranslational modifications 
(PTMs) such as phosphorylation or ubiquitylation, because it can discover them, it can 
locate the PTM with single amino acid resolution and it can be much more specific and 
quantitative than antibody based methods. The main challenge in PTM analysis is the 
low abundance of modified peptides. 
Phosphopeptides, for example, are very low abundant in protein digests and can display 
a wide dynamic range of site occupancy on proteins. Consequently, enrichment 
techniques to increase the relative proportion of phosphopeptides from protein digests 
are necessary to perform large-scale phosphoproteomics experiments by MS.308. 
Several approaches have been developed to increase selectivity including LC 
fractionation, such as hydrophilic interaction or ion exchange chromatography309-311. The 
most popular enrichment methodologies for phosphopeptide enrichment are immobilized 
metal affinity chromatography (IMAC) with Fe3+312, 313 and metal oxide affinity 
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chromatography with TiO2 beads314. Nevertheless, various complementary approaches 
have also been established, including phosphotyrosine immunoaffinity purification315. 
Several biological pathways are known to be regulated by ubiquitylation, however the 
large-scale identification of ubiquitylated proteins is still challenging. Similarly to 
phosphoproteomics experiments, the low occupancy of ubiquitylation makes the 
detection of endogenously modified proteins by MS very difficult. However, the chemical 
properties of the isopeptide bond, formed between the C-terminal glycine in ubiquitin and 
the ε-amino group of lysine residues in substrates, provide a possibility for the specific 
detection of ubiquitylated targets by MS. Tryptic digestion of ubiquitin conjugates yields 
characteristic “diGly remnants” due to cleavage of the C-terminal Arg-Gly-Gly sequence 
of ubiquitin. To globally characterize the ubiquitinome, enrichment strategies have been 
developed based on affinity capture of the diGly remnant by diGly specific antibodies316. 
The inhibition of the proteasome is also commonly used to increase the number of 
ubiquitylated substrates in the cell and thus increase the chance of their detection by MS. 
 
1.6.7. Contribution of proteomics to the understanding of HSV-1 infection 
 
MS-based proteomics has contributed to the understanding of HSV1-host interactions. 
Previous proteomics analysis focused mostly on the analysis of the HSV1 protein 
interactome or on differential quantitative proteomics to analyze virally induced changes 
in the host cellular proteome317. Several immediate early viral-protein interactomes have 
been characterized. Interaction partner and host-viral complexes have been 
characterized using immunoaffinity purification procedures for viral proteins ICP27318, 
ICP8319, ICP4320, UL46321. A few studies also characterized the composition of purified 
mature and immature extracellular and perinuclear virions by proteomics322-324. 
Proteomics studies focused on the elucidation of host proteome modifications during 
early stages of HVS-1infection. Using subcellular proteomics important insights on the 
mechanisms altered in the host during HSV1 infection were obtained. Ribosomes 
extracted from mock or HSV1 infected HeLa cells were compared325, cytosolic and 
microsomal proteomes at different early time points during infection in HuH7 cells were 
compared326 as well as the host cells nuclear proteome alterations were investigated in 
HSV1 infected HuH7 cells327. Recently, a global secretome characterization of HSV-
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infected human primary macrophages by proteomics was described328. In addition to 
subcellular studies, Antrobus et al. recently analyzed whole cell extracts from mock- and 
HSV-1-infected HEp-2 cells in the first global comparative analysis of HSV-1 infected 
cells and provided an important insight into host cell proteome changes during the early 
stages of HSV-1 infection329. 
However, until now all proteomics studies investigated early, but not late time points of 
HSV1 infection. In addition, the intracellular HSV1 proteome has not yet been 
characterized, and it would be crucial to investigate the temporal expression profiles of 
HSV1 proteins in the host cell. Furthermore, no large scale study was yet performed to 
investigate PTMs on HSV1 proteins. Obtaining a distribution of HSV1 phosphorylation, 
ubiquitylation or glycosylation sites would provide an important resource for HSV1 
biology. 
 
1.6.8. Characterization of autophagy by quantitative proteomics  
 
A few recent studies used MS-based proteomics to investigate global proteome changes 
during autophagy330. SILAC-based quantification was used to determine the relative 
abundance of proteins in mammalian cells during amino acid starvation, and their kinetic 
profiles suggested an ordered degradation of cellular components during starvation-
induced autophagy331. A few protein-protein interaction studies using proteomics in 
context of autophagy were also described. In a recent landmark study, Behrends et al. 
used affinity purification MS to obtain a human autophagy protein interaction network of 
409 proteins and 751 interactions90. Quantitative proteomics was also applied to 
elucidate the regulation of early signaling events upon autophagy and to characterize the 
temporal phosphorylation dynamics after starvation and rapamycin treatment. A 
comprehensive distribution of phosphorylation kinetics within the first 30 min upon 
induction of autophagy was obtained with both treatments affecting widely different 
cellular processes332. 
However, proteomics analyses of the autophagosome proteome composition are scarce. 
Only four previous studies described the use of MS to identify autophagosomal 
proteins333-336. In a first report, autophagosomes were analyzed using a 2-D gel approach 
and MALDI-TOF-MS, and identified relatively few proteins (39 enriched proteins), most 
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of which were associated to metabolic processing336. The conclusions from this study 
were limited by the fact that autophagosomes were isolated by density gradient 
centrifugation337, an approach where organelles are only partially separated from each 
other based on their intrinsic density. In a second report, autophagosomes were purified 
using antibodies against GFP (green fluorescence protein)-tagged LC3 in combination 
with magnetic beads333 and 101 proteins were identified, most of which have unknown 
functions in autophagy. Similar approaches based on density gradient centrifugation 
were used in 2 more recent large-scale mass spectrometry studies334, 335. Dengjel et al. 
used density gradient centrifugation relying on protein correlation profiling in combination 
with LC3-GFP pulldown assays to identify more than 700 putative autophagosome 
associated proteins from human breast cancer cells334. The most recent study from 
Mancias et al. identified a cohort of novel and known autophagosome enriched proteins 
in human cells, including cargo receptors335. They used a density gradient centrifugation 
based approach combined to high stringency filtering for abundance in the total proteome 
to remove proteins that were unspecifically captured during bulk autophagy. The overlap 
between all four autophagosomal proteomes is alarmingly low335, raising questions about 
the co-purification of contaminants or unselective capture during cytosolic bulk 
degradation.  
Accordingly, thorough characterization of the autophagosome proteome and how it is 
modulated under different conditions is still awaiting the development of efficient 
protocols for the isolation of these organelles. 
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1.7. Research objectives 
 
My research project focuses on the definition of the molecular mechanisms governing 
the involvement of autophagy in innate and adaptive immunity using novel quantitative 
proteomics methods together with functional assays as part of an integrated research 
program. Accordingly, this thesis was centered on the following objectives: 
1) Determine the role and specificity of cytokines such as TNF-α in the activation of 
macrophages using quantitative proteomics 
2) Identify the distribution of HSV1 proteins and their post-translational modifications 
following macrophage infection. 
3) Develop an efficient cell fractionation method to characterize the composition of 
autophagic vesicles such as autophagolysosomes. 
4) Determine the global changes in the viral proteome during host infection by HSV1 to 
identify proteins that are differentially abundant in total cell lysate and 
autophagolysosome extracts. 
TNF-α is one of the major proinflammatory cytokines that mediate local and systemic 
responses and direct the development of adaptive immunity. Based on these 
consideration, the first study of my PhD project was motivated by the objectives to 
perform the first comprehensive characterization of pathways and molecular 
mechanisms involved in the activation of macrophages by TNF-α in order to identify novel 
and alternative pathways induced by TNF-α stimulation as well as their functional role. 
To investigate the molecular mechanisms of TNF-α we profiled the changes in 
abundance in resting and activated RAW264.7 mouse macrophages using label-free 
quantitative proteomics. Importantly, we also integrated our proteomics dataset with 
several functional validation steps including flow cytometry, immunofluorescence 
microcopy as well as novel antigen presentation assays to perform a comprehensive 
characterization of TNF-α activated macrophages. 
Viral infection also regulates autophagy. Recently, our lab provided the first evidence that 
autophagy can contribute to the presentation of viral proteins on MHC class I molecules 
during Herpes Simplex Virus type 1 (HSV1) infection80. HSV1 are among the most 
complex and prevalent human viruses. While the composition of viral particles has been 
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investigated, less is known about the expression of the whole viral proteome in infected 
cells and no comprehensive analysis of viral protein expression kinetics in an infected 
cells have been performed to date. In order to obtain meaningful insights on how viral 
infection modulates autophagy, we first needed to comprehensively characterize the 
system. Using our well established high sensitivity mass spectrometry workflow, we 
analyzed the proteome of the prototypical HSV1 in infected macrophages by LC-MS/MS. 
In addition to protein expression levels, post translational modifications such 
ubiquitylation and phosphorylation modulate HSV1 protein function, subcellular 
localization or stability. Consequently, this study also aimed to obtain ubiquitylation and 
phosphorylation patterns for HSV1 proteins during infection of macrophages with the 
overall goal to generate a map of protein expression profiles as well as phosphorylation 
and ubiquitylation sites as an important resources for HSV1 biology. 
Remarkably, the autophagic response triggered during HSV1 infection differs in many 
ways from macroautophagy. This process, referred to as nuclear envelope-derived 
autophagy (NEDA), leads to the formation of 4-membrane layered structures originating 
from the nuclear envelope80. The discovery of this novel autophagy pathway was very 
exciting, but it also opened up several questions that we needed to address with regard 
to the protein content of NEDA-autophagosomes as well as their implication for antigen 
presentation. The characterization of the autophagosomal proteome in HSV1 infected 
cells is crucial to our understanding of the involvement of autophagy in antigen 
presentation. However, to date no efficient autophagosome isolation method that can be 
interfaced to MS-based proteomics has been established. My PhD project was thus 
motivated by the development of a new isolation method to obtain enriched 
autophagosome extracts during HSV1 infection of macrophages that could subsequently 
be analyzed by quantitative proteomics. The developed method allowed us to monitor 
the transfer of HSV1 antigens into autophagosomes using our well-established 
quantitative proteomics workflow. Furthermore, in-house developed novel antigen 
presentation assays allowed us to shed some light on the functional consequences of 
antigen relocalization on antigen presentation. 
In conclusion, the application of quantitative proteomics methods in a systems biology 
approach allowed us to identify changes occurring during the remodeling of 
autophagosomes in response to disease and inflammatory conditions such as viral 
infections.  
63 
 
1.8. Thesis overview 
 
The first chapter presents a literature review of the current knowledge on macrophage 
biology, autophagy and its role in innate and adaptive immunity as well as HSV1 infection. 
An overview of state-of-the-art techniques used in mass spectrometry-based proteomics 
is also given. Furthermore, the current knowledge was put into perspective with regard 
to the research project investigated in this thesis. 
The second chapter presents my first article describing the use of label-free quantitative 
proteomics to profile the dynamic changes of proteins from resting and TNF-α activated 
mouse macrophages published in Molecular and Cellular Proteomics338. These 
analyses revealed that TNF-α activation of macrophages led to the downregulation of 
mitochondrial proteins and the differential regulation of several proteins involved in 
vesicle trafficking and immune response. Importantly, we found that the downregulation 
of mitochondria proteins occured through mitophagy and was specific to TNF-α. 
Furthermore, using a novel antigen presentation system, we observed that the induction 
of mitophagy by TNF-α enabled the processing and presentation of mitochondrial 
antigens at the cell surface by MHC class I molecules. 
The third chapter presents the analysis of the proteome of the prototypical HSV1 in 
infected macrophages by mass spectrometry published as my second article in Journal 
of Proteome Research339. Using a high sensitivity LTQ-Orbitrap, we achieved a very 
high level of protein coverage and identified a total of 67 structural and non-structural 
viral proteins. We also identified 90 novel phosphorylation sites and ten novel 
ubiquitylation sites on different viral proteins. Treatment with inhibitors of DNA replication 
induced changes of both viral protein abundance and modifications, highlighting the 
interdependence of viral proteins during the life cycle. Given the importance of 
expression dynamics, ubiquitylation and phosphorylation for protein function, these 
findings will serve as important tools for future studies on herpes virus biology. 
The fourth chapter presents the investigation of the contribution of NEDA to antigen 
presentation. Our results indicate that NEDA is an Atg5-independent autophagic process 
distinct from macroautophagy. Using a novel antigen presentation assay, we could show 
that NEDA improves presentation of viral antigens to CD8+ T cells. Detailed proteomics 
characterization of autophagosomes formed during NEDA and macroautophagy 
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revealed the interesting finding that various autophagic pathways can be induced to 
promote the capture of selective sets of viral proteins, thus actively shaping the nature of 
the immune response during infection. This work is currently in preparation for 
submission to Immunity.  
Finally, the fifth chapter presents a discussion of the results obtained in this study as well 
as a conclusion that links all the work and findings of this thesis. Potential future 
perspectives and implications of the findings of this thesis are also discussed. 
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role of TNF-α in macrophage activation and expanded our understanding of the 
mechanisms responsible for the modification of the MHC class I peptide repertoire 
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2.2. Summary 
 
Macrophages play an important role in innate and adaptive immunity as professional 
phagocytes capable of internalizing and degrading pathogens to derive antigens for 
presentation to T cells. They also produce pro-inflammatory cytokines such as tumor 
necrosis factor alpha (TNF-α) that mediate local and systemic responses and direct the 
development of adaptive immunity. The present work describes the use of label-free 
quantitative proteomics to profile the dynamic changes of proteins from resting and TNF-
α activated mouse macrophages. These analyses revealed that TNF-α activation of 
macrophages led to the downregulation of mitochondrial proteins and the differential 
regulation of several proteins involved in vesicle trafficking and immune response. 
Importantly, we found that the downregulation of mitochondria proteins occured through 
mitophagy and was specific to TNF-α, since other cytokines such as IL-1β and IFN-γ had 
no effect on mitochondria degradation. Furthermore, using a novel antigen presentation 
system, we observed that the induction of mitophagy by TNF-α enabled the processing 
and presentation of mitochondrial antigens at the cell surface by MHC class I molecules.  
These findings highlight an unsuspected role of TNF-α in mitophagy and expanded our 
understanding of the mechanisms responsible for MHC presentation of self-antigens. 
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2.3. Introduction 
 
Macrophages are professional phagocytes that internalize large particles like dead cells 
or microorganisms, and play important roles in immunity, inflammation and tissue repair 
1. In mammals, the internalization of microorganisms at sites of infection by macrophages 
proceeds via a sequential chain of events that leads to sequestration of pathogens in 
phagosomes where they are killed and degraded by hydrolytic enzymes. The functional 
properties of phagosomes appeared relatively recently in the evolution of multicellular 
organisms through the acquisition of molecular machineries that transformed 
phagosomes from a lytic vacuole into an organelle fully competent for antigen 
presentation 2. Indeed, the processing of proteins from internalized microorganisms to 
derive antigens for presentation at the cell surface on major histocompatibility complex 
(MHC) class I and class II molecules is a key mechanism of adaptive immunity 3.   
 
Macrophages are immune effector cells that mediate defence of the host against a variety 
of bacteria, viruses, and other microorganisms. Classical activation of macrophages 
involves Toll-like receptor (TLR) ligands (e.g. lipopolysaccharides, LPS) and pro-
inflammatory cytokines such as interferon-γ (IFN-γ) produced by natural killer (NK) cells 
or activated T-helper 1 (TH1) lymphocytes 4, 5. IFN-γ activation results in the transcriptional 
regulation of hundreds of genes including nitric oxide synthase-2 and phagocyte oxidase 
that are associated with the production of reactive oxygen species (ROS), and provide 
enhanced killing abilities to macrophages 6. This cytokine also mediates phagosome 
maturation and antigen loading on MHC class I and class II molecules 7-11. Alternate 
activation of macrophages by interleukin 4 (IL-4) and IL-13 cytokines produced by TH2 
cells have also been proposed to account for allergic, cellular and humoral responses to 
parasitic and extracellular pathogens 12. These cytokines can promote the development 
of wound-healing macrophages, though this activation result in poor antigen-presenting 
cells that are less efficient at producing ROS or at killing intra cellular pathogens than 
classically activated macrophages 13. 
 
Classically activated macrophages can also secrete pro-inflammatory cytokines such as 
IL-1, IL-6 and IL-23 that can lead to the expansion of TH17 cells associated with 
autoimmune responses 14. Interestingly, macrophages activated in a MyD88-dependent 
manner through TLR ligand stimulation produce tumor necrosis factor α (TNF-α), another 
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important cytokine that synergizes with INF-γ to enhance macrophage activation. 
Exogenous stimulation of macrophages by TNF-α can also arise from the secretion of 
this cytokine by antigen presenting cells (APC). The significance of TNF-α in mounting 
an appropriate immune response is of particular importance in Leishmania infections as 
macrophages stimulated with INF-γ alone are less efficient to clear this parasite due to 
lack of TLR ligands expression. TNF-α is playing an important role in inflammatory cell 
activation and recruitment, and is associated with the development of many chronic 
inflammatory diseases such as rheumatoid arthritis 15 and Crohn’s disease 16 
 
Relatively few studies have investigated the molecular mechanisms and signaling 
associated with the activation of macrophages by TNF-α. Previous reports using TAP 
purification and mass spectrometry have provided a physical and functional map of the 
human TNF-α pathway 17. Stable isotope labeling by amino acids in cell culture (SILAC) 
was previously used to identify changes in the phosphoproteome of HeLa cells in 
response to TNF-α 18, and to determine the dynamic profiles of TNF-α-induced nuclei-
associated proteins in HEK293 cells 19. More recently, label-free quantitative proteomics 
was used to identify secreted proteins from human adipose tissue-derived mesenchymal 
stem cells during inflammation 20 and Choi et al. utilized a bio-orthogonal non-canonical 
amino acid tagging (BONCAT) in combination with proteomics and isobaric tags (iTRAQ) 
to identify newly synthesized proteins induced by TNF-α and IL-1β in human monocytic 
THP-1 cells 21.  
 
To investigate the molecular mechanisms of TNF-α, we profiled the changes in protein 
abundance in resting and activated RAW264.7 mouse macrophages using label-free 
quantitative proteomics.  We evaluated three independent separation protocols enabling 
the fractionation of intact proteins (GELFREE and macroporous RP) and peptides (SCX) 
prior to the analysis of the corresponding tryptic digests by LC-MS/MS on a LTQ-Orbitrap 
mass spectrometer to obtain a comprehensive view of the macrophage proteome 
Importantly, quantitative proteomics analyses of TNF-α activated macrophages 
highlighted the down regulation of several mitochondria proteins. This observation was 
also correlated by flow cytometry, biochemical assays and immunofluorescence 
microscopy experiments, and indicated that TNF-α impaired mitochondria functions in 
activated macrophages. The Atg5 dependent degradation of mitochondria and the 
100    
 
presentation of mitochondrial antigens by MHC class I molecules suggest that TNF-α 
macrophage stimulation led to mitophagy and contribute to the modification of the MHC 
class I peptide repertoire.  
 
 
 
  
101 
 
2.4. Experimental Procedures 
 
2.4.1. Cell lines 
 
Raw264.7 macrophage cell lines and RAW-Kb-Mito gB30-694 cell lines were grown in 
DMEM containing 10% FBS supplemented with glutamine and penicillin/streptomycin. 
MEF wildtype and Atg5-/- cells were grown in DMEM containing 10% FBS supplemented 
with glutamine and penicillin/streptomycin. The lacZ-inducible gB HSV-specific CD8+ T 
cell hybridoma HSV-2.3.2E2 was maintained in RPMI-1640 medium supplemented with 
5% fetal bovine serum, 2 mM glutamine, 100 units/ml penicillin, and 100 μg/ml 
streptomycin. 
 
2.4.2. Raw-Kb construction 
 
cDNA was prepared from purified mRNA extracted (Macherey-Nagel, Nucleospin RNA 
II) from the BMA3.1A7 cell line (haplotype H-2Kb). cDNA of H-2Kb was amplified by PCR 
using the primers GTGAATTCGCCACCATGGTACCGTG and 
GATCTCGAGTCACGCTAGAGAATG and the 1125 bp PCR product was cloned into the 
pUB6/V5-His A vector (Invitrogen) using the EcoRI and XhoI restriction sites. This 
plasmid was then transfected into RAW264.7 cells and stably transfected cells were 
selected using Blasticidin 3 µg/ml added 24 h after transfection, for a period of one week. 
Resistant cells were scraped and surface labelled with anti H-2Kb mouse antibody PE 
(BD Biosciences) using conditions that preserved cell integrity. Cells exhibiting the 
highest levels of fluorescence were sorted into 96-well plates (one cell per well) (BD 
FACS Vantage cell sorter) and amplified in culture for 2 weeks. Cell surface expression 
levels of H-2Kb in each clone were then tested by surface labelling (see above) followed 
by flow cytometry analysis and the clone showing the highest fluorescence levels was 
selected, amplified and used in the subsequent experiments (supplemental Fig. 2.S1). 
 
2.4.3. pIRES-gB30-694-Mito vector 
 
The sequence coding for amino acids 30 to 694 of HSV-1 gB (gB30-694) was cloned from 
purified HSV-1 DNA (strain F) kindly provided by Johanne Duron (Université de Montréal) 
using the primers GTAACTAGTGCTCCGACTTCCCCCG and 
GTAGATATCCTTGATCTCGTGGCGGGTGTA containing respectively the restriction 
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sites SpeI and EcoRV. gB30-694 lacked both the signal peptide and the transmembrane 
domain of the viral gB, but included the sequence gB498-505 coding for the H-2Kb restricted 
SSIEFARL peptide.  
gB30-694 was cloned in pIRES2-EGFP-Mito kindly provided by Claude Perreault 
(Université de Montréal). The resulting vector displays the backbone of pIRES2-EGFP 
including, in the MCS, a cassette containing the mitochondrial matrix-targeting sequence 
(from human cytochrome c oxidase, MSVLTPLLLRGLTGSARRLPVPRAKIHSL) followed 
by gB30-694.  
 
2.4.4. RAW-Kb-Mito gB30-694 cell line 
 
The pIRES-gB30-694-Mito vector was transfected in RAW-Kb cells. Stably transfected cells 
were selected by addition of G418 at 0,5 mg/ml in the culture medium 24 h after 
transfection. After 8 days, cells displaying high GFP levels were sorted in 96-well plates 
(one cell per well, BD FACS Vantage cell sorter). After 2 weeks of culture, expression 
and proper processing of the endogenous fusion protein in the different clones were 
tested in presentation assays. Each clone was co-cultured with gB HSV-specific CD8+ T 
cell hybridoma HSV-2.3.2E2 overnight, and the level of activation of the gB-specific 
hybridoma was tested as described below. The clone displaying the highest presentation 
levels of the gB SSIEFARL epitope was amplified and used in subsequent experiments. 
 
2.4.5. Crude membrane preparation 
 
Control cells or cells stimulated with TNF-α (10 ng/ml) for 24h were lysed in HB buffer 
(8.5% sucrose, 3 mM imidazole, protease and phosphatase inhibitors, pH 7.4). The cell 
homogenate was centrifuged at 3000 rpm (4ºC) for 5 min to remove the nuclei. The crude 
membrane extract was isolated by ultracentrifugation at 50000G at 4ºC for 30 min and 
the pellet was resuspended in 8 M urea, 10 mM ammonium bicarbonate, 1mM TCEP. 
 
2.4.6. Protein and peptide fractionation 
 
Three different methods were used to separate proteins or peptides prior to LC-MS/MS 
analyses. First, membrane proteins (200 μg/replicate; 6 M urea, 1% acetic acid) were 
separated on Macroporous Reversed-Phase C18-chromatography (mRP-C18) using an 
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Agilent 1200 LC system (Agilent Technologies). The LC column was maintained at 80 °C 
and chromatographic separations were achieved using a multi-segment elution gradient, 
with eluent A (0.1% trifluoroacetic acid, TFA in water, v/v) and eluent B (0.1% TFA in 
acetonitrile, ACN v/v). The gradient conditions consisted of two steps with increasing 
concentration of the eluent B (3-80% B 6-49 min; 80-100% B 49-59 min) followed by a 
re-equilibration at B: 3% for 15.0 min. The flow rate was maintained at 0.75 mL/min, and 
a total of 12 fractions were collected. 
The second method used a gel-eluted liquid fraction entrapment electrophoresis 
(GELFREE) 8100 system (Protein Discovery) that enabled the separations of membrane 
proteins (200 μg/replicate in Laemmli buffer) into 12 fractions across the mass range 30-
150kDa. SDS was removed from fractions by buffer exchange to 8M urea using Ultracel 
– 10 Multiscreen filterplates (Millipore) before proteolytic digestion.  
Third, membrane protein extracts (200 μg/replicate) were digested with trypsin 
(sequencing grade, Promega) and the resulting peptides were separated on a strong 
cation exchange (SCX) column (Polysulfoethyl A, PolyLC Inc.). Chromatographic 
separations were achieved on an Agilent 1200 LC system using a multi-segment elution 
gradient with 10 mM Ammonium formate, 25% ACN, pH 3.1 (buffer A) and 500 mM 
ammonium formate, 25 % ACN, pH 6.7 (buffer B). The gradient conditions consisted of 
two steps with increasing concentrations of the eluent B (0-65% B 10-65 min; 65-100% 
B 65-71 min) followed by a re-equilibration at B: 0% for 15.0 min. The flow rate was 
maintained at 0.3 mL/min, and a total of 12 fractions were collected. 
 
2.4.7. Proteolytic digestion 
 
Proteins fractionated by mRP or GELFREE were digested by Lys-C and trypsin as 
follows. Lyophilized protein samples (10-20 μg) were resolubillized in 40 μl of 8 M urea, 
50 mM ammonium bicarbonate and reduced by incubation with 3 mM TCEP (Thermo 
Scientific) for 20 min at room temperature (RT). Reduced cysteines were alkylated with 
10 mM chloroacetamide (Sigma) and incubated for 15 min at RT in the dark.  Samples 
were diluted to a final concentration of 2 M urea with 50 mM ammonium bicarbonate, 1 
mM CaCl2 and digested with 0.5 μg of trypsin overnight at 37 ºC. The digestion was 
subsequently quenched by adding formic acid to a final concentration of 5%.  
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2.4.8. Mass spectrometry 
 
Peptides were separated on a 150 µm ID, 10 cm reversed phase nano-LC column 
(Jupiter C18, 3 μm, 300 Å, Phenomex) with a loading buffer of 0.2% formic acid (FA). 
Peptide elution was achieved using a linear gradient of 5-40% ACN in 90 min on an 
Eksigent 2D-nanoLC (Dublin, CA) with a flow-rate of 600 nL/min. The nano-LC was 
coupled to an LTQ-Orbitrap XL mass spectrometer (Thermo-Electron, Bremen, 
Germany) and samples were injected in an interleaved manner. The mass spectrometer 
was operated in a data-dependent acquisition mode with a 1 sec full range mass scan at 
60,000 resolution, followed by five product ion scans (MS/MS) of the most abundant 
precursors above a threshold of 10,000 counts. CID was performed in the LTQ at 35% 
collision energy and an Activation Q of 0.25. 
 
2.4.9. Protein identification and quantitative analysis 
 
The centroided MS/MS data were merged into single peak-list files for each of the three 
fractionation platforms used (Distiller, V2.4.2.0) and searched with the Mascot search 
engine v2.3.01  (Matrix Science) against a concatenated forward and reversed mouse 
IPI database (IPI mouse rel. 3.54) containing 55 987 forward protein sequences. Mascot 
was searched with a parent ion tolerance of 10 ppm and a fragment ion mass tolerance 
of 0.5 Da.  Carbamidomethylation of cysteine, oxidation of methionione, deamidation, 
phosphorylation of serine, threonine and tyrosine residues and ubiquitination of lysine 
residues (GlyGly) were specified as variable modifications. The confidence in 
ubiquitination site assignments was determined using a probability score function based 
on the method of Olsen et al. 22 integrated in the proteoconnections platform. 23. The false 
discovery rate (FDR), was calculated as the percentage of positive hits in the decoy 
database versus the target database, and a FDR of 2% was considered for both proteins 
and peptides. Protein identification are reported only for those assigned with a minimum 
of 2 peptides per protein.  
Label-free quantitative proteomics was used to profile protein abundance across sample 
sets, as reported previously 8, 24. Briefly, Mascot peptide identifications were matched to 
ion intensity (MS peak intensity, minimum threshold: 8000 counts) extracted from the 
aligned MS raw data files (tolerances set to m/z: 15 ppm and RT: 1 minute). For each 
LC-MS run, we normalized peptide ratios so that the median of their logarithms was zero, 
105 
 
to account for unequal protein amounts across conditions and replicates. Intensities were 
summed across fractions for peptides of identical sequences, and protein ratios were 
calculated as the median of all peptide ratios, while minimizing the effect of outliers. Only 
proteins defined by two or more peptide quantification events were considered. Relative 
standard deviation was below 58% for 95% of the detected proteins. Proteins with a 2-
fold variation and a p-value below 0.1 were considered differentially regulated.  
 
2.4.10. Bioinformatics analysis 
 
Transmembrane proteins were predicted using TMHMM 2.0.25 Gene Ontology 
annotations for cellular component, biological process and molecular function were 
obtained from the Gene Ontology project using the DAVID Bioinformatics resources 
(http://david.abcc.ncifcrf.gov/)26, 27. To identify cellular components or biological 
processes that were statistically over represented in our protein list, we used the binomial 
statistics tool to compare classifications of multiple clusters of lists to a reference list (Mus 
musculus total proteome). Only terms that were significantly enriched/depleted with a p-
value <0.05 were used for the analysis. A global protein-protein interaction network was 
generated using Cytoscape Version 2.8.0 28 by submitting all MS-identified proteins to 
the Cytoscape plugin Bisogenet Version 1.41 29 By using the gene names of MS-
identified proteins, this plugin allowed us to query simultaneously 6 human protein-
protein interaction databases: Biogrid, Intact, Mint, Dip, Bind and HPRD, in order to 
generate a global interactome that contains neighbours of MS-identified proteins up to a 
distance of 1. Subnetworks were created by manually annotating the MS-identified 
proteins with the Uniprot database 30 and by functionally clustering the proteins of the 
global protein-protein interaction network.   
 
2.4.11. Western Blot 
 
Protein samples were separated by 4-12% SDS-PAGE (Invitrogen) and transferred onto 
nitrocellulose membrane (Pall Corporation, USA). Proteins of interest were detected 
using a rabbit polyclonal anti-cPLA2 (cytosolic phospholipase A2) antibody (Cell 
Signaling) or a mouse monoclonal anti-GAPDH (Glyceraldehyde 3-phosphate 
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dehydrogenase) antibody (Millipore), followed by a secondary antibody coupled to 
horseradish peroxidase (Millipore) for ECL detection (GE Healthcare). 
 
2.4.12. Flow Cytometry Analysis 
 
JC-1 Mitochondrial Membrane Potential Assay Kit (Cayman Chemical Company, Ann 
Arbor, MI) was used to quantify the amount of mitochondria in control and TNF-α 
stimulated cells (24h) by flow cytometry on a FACSCalibur flow cytometer (BD 
Biosciences). RAW 267.4 macrophages or mouse embryonic fibroblasts (MEF) were 
incubated with the JC-1 dye for 30 minutes. Cells were harvested and analyzed 
immediately after.  Healthy, functional mitochondria with a high potential contained red 
JC-1 J-aggregates that were quantified in the FL2 channel (Excitation: 520-570 nm: 
Emission: 570-610 nm). Apoptotic, unhealthy mitochondria with low potential contained 
mainly green JC-1 monomers detectable in the FL1 channel (Excitation: 485 nm: 
Emission: 535 nm). Mitochondria were quantified using relative fluorescence intensities 
on a gated population of a uniform cell population. Autophagy was blocked using 3-
methyl adenine, 3-MA (10 mM, Sigma-Aldrich) for the last 3 h of the TNF-α stimulation. 
Lysosensor (Invitrogen) was used to quantify the acidity of lysosomes by flow cytometry 
on a FACSCalibur flow cytometer (BD Biosciences). RAW 267.4 macrophages were 
incubated with lysosensor. Cells were harvested and analyzed immediately after. The 
acidification of lysosomes was quantified using relative fluorescence intensities on a 
gated population of a uniform cell population. 
 
2.4.13. Immunofluorescence 
 
Cells were fixed and permeabilized according to the manufacturer's indications 
(Cytofix/Cytoperm Kit, BD). Mitochondria were labelled using a Tim23 or Tom20 
antibodies (BD Biosciences), and we used antibodies against LC3 (Abgen) and gB 
(Santa Cruz) to label autophagosomes  or gB glycoprotein, respectively. Antibodies were 
revealed using IgG Alexa-488- and 568-coupled secondary antibodies (Invitrogen). 
Samples were analyzed using a confocal laser scanning microscope (Zeiss LSM510) 
with a 63x objective.  
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2.4.14. Electron microscopy  
 
For morphological analyses, cells were fixed overnight at 4°C, in 2.5% glutaraldehyde 
(Canemco) in 0,1M Na Cacodylate (Canemco) buffer, followed by a post-fixation in 1% 
osmium tetroxyde (Canemco) in 0,1M Na Cacodylate buffer for 1 hour at 4C. Contrast of 
cell membranes was enhanced by uranyl acetate (Mecalab) treatment. Cells were 
dehydrated in ethanol, followed by 1:1 mixture of ethanol/Epon, embedded in Epon, and 
then polymerized at 60˚C for 3 days. Sections were examined on a Phillips CM 100 
Transmission Electron Microscope. 
 
2.4.15. Antigen presentation Assay 
 
RAW-Kb-Mito gB30-694 cells   (75 x 104 cells) treated with TNF-α (10 ng/mL) for 24h and 
3-MA (10mM, Sigma Aldrich), Rapamycin (10 μg/ml, Calbiochem) or CCCP (carbonyl 
cyanide m-chlorophenyl hydrazone; 20 μM; Sigma Aldrich) for 3h  were fixed for 10 min 
at 23 °C with 1% (w/vol) paraformadehyde, followed by three washes in complete DMEM.  
Antigen presentation assays were performed as described previously 31. Briefly, antigen-
presenting cells were cultured for 12 h at 37°C together with 4 x 105 HSV-2.3.2E2 cells 
(β-galactosidase–inducible, gB-specific CD8+ T cell hybridoma) for analysis of the 
activation of T cells.  Cells were then lysed (0.125 M Tris base, 0.01 M cyclohexane 
diaminotetraacetic acid, 50% glycerol (v:v), 0.025% (v:v) Triton X-100 and 0.003 M 
dithiothreitol, pH 7.8). A β-galactosidase substrate buffer (0.001 M MgSO4 x 7 H2O, 0.01 
M KCl, 0.39 M NaH2PO4 x H2O, 0.6 M Na2HPO4 x 7 H2O, 100 mM 2-mercaptoethanol 
and 0.15 mM chlorophenol red β-D-galactopyranoside, pH 7.8) was added for 2–4 h at 
37 °C.  Cleavage of the chromogenic substrate chlorophenol red- β-D-galactopyranoside 
was quantified in a Gemini plate reader (Molecular Devices) at 595 nm. The data and 
error bars are shown as means of three replicate experiments with their respective 
relative standard deviation.  
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2.5. Results 
 
To obtain a full repertoire of proteins associated with TNF-α activated macrophages we 
isolated crude membrane extracts from post-nuclear supernatant of mouse macrophage 
RAW264.7 cells using ultra-centrifugation, and monitored the fractionation efficiency 
using immunoblots for several cellular markers (supplemental Fig. 2.S2). This cell 
fractionation afforded protein extracts of reduced sample complexity while 
simultaneously enriching for potentially interesting organellar and vesicular proteins. 
Preliminary proteomics analyses of crude membrane extracts (200 μg aliquots each) 
were performed using three independent separation platforms namely mRP-C18, 
GELFREE, and SCX fractionation to obtain a comprehensive identification of the 
corresponding samples. While the first two platforms separated intact proteins, SCX 
enabled efficient separation of peptides following tryptic digestion of the crude membrane 
extract. In each case, three biological replicates were separated into 12 fractions. 
Fractionated proteins (mRP-C18, GELFREE) were digested by trypsin, and fractions 
from all three separation platforms were analyzed on a LTQ-Orbitrap mass spectrometer. 
We compared the distribution of quantifiable peptides detected in one, two, or three 
replicates using label-free quantitative proteomics (supplemental Fig 2.S3), and 
observed that mRP-C18 provided the highest number of reproducibly detected peptides 
in all replicates (91 %) compared to SCX (88%) and GELFREE (47%). The reproducibility 
of protein fractionation across biological replicates and the enhanced sequence coverage 
observed for mRP-C18 compared to the other two platforms provided significant 
advantages for quantitative proteomics. Supplemental Fig 2.S4 shows the overlap in 
protein identification and sequence coverage obtained for each platform, and the list of 
protein and peptide identifications are provided as supplemental Tables II-S1 and II-S2, 
respectively. Phosphopeptide identifications obtained from these analyses are provided 
as supplemental Fig. 2.S5. These experiments indicated that mRP-C18 enabled more 
accurate measurements of peptide abundance compared to the other two platforms 
examined, and was selected in subsequent quantitative proteomics experiments. The 
experimental workflow used in the present study is summarized in Figure 2.1.  
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Figure 2.1. Workflow for large-scale quantitative proteomics analyses of RAW264.7 
macrophages.  
Crude membrane extracts were obtained from resting or TNF-α stimulated (24h) macrophages 
by ultracentrifugation. Protein extracts (n=3) were fractionated by macroporous reversed phase 
followed by tryptic digestion. Peptides were analysed by LC-MS/MS on a LTQ-Orbitrap XL mass 
spectrometer. Label-free quantitative proteomics was used to correlate changes in protein 
abundances across control and TNF-α activated macrophage extracts. GO terms enrichment and 
protein network were obtained from identified proteins. The proteomics dataset was validated 
functionally by several biochemical assays. 
 
2.5.1. Quantitative proteomics of TNF-α activated macrophages 
 
Label-free quantitative proteomics experiments were performed on mRP-C18 fractions 
to identify differentially regulated proteins upon TNF-α stimulation of macrophages. The 
database search enabled the identification of 13808 peptides and 1516 proteins with a 
2% FDR (see Experimental Procedures). We identified 1373 proteins with at least two or 
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more unique peptides with quantifiable abundance measurements (supplemental Table 
II-S3). Scatter plots of abundance measurements for peptide ions identified in either 
control or TNF-α stimulated extracts indicated that 95 % of all ions showed RSD values 
less than 58 % across all three biological replicates, attesting of the reproducibility of the 
method (supplemental Fig. 2.S6). The consistency of fold change measurements is also 
shown in supplemental Fig. 2.S7 for citrate synthase and ATP synthase subunit b, each 
identified with 9 peptides. The distribution of fold-change vs. p-values is represented in 
the volcano plot of Fig. 2.2.  
 
Figure 2.2. Large Scale membrane proteome analysis of resting and TNF-α activated 
macrophages.  
Volcano plot representation of protein abundance changes upon TNF-α activation. A total of 189 
differentially regulated proteins with fold change ≥ 2 and p-values < 0.1 were identified upon TNF-
α stimulation. 
 
Based on the reproducibility of abundance measurements, we used a fold change of ≥ 2 
and p-values ≤ 0.1 to define differential regulation across biological replicates. Peptides 
assigned to the same protein were regrouped together to determine the overall fold-
change of abundance upon TNF-α stimulation. Out of 1373 proteins, we identified 174 
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and 15 proteins that were down- and up-regulated upon TNF-α stimulation, respectively. 
Several proteins previously reported to be modulated by TNF-α included TNF receptor-
associated protein 1 (TRAP1) and cytosolic phospholipase A2 (cPLA2) (Table II-1). The 
overexpression of cPLA2 upon TNF-α stimulation was validated by immunoblots (Fig. 
2.3A) and confirmed the abundance measurement obtained by mass spectrometry (Figs. 
2.3B, 2.3C).   
Table II-1. Changes in abundance of selected macrophage membrane proteins upon TNF-α 
stimulation.  
 Expression 
log2(TNF-α/control) 
Sequence 
Coverage 
Known TNF-α modulated proteins  
Cytosolic phospholipase A2  1.2 9% 
Keratin 17  1.4 11% 
TNFR-associated protein 1 (HSP75)  -1.3 43% 
Mitochondrial proteins  
Enoyl-CoA hydratase    -1.9 31% 
Mitochondrial 2-oxoglutarate/malate 
carrier  
 -2.1 40% 
Trifunctional enzyme subunit alpha  -1.1 37% 
Mitochondrial import receptor subunit 
TOM22 homolog 
 -1.3 47% 
Cytoskeleton proteins  
Actin cytoplasmic 1  -1.1            75% 
Tubulin alpha-4A chain  -1.3 52% 
Vesicle trafficking and lysosome  
Cathepsin Z  1.2 9% 
Vesicle trafficking protein SEC22b    -1.6 32% 
Translocon-associated protein subunit 
beta (Ssr2) 
 1.1 5% 
Sorting nexin-1  -1.1 18% 
Lysosome-associated membrane 
glycoprotein 1 (LAMP1) 
 -1.3 13% 
Immune response  
Osteopontin  1.1 15% 
H-2 class I histocompatibility antigen  
K-D alpha chain 
 -1.1 29% 
Protein degradation  
Proteasome activator complex 
subunit 1 
 -1.0 26% 
Ubiquitin carrier protein  -1.2 26% 
Autophagy related proteins   
HSP90 α 
HSP90 β 
 -1.4 
 -1.3 
49% 
53% 
14-3-3 protein epsilon  -1.7 60% 
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Figure 2.3. Quantitative proteomics analysis of membrane proteins in TNF-α stimulated 
macrophages identified the overexpression of cPLA2. (A) Immunoblot showing the increased 
abundance of cPLA2 upon TNF-α stimulation. (B) Extracted ion chromatogram of m/z 597.82+ 
corresponding to the peptide DAIVESIEYR from cPLA2 in control (dashed black) and TNF-α 
activated macrophage extracts (black). (C) MS/MS spectrum of m/z 597.82+ confirming the peptide 
identification. 
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Our quantitative proteomics analyses also revealed the differential regulation of several 
proteins involved in lysosomal degradation (e.g. Cathepsin Z) and vesicle trafficking (e.g. 
Sec22b, Sorting nexin1). Previous studies have indicated a role for TNF-α in stimulating 
autophagy in different cell types though the exact mechanism is presently unknown 32-34. 
Interestingly, we observed that 37 mitochondrial proteins, accounting for 21 % of all down 
regulated proteins, were modulated by TNF-α. An example is shown in supplemental Fig. 
2.S7 for citrate synthase, an acetyl-CoA dependent mitochondrial enzyme involved in the 
conversion of oxaloacetate into citrate. We obtained a sequence coverage of 33 % and 
all corresponding peptides showed a consistent decrease in abundance following 
activation of macrophages with TNF-α. Interestingly, we also noted that a number of 
mitochondrial proteins such as DNA topoisomerase 1 mitochondrial and ATP-dependent 
Clp protease ATP-binding subunit clpX-like mitochondrial were ubiquitinated in response 
to TNF-α (Supplemental Table II-S4, supplemental Fig. 2.S8). This result is consistent 
with a recent report indicating the activation of the ubiquitin-proteasome system in 
mitophagy 35  
 
2.5.2. Protein interaction network analysis of TNF-α activated macrophages 
uncovers the regulation of mitochondrial proteins  
 
To obtain additional functional insights into proteins and pathways that are differentially 
regulated in macrophages, we conducted bioinformatics analyses of our proteomics data 
sets. First, we grouped differentially abundant proteins according to their GO terms 
compared to those of the mouse reference proteome. GO-terms were considered 
significant when they had p-values <0.05 in a Fisher exact test, resulting in 168 significant 
terms. Protein groups were then sorted according to Cellular Component, Biological 
Processes and Molecular Function GO categories (Fig. 2.4A).  
Upregulated proteins comprised GO terms associated with cytoskeleton and structural 
molecule activity. Interestingly, we also observed the enrichment for hydrolase activity 
and cellular nitrogen metabolic processes. Proteins that did not show any significant 
change in abundance upon TNF-α activation were enriched in mostly basal processes 
and non redundant pathways (data not shown). Downregulated proteins were mostly 
associated to vesicles and mitochondrial functions. Interestingly, proteins located at the 
mitochondrial inner membrane showed a more pronounced enrichment than those 
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located at the mitochondrial outer membrane, suggesting that specific subsets of proteins 
are downregulated upon TNF-α stimulation. More specifically, we noted that proteins 
implicated in energy generation or cellular respiration were represented in the subset of 
downregulated proteins. Taken together these analyses suggest that TNF-α activation 
resulted in extensive cytoskeleton remodeling and vesicular trafficking, and contributed 
to the downregulation of mitochondrial proteins involved in metabolism and in energy 
generation. 
Next, we used the protein expression data to develop a protein interaction network using 
Cytoscape. The combination of interactions found in mouse and their human orthologs 
resulted in a network of 7439 proteins (nodes) and 80449 connections (edges). From this 
complex network we extracted sub-networks using Uniprot annotations. We identified 
several groups of membrane proteins modulated by TNF-α , including subnetworks 
comprising proteins involved in TNF-α signalling, vesicular trafficking, immune response, 
ROS and mitochondria, and mitophagy and autophagy (Fig. 2.4B). This network 
highlights the perturbation of different mitochondria functions in response to TNF-α 
activation of macrophages. However, not all mitochondrial proteins were affected equally 
by TNF-α. Several mitochondrial proteins involved in ROS were downregulated upon 
TNF-α activation, while mitochondrial ribosomes were unaffected. This interaction 
network further underscores the modulation of different Rab and effector proteins 
involved in the control of membrane trafficking such as Rab5, Rab10 and Rab11 together 
with the downregulation of several proteins participating in SNAREs fusion including 
AnxA7, Vti1b, Vapb and Vat1. Importantly, we also identified subnetworks related to 
immune response (e.g. proteasome, antigen processing) and autophagy that were 
regulated by TNF-α, suggesting a potential association between autophagy and antigen 
presentation and processing.  
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Figure 2.4. Bioinformatics analyses of the membrane proteome from TNF-α activated 
macrophages reveals the downregulation of mitochondria proteins. 
 (A) Gene Ontology enrichment analysis of upregulated proteins shows a strong enrichment for 
terms related to mitochondria and energy production while terms associated with vesicle 
trafficking and mitochondrial functions are downregulated. (Numbers represent distinct proteins) 
(B) Global protein-protein interaction network comprising 7439 nodes and 80 449 edges. 
Subnetworks were created by manually annotating the MS-identified proteins with the Uniprot 
database and by functionally clustering the proteins from the global protein-protein interaction 
network.  Subnetworks affected by TNF-α activation, such as immune response, ROS & 
mitochondria and vesicular trafficking are displayed.  
116    
 
2.5.3. TNF-α induces specific autophagic elimination of mitochondria in 
macrophages 
 
Our quantitative proteomics analyses indicated that mitochondria proteins were down-
regulated in TNF-α activated macrophages. This cytokine is known to induce several 
types of cell signaling events including apoptosis, activation of NF-kB and activation of 
different kinases (e.g. p38, c-Jun, and the extracellular signal regulated kinase, ERK) 36. 
Mitochondria are key components in a pathway to programmed cell death, through the 
release of death-promoting factors (e.g. cytochrome c, Smac, and endonuclease G) from 
the intermembrane space 37. To determine if reduced mitochondrial proteins arose from 
pre-apoptotic signal, we monitored the abundance of fluorescently-labeled Annexin A5 
at the plasma membrane using flow cytometry (Supplemental Fig. 2.S9). Annexin A5 is 
used as a probe to detect cells that express phosphatidylserine on the cell surface, an 
event associated with apoptosis and other forms of cell death 38. Flow cytometry analyses 
revealed that apoptotic and dead cells represented approximately 15 % of the cell 
population in both control and TNF-α activated macrophages. Similar results were also 
obtained when cells were stained with 7-amino actinomycin D, a compound that 
intercalates with double-stranded DNA and penetrates cell membranes of necrotic or 
dead cells but is excluded from viable cells (Supplemental Fig. 2.S9). Furthermore, no 
significant change in cell count was observed between control and activated 
macrophages, confirming that TNF-α does not impair cell viability (data not shown).      
To determine the extent of changes in mitochondrial functions associated with TNF-α, 
we examined the effect of this cytokine on the opening of the mitochondrial permeability 
transition pore, a property that reflects the integrity of the mitochondrial membrane and 
its transmembrane potential, ΔΨmt. We used JC-1 (5,5',6,6'-tetrachloro1,1',3,3'-
tetramethyl benzimidazolyl carbocyanine iodide), a fluorescent dye that is taken up by 
cells and specifically accumulates inside mitochondria. The fluorescence of JC-1 shifts 
from 527 nm to 590 nm upon aggregation, and the ratio of the green/red fluorescence is 
used to probe changes in ΔΨmt and provided a direct measurement of the population of 
healthy (high potential) versus impaired mitochondria (low potential). We first compared 
the flow cytometry profile of control macrophages stained with JC-1 to those of cells 
stimulated for 24 h with different cytokines. We observed that macrophages activated by 
IL-4, Il-13, IL-10, IL-1β had ratios of healthy to impaired mitochondria comparable to 
those of control cells (Fig. 2.5A). However, macrophages stimulated with TNF-α and IFN-
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γ showed a 30 % decrease and 25 % increase in the ratio of healthy to impaired 
mitochondria, respectively (Fig. 2.5A). The increase in mitochondrial activity upon IFN-γ 
stimulation is consistent with previous reports indicating that activated macrophages 
utilize significant amounts of glycolytically generated ATP to maintain high ΔΨmt and 
prevent apoptosis 39. In contrast, the decrease in mitochondrial potential in non apoptotic 
macrophages suggests that TNF-α induced selective degradation of mitochondria, in 
agreement with our quantitative proteomics experiments. Importantly, these results also 
indicated that TNF-α is the only major immune response modulating cytokine leading to 
a decrease in healthy mitochondria in activated macrophages.                
The selective degradation of mitochondria proteins upon TNF-α activation prompted us 
to examine the mechanism by which this could take place and the effect of this cytokine 
on other cell types. We used mouse embryonic fibroblast (MEF) cells that are 
morphologically and functionally similar to mouse macrophages. MEF cells stimulated 
with TNF-α led to a decrease in the ratios of healthy to impaired mitochondria comparable 
to those observed for RAW 264.7 macrophages (Fig. 2.5B). Also, TNF-α activation of 
MEF cells did not lead to decreased cell counts or increased apoptosis (data not shown). 
We surmised that the impaired mitochondrial activities observed in both TNF-α activated 
macrophages and MEF cells could arise from an autophagy-mediated degradation of 
mitochondria, or mitophagy 40. To verify this proposal, we compared the change in 
mitochondrial potential of TNF-α activated macrophages with and without 3-methyl 
adenine (3-MA), a compound that prevent autophagy by blocking the formation of 
autophagosome via the inhibition of phosphatidylinositol 3-kinases (PI-3Ks) 41. These 
experiments indicated that 3-MA restored normal mitochondrial activities in TNF-
α activated macrophages (Fig. 2.5B). Furthermore, the effects of TNF-α on mitochondrial 
functions were also abrogated in MEF cells isolated from Atg5 -/- mice (Fig. 2.5B). The 
autophagy-related protein Atg5 is required in the formation of autophagosome, a vacuole 
in which intracellular components like mitochondria are sequestered before their 
degradation in the lysosome 42. Consistent with this observation, we also noted that 
macrophages stimulated with TNF-α displayed increased lysosomal degradation 
activities when stained with LysoSensor, a pH-sensitive fluorescent probe that 
accumulates in acidic organelles (Supplemental Fig. 2.S10).  
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Figure 2.5. Changes in mitochondrial functions associated with TNF-α activated 
macrophages.   
(A) Flow Cytometry analysis of changes in mitochondrial membrane potential using JC-1 in 
RAW264.7 macrophages following stimulation with TNF-α, IL-4, IL-13, IL-10, IL-1β and IFN-γ. 
Macrophages were stimulated with cytokines for 24 hr and the proportion of healthy versus 
functionally impaired mitochondria in macrophages was determined using mean fluorescence 
values of monomeric JC-1 or J-aggregates. TNF-α strongly reduces the ratio of healthy to 
functionally impaired macrophages, while the other cytokines have no significant effect on the 
mitochondrial membrane potential. (B) Flow Cytometry analysis of changes in mitochondrial 
membrane potential using JC-1 in RAW264.7 macrophages and MEF stimulated with TNF-α for 
24h. The ratio of healthy versus functionally impaired mitochondria in macrophages was 
determined using mean fluorescence values of monomeric JC-1 or J-aggregates. Treatment with 
the autophagy inhibitor 3-methyladenine for 3h abolished the effect of TNF-α on mitochondrial 
potential. Knock-down of Atg5 restored original ratio of healthy mitochondria in TNF-α activated 
MEF cells.  
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We used immunofluorescence microscopy to confirm that mitochondria were degraded 
in autophagosomes upon TNF-α activation. Macrophage cells were stained for the 
mitochondrion inner membrane protein Tim23 and the autophagic marker LC-3 II to 
monitor their respective subcellular distribution. In unstimulated cells, Tim23 was evenly 
distributed across cells while LC3 II was barely detectable (Fig 2.6A). A significant 
increase in LC3 II abundance was observed following 24 h stimulation with TNF-α, 
confirming the autophagic activation and the formation of characteristic cellular 
autophagosome punctae containing LC3 II (Fig. 2.6A). Interestingly, we noted the co-
localization of mitochondria and autophagosomes, and the striking disappearance of 
mitochondria in regions where autophagosomes were more densely distributed, 
consistent with increased mitophagy activities. A salient feature of autophagy is the 
sequestration of cytosolic organelles and protein aggregates in double membrane-bound 
compartments to be transported to and degraded in the lysosomal vacuoles 43. 
Morphological analyses performed using electron microscopy revealed the 
encapsulation of mitochondria by a double-membrane in TNF-α activated macrophages 
(Fig. 2.6B). Under control conditions mitochondria appeared intact while TNF-α activation 
of macrophages led to impaired mitochondrial structure. In addition, we observed that 
mitochondria fused with lysosomes upon TNF-α stimulation. Collectively, these results 
confirmed that TNF-α selectively led to the degradation of mitochondria via the induction 
of autophagy.    
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Figure 2.6. TNF-α induces mitophagy.  
(A) TNF-α stimulation for 24h induces LC3-II punctae (red), and confirmed the colocalization of 
autophagosomes and mitochondria. In control cells, no LC3-II punctae are detected and 
mitochondria are distributed throughout the cell. (B) Morphological analyses using electron 
microscopy (EM) of control and TNF-α stimulated macrophages. Electron micrograph images 
showed the presence of functionally impaired mitochondria in TNF-α stimulated RAW264.7 
macrophages. Mitochondria from TNF-α activated macrophages are enclosed by 
autophagosomal-like double-membrane vesicles while healthy and functional mitochondria are 
observed in control cells.  
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2.5.4. Macrophage activation by TNF-α increases MHC Class I presentation 
of mitochondrial antigens  
 
Autophagy is not limited to the clearance of intracellular components, but also plays 
important roles in both innate and adaptive immunity 44, 45. Previous reports highlighted 
the significance of autophagy in promoting the presentation of endogenous antigens on 
MHC class II molecules, thus leading to the activation of CD4+ T cells 46, 47. Interestingly, 
recent studies also proposed the regulation of macroautophagy and MHC class II 
expression by TNF-α 34, and a potential interplay between the vacuolar and MHC class I 
presentation pathways in IL-1β− activated autophagy 31. Results from this proteomics 
study suggest a strong modulation of proteins involved in MHC class I antigen 
presentation in TNF-α-activated macrophages. In particular, in TNF-α regulated proteins 
we observed several proteins involved in vesicular trafficking (e.g. sorting nexin-1 and 2, 
vesicle-trafficking protein SEC22b) and degradation (e.g. LAMP1 and beta-
hexosaminidase α and β subunits) as well as proteins directly implicated in antigen 
presentation (e.g. H2 class I histocompatibility antigen K-D, D-D and L-D alpha chain, 
protein transport protein SEC61β) and proteasomal degradation (e.g. proteasome 
activator complex subunit I, 26S proteasome non-ATPAse regulatory subunit 14, 
proteasome subunit beta type-3). To our knowledge, the role of the MHC class I 
presentation machinery in displaying intracellular antigens following the activation of 
autophagy by TNF-α has not been described thus far. To further investigate the influence 
of TNF-α on the presentation of mitochondrial antigens via the MHC class I pathway, we 
developed a system allowing us to study and compare the molecular mechanisms 
involved in the processing and presentation of endogenous antigens by macrophages. 
We produced a RAWKb macrophage cell line that stably expressed a truncated form of 
glycoprotein B (gB) from Herpes Simplex Virus 1 (HSV-1), and targeted its localization 
to mitochondria using a mitochondrial matrix targeting sequence from cytochrome c 
oxidase. The vacuolar response initiated by autophagy increases the processing and 
presentation of gB antigens on MHC class I molecules that can be monitored via the 
activation of CD8+ T cells.     
The subcellular distribution of HSV-1 gB was determined by immunofluorescence 
microscopy and confirmed its co-localization with the mitochondrial marker Tom20 (Fig. 
2.7A). Next, we cultured these cells for 24 h with TNF-α and/or specific pharmacological 
inhibitors to evaluate their functional effects on antigen presentation. Following 
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stimulation, cells were fixed with paraformaldehyde and then co-cultured with lacZ-
inducible gB-specific CD8+ T cell hybridoma to measure T cell activation against the 
HSV-1 gB antigen 12 h later. We observed a 30% increase in MHC class I presentation 
of gB antigens for macrophages stimulated by TNF-α (Fig. 2.7B). Stimulation of the CD8+ 
T cell hybridoma was decreased after treatment of activated macrophages with PI-3K 
inhibitor 3-MA, further supporting the proposal that autophagy contributes to the vacuolar 
processing and presentation of gB antigen on MHC class I molecules. The effect of 
mitophagy on antigen presentation was confirmed separately using carbonyl cyanide m-
chlorophenyl hydrazone (CCCP), a protonophore that lead to rapid membrane 
depolarization and degradation of mitochondria (Fig. 2.7B). Interestingly, macrophages 
treated with rapamycin, an inhibitor of the kinase mTOR that normally induce autophagy, 
had no effect on CD8+ T cell stimulation. Together, these results indicate that TNF-α 
promoted the selective vacuolar processing of mitochondria proteins and improved the 
ability of activated macrophages to cross present mitochondrial antigens to CD8+ T cells.  
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Figure 2.7. Influence of TNF-α on antigen presentation.  
(A) gB antigen peptide (green) expressed in RAW264.7 cells is targeted to mitochondria and co-
localized with Tim23 (red). (B) TNF-α enhanced MHC class I cross presentation of gB antigen. 
RAW macrophages (control or 24 hr following TNF-α activation) were incubated with different 
pharmacological inhibitors. Macrophages were fixed and co-cultured with lacZ-inducible gB HSV-
specific CD8+ T cell hybridoma for 12 hr, and cell activation was measured using UV-VIS 
spectrometer following the hydrolysis of β-Gal. 
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2.6. Discussion 
 
In this report, we described a comprehensive proteomics study aimed at characterizing 
the proteome of resting and TNF-α−activated mouse macrophages. Label-free 
quantitative proteomics analysis of crude membrane extracts from TNF-α stimulated 
macrophages revealed the differential regulation of several proteins involved in vesicular 
trafficking, protein degradation, and immune response (Table II-1). These analyses also 
confirmed the identification of several proteins known to be modulated by TNF-α such as 
cPLA2 and TRAP1. Previous reports have described the activation of cPLA2 upon TNF-
α activation of macrophages 48, 49. This protein is activated by calcium and comprise both 
lysophospholipase and transacylase activities. cPLA2 selectively hydrolyzes arachidonyl 
phospholipids in the sn-2 position releasing arachidonic acid, and this enzyme plays a 
major role in the initiation of the inflammatory response. In comparison, TRAP1, also 
refered to as heat shock protein 75, is a member of the HSP90 family 50 that interacts 
with the intracellular domain of type I TNF receptor. TRAP1 was found to localize to 
mitochondria and exhibited ATPase activities, but does not form stable complex with 
classic HSP90 co-chaperones 51.  
It is noteworthy that the activation of cPLA2 increases the intracellular levels of 
arachidonic acid and mediates the production of ROS. While low levels of ROS act as 
signaling molecules, their prolonged production can impair mitochondrial functions 
through oxidative damage 52 and depolarization of the transmembrane potential, ΔΨmt 
(Fig. 2.5). Interestingly, we observed a consistent downregulation of mitochondrial 
proteins in response to TNF-α activation (Fig. 2.4 and supplemental Fig. 2.S7). We also 
noted that mitochondrial proteins were not all affected in a similar manner upon TNF-
α activation, and downregulated proteins represented mostly enzymes (65%) and 
transporters (30%), while proteins associated with mitochondrial ribosomes remained 
largely unaffected.  
Importantly, we observed that TNF-α was the only molecule amongst all cytokines 
examined that led to the selective degradation of mitochondria in lytic vesicles through 
autophagy. Several studies have suggested a role for TNF-α in stimulating autophagy in 
human and murine macrophages 32-34, 53, but the exact mechanism by which TNF-α 
stimulates autophagy is not fully understood, and may differ depending on cell types. 
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This process is initiated by damaged mitochondria which upon loss of ΔΨmt stabilize the 
voltage-sensitive kinase Pink1 on the outer mitochondrial membrane leading to the 
recruitment of the E3 ubiquitin ligase Parkin and the ubiquitination of mitochondrial 
proteins 54, 55. It is noteworthy that the regulation of Pink, Parkin, or Nix upon TNF-α 
stimulation was not determined in the present study, and that macroautophagy could 
possibly be involved in the elimination of mitochondria. Interestingly, we noted that a 
number of mitochondrial proteins were ubiquitinated including DNA toposiomerase 1 
mitochondrial. The accumulation of ubiquitylated mitochondrial proteins is thought to 
facilitate the recruitment of the ubiquitin-binding protein p62 (sequestosome-1), an 
adaptor protein that binds to Lys-63 polyubiquitin chains of ubiquitylated substrates and 
mediates the interaction with LC3 to facilitate the autophagosomal degradation of the 
damaged mitochondria 56. A schematic representation of the autophagic pathways is 
presented in Supplemental Fig. 2.S11. 
Impaired mitochondria are first encapsulated in a characteristic double-membrane 
structure known as the autophagosome prior to fusing with lysosome where their cargo 
are degraded (Fig. 2.6B). This double-membrane can arise from an extension of 
endoplasmic reticulum (ER) known as the omegasome that contributes important 
components to the formation of autophagosomes 57. These vesicles are coated with the 
autophagosome marker microtubule associated protein 1 (MAP1) light chain 3 (LC3), an 
ubiquitin-like protein that is covalently attached to phosphatidylethanolamine during their 
biogenesis. Consistent with this notion, immunofluorescence microscopy experiments 
indicated that LC3-II punctae were present in TNF-α stimulated macrophages but not in 
resting macrophages (Fig. 2.6A). We also confirmed that the selective degradation of 
mitochondria was dependent on both PI-3K and Atg5 (Fig. 2.5B). During the induction of 
autophagy, Atg5 conjugates to the ubiquitin-like protein, Atg12, and interacts with Atg16 
to form an oligomeric complex that localizes to nascent autophagosomes 58. The 
formation of the Atg12-Atg5-Atg16 complex is a prerequisite to the lipidation of LC3 and 
its targeting to autophagosomes prior to their fusion with either late endosomes 
(amphisomes) or lysosomes (autolysosomes) 59, 60.  
In addition to the elimination of dysfunctional mitochondria, autophagy also plays 
important roles in innate and adaptive immunity via the processing and presentation of 
endogenously expressed antigens by MHC class I and class II molecules 61-63. The notion 
that the degradation of intracellular antigens after autophagy is used by the mammalian 
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immune system to display intracellular antigens on MHC class II for CD4+ T cell 
stimulation was recently expanded to include antigen processing via MHC class I 
presentation 31.  Indeed, previous results from our group indicated that in addition to the 
classical MHC class I pathway, viral proteins can be engulfed later during HSV-1 infection 
by autophagosomes formed from the membrane of the outer nuclear envelope. Inhibition 
of autophagy was confirmed by siRNA silencing of the Atg5 gene and abrogated HSV-1 
specific CD8+ T cell stimulation 31. In the present study, we further expanded the role of 
autophagy in the processing of intracellular antigens and their presentation by MHC class 
I molecules. Using a RAWKb macrophage cell line that stably expressed a truncated form 
of gB from HSV-1 targeted to mitochondria, we showed that autophagy increased the 
processing and presentation of mitochondrial viral antigens on MHC class I molecules 
following TNF-α activation (Fig. 2.7). CD8+ T cell activation was modulated by PI-3K 
inhibition and loss of ΔΨmt consistent with the notion that autophagy contributes to the 
processing and presentation of mitochondria-specific gB antigen on MHC class I 
molecules. This pathway is independent of autophagy induced by mTORC1 inhibition as 
macrophages treated with rapamycin showed no increase in CD8+ T cell stimulation. 
Taken together, these findings highlight a novel role for TNF-α in mitophagy and in the 
processing and presentation of mitochondrial antigens by MHC class I molecules. It is 
interesting to note that increased ROS production and oxidative stress induced by the 
accumulation of damaged mitochondria can lead to a host danger signal initiated by 
NLRP3 inflammasomes often associated with many chronic inflammatory diseases 64. 
NLRP3 inflammasome is negatively regulated by autophagy, and targeted removal of 
dysfunctional mitochondria following TNF-α prevents progressive cell damage and 
inflammation.   
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2.8. Supplemental data 
 
2.8.1. Supplementary figures 
 
 
Supplementary Figure 2.S1. Flow cytometry analysis and clone showing the highest 
fluorescence levels selected, amplified and used.  
(A) Kb heavy chain of the MHC class I molecule is expressed at the cell surface of Raw-Kb murine 
macrophages. (B) Kb efficiently binds the Kb-restricted epitope SSIEFARL (derived from gB), as 
revealed by the strong 2E2 activation when exogenous peptide was added to the culture medium 
for 30 minutes before fixation and addition of the CD8+ T cells. 2E2 activation is measured by 
quantifying beta-galactosidase produced by the hybridoma. 
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Supplementary Figure 2.S2. Fractionation efficiency using immunoblots for several 
cellular markers.  
Western blot analysis of 10 µg of protein of total membrane (TM) and total cell lysate (TCL) 
preparations of RAW 267.4 mouse macrophages. Western blots confirm the high purity of our TM 
preparations. The following antibodies were used: gamma-actin (actin, cytoplasm), nucleoporin 
p62 (nucleus), Na+/K+ ATPase (Plasmamembrane), Annexin II (Plasmamembrane), lysosome-
associated membrane glycoprotein 1 (LAMP1, lysosomal membrane), mitochondrial import 
receptor subunit Tom20 (Tom20, mitochondrial membrane).  
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Supplementary Figure 2.S3. Reproducibility of peptide intensities across replicates.  
Scatter plots of abundance measurements for peptide ions identified using mRP-C18, SCX and 
GELFREE as first dimension of separation. While SCX and GELFREE display quite wide 
distributions of peptide intensities, mRP-C18 displays a very narrow distribution. mRP-C18 also 
has the lowest CV of 27% attesting its reproducibility. 91% of quantified peptides using mRP-C18 
have been detected in 3 replicates, while in GELFREE only 46% have been detected in 3 
replicates respectively. 
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Supplementary Figure 2.S4. Comparison of three different fractionation techniques for 
quantitative membrane proteomics of RAW264.7 macrophages.  
(A) Venn diagram representation of protein identification obtained using strong cation exchange 
(SCX), GelFREE and macroporous reversed phase (mRP) fractionation of macrophage 
membrane proteins. Different fractionation techniques complement each other for comprehensive 
large-scale proteomics. (B) Distribution of sequence coverage for separation techniques. A higher 
sequence coverage of identified proteins is typically obtained using mRP fractionation compared 
to SCX and GELFREE.  
 
 
Supplementary Figure 2.S5. MS/MS spectra of phosphopeptides (CD-ROM).  
Annotated MS/MS spectra of phosphopeptides identified in experiments from fractionation of 
membrane proteins using SCX, GELFREE and mRP. 
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Supplementary Figure 2.S6. Scatter plots of abundance measurements for peptide ions 
identified in control and TNF-α stimulated extracts.  
Peptide ion intensity distributions for 3 replicates are very narrow in control and TNF-α stimulated 
macrophages. 95 % of all ions showed RSD values less than 58 % across all three biological 
replicates, attesting of the reproducibility of the method. 
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Supplementary Figure 2.S8: MS/MS spectra of ubiquitinated peptides (CD-ROM).  
Annotated MS/MS spectra of ubiquitinated peptides identified in TNF-α activated macrophages. 
 
 
 
 
Supplementary Figure 2.S9. Abundance of fluorescently-labeled Annexin A5 at the plasma 
membrane and 7-amino actinomycin D using flow cytometry.  
Flow cytometry analyses revealed that apoptotic and dead cells represented approximately 15 % 
of the cell population in both control and TNF-α activated macrophages. Similar results were also 
obtained when cells were stained with 7-amino actinomycin D. 
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Supplementary Fig. 2.S10. Lysosomal degradation activities when stained with 
Lysosensor.  
Macrophages stimulated with TNF-α displayed increased lysosomal degradation activities when 
stained with LysoSensor, a pH-sensitive fluorescent probe that accumulates in acidic organelles. 
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Supplementary Figure 2.S11. Integrated model of the TNF-α modulated functions favoring 
antigen MHC class I presentation.  
TNF-α can mediate the induction of mitophagy in murine macrophages through the activation of 
cPLA2. This activation leads to the induction of lipid mediators such as arachidonic acid, which 
promotes the formation of reactive oxygen species. Increased ROS levels can impair 
mitochondrial functions resulting in a decrease in their transmembrane potential, ΔΨmt. Impaired 
mitochondrial proteins are engulfed in a double membrane organelle called the autophagosome 
that later fuses with lysosomes to form autophagolysosomes where they are degraded. 
Mitochondrial peptides/antigens engulfed in the autophagolysosome can be retrotranslocated into 
the cytosol where they can be further degraded by the proteasome and processed by the 
conventional MHC class I machinery. Alternatively, they can remain within the vacuolar 
compartment where they are degraded by lysosomal proteases, and the resulting peptides are 
cross-presented to MHC class I molecules. 
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2.8.2. Supplemental tables 
 
Table II-S1: Protein identification for different separation platforms: mRP-C18, 
GELFREE and SCX (CD-ROM). 
Table II-S2: List of peptides identified in each separation platforms (mRP-C18, 
GELFREE and SCX) (CD-ROM). 
Table II-S3: Quantification of protein abundance changes upon TNF-alpha stimulation 
(CD-ROM). 
Table II-S4: Ubiquitinated peptides upon TNF-alpha stimulation (CD-ROM). 
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3.2. Abstract 
 
Herpesviruses are among the most complex and widespread human viruses, and cause 
a number of diseases ranging from cold sores to genital infections and encephalitis. 
While the composition of viral particles has been studied, less is known about the 
expression of the whole viral proteome in infected cells. Here, we analysed the proteome 
of the prototypical Herpes Simplex Virus type 1 (HSV1) in infected cells by mass 
spectrometry (MS). Using a high sensitivity LTQ-Orbitrap, we achieved a very high level 
of protein coverage and identified a total of 67 structural and non-structural viral proteins. 
We also identified 90 novel phosphorylation sites and ten novel ubiquitylation sites on 
different viral proteins. Ubiquitylation was observed on nine HSV1 proteins. We identified 
phosphorylation sites on about half of the detected viral proteins; many of the highly 
phosphorylated ones are known to regulate gene expression. Treatment with inhibitors 
of DNA replication induced changes of both viral protein abundance and modifications, 
highlighting the interdependence of viral proteins during the life cycle. Given the 
importance of expression dynamics, ubiquitylation and phosphorylation for protein 
function, these findings will serve as important tools for future studies on herpesvirus 
biology. 
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3.3. Introduction 
 
Herpes Simplex Virus type 1 (HSV1) is the prototype of a family of viruses that cause 
numerous diseases ranging in severity from the common cold sore and genital herpes to 
life threatening encephalitis in humans1 or Aujeszky’s Disease in swine2. About 80% of 
the world’s population is infected with HSV1, although many people may never show any 
sign or symptom of infection1. After a primary infection that often occurs in early 
childhood, the virus establishes a latent infection in the cranial ganglia. Reactivation is 
triggered by various stimuli including a compromised immune system or UV light.  
 
Mature viral particles consist of three layers: the icosahedral capsid that contains the viral 
DNA genome, a less structured protein layer that is called tegument, and an envelope 
consisting of a host-derived membrane studded with viral membrane proteins3. The viral 
genome encodes at least 82 proteins4, granting HSV1 a place among the most complex 
human viruses. In comparison, Hepatitis C Virus consists of only 11 proteins5, and the 
genome of Human Immunodeficiency Virus comprises only nine open reading frames6.  
 
During an active lytic infection, HSV1 gene expression is tightly regulated, and proteins 
are expressed in at least four kinetic classes. The proteins that are expressed first are 
called immediate early proteins. They prepare the cell for its new role as a virus 
replication machine, and can also prevent it from alerting immune cells and neighbouring 
cells e.g. by interfering with antigen presentation4, 7. The immediate early proteins also 
regulate the expression of the next set of viral proteins, the early proteins. This group 
contains proteins that catalyze viral DNA replication. This process in turn constitutes a 
check-point that allows the large scale production of structural viral proteins, and thus 
assembly of new viral particles that can spread the infection within or between hosts8. 
This last kinetic wave of proteins is broadly classified as ‘late’. But not all late proteins 
are expressed simultaneously. Rather, they can be further divided into leaky late proteins 
that are expressed at low levels prior to the onset of viral DNA replication and at high 
levels thereafter, while true late proteins are only expressed after the onset of viral DNA 
replication and are thought to require continuous DNA replication8.  
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In addition to protein expression levels, ubiquitylation and phosphorylation are likely to 
influence HSV1 protein function, subcellular localisation, or stability. This has been 
shown previously for some viral proteins4, 9-11. 
 
Previous proteomics analyses of herpes viruses have focused on identifying components 
of mature and immature viral particles12-16, and on changes of the host cell proteome or 
macrophage secretome induced by infection17-20. Here, we performed a comprehensive 
quantitative analysis of the HSV1 proteome of infected cells with and without inhibition of 
DNA replication. Furthermore, we analysed the HSV1 proteome for the presence of 
modified residues and identified 90 novel phosphorylation and 10 novel ubiquitylation 
sites on HSV1 proteins. The inhibitors affected not only the expression of late, but also 
some early proteins, highlighting a dynamic and probably highly interdependent 
regulation of protein expression and stability within the HSV1 proteome. In addition to 
protein expression, phosphorylation and ubiquitylation patterns were also altered by the 
inhibitors, stressing the highly dynamic nature of these modifications. 
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3.4. Experimental Procedures 
 
3.4.1. Cells & viruses  
 
The BMA3.1A7 macrophage cell line was derived from C56/BL6 mice21 and cultured in 
DMEM containing 10% (v/v) FCS and 2 mM glutamine. HSV1 17+ was kindly provided 
by Roger Lippé (Université de Montréal), and stocks were propagated in BHK-21 (ATCC 
CCL-10) and titered on Vero cells (ATCC CCL-81) as described previously22.  
 
3.4.2. Infection & drug treatment  
 
Cells were inoculated at a multiplicity of infection (moi) of 5 on a rocking platform at 37°C 
for 30min. The inoculum was replaced by medium, and infected cells were incubated until 
8h post infection (pi). Acyclovir, phosphonoacetic acid (PAA) and cycloheximide (CH) 
were purchased from Sigma-Aldrich (Oakville, Canada), and added directly after 
inoculation for 8h at final concentrations of 400 µM, 4 mg/ml or 0.5 mM, respectively. At 
8h pi, cells were washed once with PBS, sedimented and taken up in sample buffer (10% 
ß-mercaptoethanol, 5% SDS, 20% glycerol, 200 mM Tris-HCl pH 6.8, 0.05% 
bromophenol blue). 
 
3.4.3. SDS-PAGE and Mass Spectrometry  
 
Twenty μg of total cell lysate proteins were separated on a 4-12% pre-cast NuPAGE gel 
(Invitrogen). The gel was Coomassie stained and the lanes were cut into 12 equal-sized 
pieces using an in-house cutting device. The gel pieces were reduced with tris(2-
carboxyethyl)phosphine (Pierce), alkylated with chloroacetamide (Sigma-Aldrich, 
Oakville Canada) and digested with trypsin. Peptides were extracted three times with 
90% acetonitrile/0.5 M urea. Combined extracts were dried and re-suspended in 5% 
acetonitrile, 0.1% formic acid for MS analyses. Peptides were separated on a 150 µm ID, 
15 cm reversed phase nano-LC column (Jupiter C18, 3 μm, 300 Å, Phenomex) with a 
loading buffer of 0.2% formic acid. Peptide elution was achieved by a gradient of 5-40% 
acetonitrile in 70 min on an Eksigent 2D-nanoLC (Dublin, CA) operating at a flow-rate of 
600 nL/min. The nano-LC was coupled to an LTQ-Orbitrap XL mass spectrometer 
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(Thermo-Electron, Bremen, Germany) and samples were injected in an interleaved 
manner. The mass spectrometer was operated in a data-dependent acquisition mode 
with a 1s survey scan at 60,000 resolution, followed by six product ion scans (MS/MS) of 
the most abundant precursors above a threshold of 10,000 counts in the ion trap.  
 
3.4.4. Protein identification and data analysis  
 
The centroided MS/MS data were merged into single peak-list files (Distiller, v2.4.2.0) 
and searched with the Mascot search engine v2.3.01 (Matrix Science) against the 
forward and reversed HSV1 Uniprot release 2011 database. Mascot was searched with 
a parent ion tolerance of 10 ppm and a fragment ion mass tolerance of 0.5 Da.  
Carbamidomethylation of cysteine, oxidation of methionione, deamidation, 
phosphorylation of serine, threonine and tyrosine and ubiquitinylation (GlyGly) of lysine, 
serine, cysteine and threonine residues were specified as variable modifications. 
Proteins were identified when the combined score of unique peptide identifications 
exceeded the score of the first reversed-database hit reaching 1%. This resulted in a 
false-discovery rate of <1 % at the peptide level. Relative protein abundance was 
determined using a redundant peptide counting approach (spectral counts)23-25. The 
value of redundant peptide counts from 3 identification cycles (on 3 independent 
biological replicates, %SD 17-24%) was used to generate heatmaps. Unsupervised 
clustering was performed using the Graphical Proteomics Data Explorer (GProX) 
software platform in default settings26.  
 
3.4.5. Identification of ubiquitylated and phosphorylated residues 
 
 Phosphorylation and ubiquitylation sites were determined and validated using the 
Proteoconnection bioinformatics platform27. Ubiquitylation was detected by the 
ubiquitinylation signature di-glycine remnant of ubiquitin following trypsin cleavage 
(114.043 Da) on lysine, serine, cysteine and threonine residues. Ubiquitylation site 
assignments were then evaluated based on a scoring threshold (Mascot Score: 15) 
followed by manual verification and validation. Peptides that were extensively modified 
(chemically and posttranslationally) were excluded from our dataset. In addition peptides 
with a GlyGly residue on the C-terminal lysine were discarded. Phosphorylation on 
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serine, threonine and tyrosine residues was detected by the neutral loss of H3PO4 (98 
Da). The confidence in the location of phosphorylation sites was determined using a 
probability score function28 integrated in the proteoconnections platform and only high 
confidence assignments (>75%) were considered for inclusion in our study. Motif-x 
(http://motif-x.med.harvard.edu) was used to extract overrepresented patterns from our 
phosphopeptides sequence data set through comparison to the total HSV1 proteome 
statistical background29.  
 
3.4.6. Immunoblot  
 
Protein samples were separated by linear 4 – 15% SDS-PAGE (BioRad) and transferred 
onto nitrocellulose membrane (Pall Corporation, USA). Proteins of interest were detected 
using a rabbit polyclonal anti-HSV1 antibody (RB-1425-A, Neomarkers) or a rabbit 
polyclonal anti-calnexin antibody (kindly provided by John Bergeron, McGill University, 
Montreal, Canada), followed by a secondary antibody coupled to horse-radish 
peroxidase (Jackson ImmunoResearch, West Grove, USA) for ECL detection 
(PerkinElmer, Waltham, USA).  
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3.5. Results & Discussion 
 
In this study, we performed a comprehensive quantitative analysis of the HSV1 proteome 
in infected cells to assess expression levels and posttranslational modifications of both 
structural and non-structural proteins with and without inhibition of DNA replication. 
Briefly, we obtained lysates of cells that had been infected with HSV1 wt for 8h, a time 
when immediate early, early and late viral proteins were expected to be present in the 
cell. Proteins were separated by SDS-PAGE followed by tryptic in-gel digestion. The 
corresponding peptides were subsequently analyzed by LC-MS/MS on a LTQ-Orbitrap 
XL mass spectrometer. 
 
3.5.1. Coverage of HSV1 proteins 
 
The HSV1 proteome comprises at least 82 proteins that promote and regulate viral 
infection and spread4. MS/MS analyses of the corresponding protein extracts enabled 
the identification of 67 out of the 82 predicted HSV1 gene products with two or more 
unique peptides (see Supplementary Tables III-S1 for proteome coverage & and 
Supplementary Table III-S2 for details on identified peptides). Of the 15 unidentified gene 
products, eight do not yield unique peptides since they represent shorter versions of other 
proteins (pUL8.5, pUL9.5, pUL12.5, pUL20.5, pUL26.5, pUL27.5, pUL43.5 and pUS1.5)4. 
They might have been detected in our samples, but since we could not distinguish them 
from the larger proteins, we assumed only the presence / detection of the largest form 
(denoted as pULX and not pULX.5). Taking this into consideration, our analyses covered 
90% of all expected HSV1 proteins. The remaining seven proteins (pUL11, pUL20, 
pUL33, pUL43, pUL49.5, pUS5 and LAT) might not have been detected due to technical 
limitations like insufficient solubility or masquing by highly abundant host proteins, or they 
might not have been expressed under our experimental conditions. 
Of the 53 predicted structural proteins that form the viral particle, we detected 49 proteins 
with two or more unique peptides (Supplementary Figure 3.S1 A). For comparison, a 
previously published analysis of purified extracellular virions reported the identification of 
37 of these predicted structural proteins with two or more peptides12. We detected 91% 
of all capsid proteins and 96% of all tegument proteins, but only 79% of envelope 
proteins. The lower number of identified envelope proteins might be due to the fact that 
most of these viral components are transmembrane or membrane associated proteins, 
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which are notoriously difficult to analyze by MS because of their hydrophobicity and 
limited number of proteolytic peptides. Indeed, four of the seven proteins we did not 
detect are membrane-associated proteins (pUL20, pUL43, pUL49.5 and pUS5).  
We detected more than 80% each of viral proteins expressed with immediate early, early 
or late expression kinetics, suggesting that all three classes of HSV1 proteins were 
present after the selected infection period (Supplementary Figure 3.S1 B). Since our 
analysis covered nearly the whole HSV1 proteome, and proteins of all kinetic classes 
were detected with similar efficiency, we concluded that our proteomics platform could 
be used to monitor HSV1 protein expression under experimental conditions known to 
influence HSV1 protein expression. 
 
3.5.2. Dynamic changes in the HSV1 proteome after inhibition of DNA 
replication 
 
We analyzed the effects of two different inhibitors of DNA replication, acyclovir and PAA, 
on HSV1 protein levels to assess the influence of DNA replication on late protein 
expression. Acyclovir is a prodrug of an acyclic nucleoside analogue that is processed 
only in infected cells, and incorporated into nascent DNA where it causes DNA strand 
termination30. This compound is the active ingredient of many common anti-cold sore 
drugs, such as Zovirax. In contrast, PAA binds to and inhibits the DNA polymerase 
directly31. Since one drug acts as a substrate and the other inhibits the enzymatic activity 
of the DNA polymerase, we assumed that the latter would more efficiently inhibit DNA 
replication and thus late protein production. We determined the levels of HSV1 proteins 
expressed in untreated cells or in the presence of acyclovir or PAA using MS/MS analysis 
on three biological replicates (statistics shown in Supplementary Table III-S3). 
Redundant peptide count was used to monitor protein expression. Changes in protein 
abundance were visualized on the heat map shown in Figure 3.1 A. Proteins were 
grouped into four distinct clusters depending on their sensitivity to both drugs 
(Supplementary Table III-S4). The first cluster contained proteins whose expression was 
strongly down regulated by PAA but less so by acyclovir. Proteins in the second cluster 
were affected equally by both inhibitors. The third cluster contained proteins that were 
not significantly affected by either drug, and the fourth cluster contained proteins that 
were affected only by PAA, but not acyclovir. While both acyclovir and PAA reduced 
protein abundance levels compared to untreated samples, PAA had a more pronounced 
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effect and affected a broader range of proteins. Western blot analysis with a polyclonal 
anti-HSV1 antibody confirmed these findings (Figure 3.1 B). 
Next, we analyzed how our clusters correlated with previously published kinetics of HSV1 
protein expression4 (Figure 3.1 C). The majority of immediate early and early proteins 
was not significantly affected by acyclovir or PAA, and grouped into cluster 3. This 
observation supported the hypothesis that these proteins were expressed independently 
of DNA replication. Some immediate early and early proteins were grouped into clusters 
1 and 4, indicating that they were sensitive to PAA but not or to a lesser extend to 
acyclovir. Two early proteins, pUL52 and pUL9, were grouped into cluster 2 since their 
expression was strongly affected by both drugs.  
About 40% of the late proteins were grouped into cluster 1, and 8% into cluster 4, 
indicating that almost half of the late proteins were more sensitive to PAA than to 
acyclovir. Since these proteins were still produced at high levels in the presence of 
acyclovir, their expression did not appear to require efficient DNA replication. However, 
their sensitivity to PAA indicated that their expression was less effective when DNA 
replication was strongly repressed. Only 23% of late proteins were grouped into cluster 
2, since they were strongly affected by both inhibitors, suggesting that their expression 
strictly depended on continuous DNA replication. Interestingly, 29% of late proteins were 
not strongly affected by the inhibitors, like the majority of immediate early and early 
proteins. This insensitivity of some late proteins to DNA replication inhibition, as well as 
the sensitivity of some early and immediate early proteins, was unexpected. It does not 
quite fit the current model of HSV1 protein expression regulation. A similar slight 
deviation from previously published expression kinetics has been observed by Wagner 
and colleagues, who have studied HSV1 gene expression at the mRNA level32. These 
deviations could be explained by an interdependency of HSV1 proteins for expression as 
well as for protein or mRNA stability. Variations between different cell lines might be 
another factor, and have indeed been previously reported32. Together, these data 
suggest that protein expression might be controlled in a more complex manner than 
previously assumed, and that the classification into immediate early, early and late 
proteins might not sufficiently describe the more subtle differences between individual 
proteins. Clearly, kinetic experiments analyzing the expression of the whole HSV1 
proteome at various times of infection will be required to understand these differences in 
more detail, and to determine the changes in abundance of individual proteins in 
correlation to their putative viral and cellular regulators. 
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Figure 3.1. Effect of DNA replication inhibitors on HSV1 protein expression.  
A: Heatmap of relative HSV1 protein abundance in control and treated cells. red: Protein amount 
equal to 100% redundant peptide count (%count), green: downregulation by 40% or more. HSV1 
proteins were sorted according to a hierarchical unsupervised clustering by the effect of acyclovir 
and PAA. B: Immunoblot of cell lysates treated with acyclovir or PAA. The general translation 
inhibitor cycloheximide (CH) was used as a control. HSV1 proteins were labelled with a polyclonal 
antibody, and calnexin was used as a loading control. C: Immediate early, early and late proteins 
were distributed differently among the clusters specified in A (blue cluster 1, yellow cluster 2, grey 
cluster 3, orange cluster 4; number of proteins given in pie segments). D: Most proteins involved 
in DNA replication and gene expression were found in cluster 3, and most proteins involved in 
virus particle formation in cluster 1. 
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Next, we wanted to assess whether proteins involved in viral DNA replication and gene 
expression were down regulated by PAA and acyclovir (Figure 3.1 D). About 65% of 
these viral proteins were found in cluster three, and thus their expression levels were not 
significantly affected by either inhibitor. The remaining 35% might be down regulated 
indirectly, e.g. because a stabilizing interaction partner was missing. For comparison, 
proteins involved in viral particle formation were found in all four clusters, with a slight 
preference for cluster one. Thus, these proteins displayed a variable sensitivity to the 
inhibitors, and were generally more down regulated than proteins involved in DNA 
replication. 
 
3.5.3. Ubiquitylation might regulate protein trafficking during the viral life 
cycle 
 
Post-translational modifications such as ubiquitylation play important roles in the 
regulation of cellular protein stability and localization. Depending on the number and 
branching of ubiquitin chains, ubiquitylation can control several cellular pathways, 
including proteasomal degradation. They can also act as sorting signals for vesicular 
trafficking in the secretory and endocytic pathway33. Given the importance of 
ubiquitylation for cellular proteins, it is likely that viral proteins might undergo similar 
modifications. The HSV1 protein pUL27 is known to be ubiquitylated on its cytoplasmic 
tail, and this modification has been linked to the protein’s trafficking to multivesicular 
bodies11. Some herpesviral proteins can modify protein ubiquitylation. The HSV1 protein 
pRL2 can act as an E3-ubiquitin ligase34 that promotes infection35, and the protein pUL36 
contains an ubiquitin-specific protease domain36. The fact that the HSV1 proteome 
contains ubiquitin-modifying proteins highlights the importance of tightly controlled 
ubiquitylation and de-ubiquitylation events during the viral life cycle.  
However, the extent of ubiquitylation on HSV1 proteins is not well known. To better 
understand the role of ubiquitination of herpesviral proteins, it would be necessary to 
identify which proteins are modified. A detailed knowledge of ubiquitylated residues 
would facilitate functional studies using viruses in which those residues have been 
mutated. 
Here, we analyzed the 67 previously detected HSV1 proteins for ubiquitylated residues. 
Although no affinity enrichment method was used, we detected 10 ubiquitylated residues 
on nine viral proteins (Table III-1, Supplementary Table III-S5 for peptide details and 
spectra & Supplementary Table III-S6 for statistics of replicate experiments). To our 
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knowledge, only one of these sites has been previously published. Some of the modified 
sites were detected only in samples treated with inhibitors of DNA replication (Figure 3.2 
A), indicating that ubiquitylation is dynamic and influenced by the environmental cues 
that define the viral proteome. 
 
Table III-1. Ubiquitylation sites in HSV1 proteins. 
HSV1 
protein 
Ubiquitylated residues Residue 
published untreated Acyclovir PAA 
pUL1 K137, K213 K213 -  
pUL3 K120 - -  
pUL4 K88 K88 -  
pUL15 K19 - -  
pUL22 - K716 K716  
pUL27 K72 K866 - K63 in strain F 11 
pUL36 - - K461  
pUL47 - K176 K176  
pUL55 - - K181  
 
To better understand which pathways of the viral life cycle might be affected and/or 
regulated by ubiquitylation, we grouped the modified viral proteins according to function 
and subcellular localisation. Interestingly, all ubiquitylated proteins could either localize 
to the nucleus and in some cases fulfil a known function inside the nucleus, or they can 
associate with cellular membranes and participate in membrane fusion events (Figure 
3.2 B).  
We detected ubiquitylation of proteins pUL22 and pUL27 that can facilitate membrane 
fusion, and of protein pUL1 that binds to pUL22 (Figure 3.2 C). The ubiquitylation of the 
cytoplasmic tail of pUL27 has been described previously, and might direct the trafficking 
of this protein to multivesicular bodies11. Taking into consideration that ubiquitylation of 
host proteins is well known to control vesicular trafficking33, these data suggest that 
herpesviral membrane protein trafficking might be regulated in a similar manner. 
Alternatively, protein ubiquitylation might function as a signal for proteasomal 
degradation. In both cases, the modification would allow a regulation of membrane fusion 
events, either by directing subcellular localisation, or by controlling protein amounts. 
Interestingly, we also detected ubiquitin residues on domains of both pUL22 and pUL27 
that are predicted to be luminal. This could indicate that their topology differs from the 
prediction, or that these proteins can flip their topology as has previously been shown for 
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some transmembrane proteins in E. coli37, 38. Alternatively, protein ubiquitylation might 
occur after partial degradation and relocation of peptides into the cytosol, likely marking 
peptides for further proteasomal degradation. 
 
 
Figure 3.2. Ubiquitylation of HSV1 proteins.  
We detected 11 ubiquitylation sites in nine HSV1 proteins. A: Ubiquitylation patterns were altered 
by acyclovir and PAA. B: Ubiquitylated proteins were grouped according to protein function and 
subcellular localisation. They fell into two different groups: proteins involved in membrane fusion, 
or proteins localizing to the nucleus. C & D: Schematic drawings of HSV1 proteins containing 
ubiquitylation sites. The colors denote the condition in which ubiquitylation was detected (yellow: 
control, blue: acyclovir, green: PAA). C: Ubiquitins found on fusion machinery pUL22, pUL27, and 
pUL1. D: Ubiquitins found on proteins with partial or predominant nuclear localisation. Ub: 
ubiquitin, P: phosphorylation, NLS: nuclear localisation signal, NES: nuclear exit signal, TM: 
transmembrane domain.  
 
Furthermore, we detected ubiquitin residues on proteins that can localize to the nucleus 
during infection (Figure 3.2 D), indicating that ubiquitylation might regulate nuclear import 
or export, or intranuclear protein functions. The ubiquitylated proteins pUL3, pUL4, 
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pUL15, pUL36 and pUL47 contain nuclear localisation signals and / or nuclear export 
signals4, 39-41. In the case of pUL3, the ubiquitin residue is located directly within the 
nuclear export signal. As mentioned above, ubiquitylation might also serve to control the 
amounts of these proteins. A tightly controlled degradation of viral proteins is likely 
essential to facilitate the different stages of the viral life cycle. 
Taken together, our data suggest a role for ubiquitylation in trafficking events during 
herpesviral infection. Our identification of ubiquitylated residues will facilitate further 
studies on the function of this modification on individual viral proteins. 
 
3.5.4. Phosphorylation of HSV1 regulatory proteins 
 
Phosphorylation of HSV1 proteins has been widely studied, and is known to regulate 
various aspects of the viral life cycle. The viral proteome contains two serine-threonine 
kinases, pUS3 and pUL134, 42, 43, which are known to phosphorylate many cellular and 
viral proteins. One prominent highly phosphorylated protein is pRL2. Phosphorylation of 
the viral E3 ubiquitin ligase pRL2 on T67 allows binding to a cellular E3 ligase, thereby 
indirectly promoting viral transcription and replication44. A study using site-directed 
mutagenesis of putative phosphorylated residues indicated that phosphorylation in other 
regions of the protein also influenced productive infection45.  
Although no phosphopeptide enrichment method was used in the present study, we 
identified 95 phosphorylated residues on 37 HSV1 proteins (Table III-2, Supplementary 
Table III-S7 for peptide details and spectra & Supplementary Table III-S8 for statistics of 
replicate experiments). Of these 37 proteins, at least a third have been previously shown 
to be phosphorylated by biochemical methods4, 46-48. However, to our knowledge only five 
of the 95 potential phosphorylated residues have been identified previously. Some 
published phosphorylation sites were not identified, either due the limited sensitivity of 
our approach, or because these proteins were not phosphorylated under our 
experimental conditions. Interestingly, a few phosphorylation sites were only detected in 
the presence of PAA and acyclovir, others only in the absence of these drugs (Figure 3.3 
A).  
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Table III-2. Phosphorylation sites identified in HSV1 proteins. Confidence >75. 
HSV1 
protein 
Phosphorylated residues Residues 
published untreated Acyclovir PAA 
pRL2 S508, S514 S508 S508  
pRS1 S11, T21, S23, S80, 
S106, S157, T235, 
S491, S536, T772, 
S909, T1271, S534 
S80, S106, T153, 
S157, T235, 
S491, S536, 
T772, T1271, 
S534 
S80, T100, 
S106, T235, 
S491, S534, 
S536, T772, 
T1271 
T1271 19 
pUL3 S60 S60 S125  
pUL4 - S187 -  
pUL6 - S459 -  
pUL10 S391, S417 - -  
pUL11 S66 S66   
pUL12 S604, S618 S604, T614, T621 S604 S604, T614 19 
pUL13 S18, S91, S109, S119 - S119, S293  
pUL17 - - T272  
pUL22 S326 - -  
pUL23 - - Y239  
pUL24 T195 T120 -  
pUL25 - T383 -  
pUL27 - T868 -  
pUL28 - S283 -  
pUL30 S1113    
pUL34 S42, S198 S198 S198 S198 53 
pUL35 T111 - -  
pUL36 T702 - S832, T1618  
pUL37 S550, S977, S1054 T342 -  
pUL38 T110 - -  
pUL39 T308 S100, T308 T308, T999  
pUL42 S358, S468 T95, S100 -  
pUL46 S478, S554, S557, 
S617, S679, S681 
S478, S554, 
S557, S679, S681
S681  
pUL47 S20, S173 - S173  
pUL49 S35, S71, S89, T114, 
S145, S277 
S35, S89, S145 S35  
pUL50 S187 S187, T199 S187  
pUL51 S184, T190 T190 T190  
pUL54 S114, T132 S114, S116 - S114 54 
pUL56 S101 - -  
pUS1 S22, T27, S135, 
T162, S167, T258 
S167 S167  
pUS3 S139, S396 S396 S139  
pUS7 T341 - -  
pUS8 S31, T451 - -  
pUS9 S53 - -  
pUS12 S81 - -  
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In grouping phosphorylated proteins according to subcellular localisation and function, 
we found that they mostly localize to the nucleus, where some of them are known to 
perform intranuclear functions (Figure 3.3 B). We further divided these proteins in groups 
as follows: (i) proteins that are localized to the nucleus but whose function is unknown, 
(ii) those that are involved in DNA replication and packaging, (iii) proteins involved in the 
regulation of gene expression, and (iv) those involved in nuclear egress.  
 
 
 
Figure 3.3. Phosphorylation of HSV1 proteins.  
We detected 95 phosphorylation sites in 37 HSV1 proteins. A: Phosphorylation patterns were 
altered by acyclovir and PAA. B: Phosphorylated proteins were grouped according to protein 
function and subcellular localisation. They predominantly fulfilled functions in the nucleus (light 
segments), or were involved in immune evasion, or fulfilled a function in the cytosol (dark 
segments). C: Schematic drawings of HSV1 proteins containing more than four phosphorylation 
sites, detected with and without inhibitors (yellow: control, blue: acyclovir, green: PAA).  
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Next, we compared the abundance of phosphorylation sites on individual proteins. We 
detected five or more phosphorylation sites on pRS1, pUL46, pUL49, pUS1 and pUL13 
(Figure 3.3 C), all of which are known to affect HSV1 gene expression, either directly by 
binding to promotor regions (pRS1) or indirectly by binding or modifying other regulatory 
proteins (pUL46, pUL49, pUL13, pUS1) 43, 49 - 50.  
These findings highlight the dynamics of phosphorylation and de-phosphorylation events, 
and point towards a possible role of this modification for the regulation of viral protein 
expression. Our identification of novel phosphosites should facilitate further studies on 
the role of phosphorylation of individual viral proteins, and the function of different 
phosphorylation patterns on proteins harbouring many phosphorylation sites. 
 
3.5.5. Phosphorylated protein motifs display great variability 
 
Our data showed the down regulation of both HSV1 kinases pUL13 and pUS3 by the two 
DNA replication inhibitors (Figure 3.1 A). Interestingly, while acyclovir treatment reduced 
the amounts of pUL13 and pUS3 only moderately, PAA treatment almost completely 
abolished their expression. Consequently, changes in HSV1 protein phosphorylation 
patterns in the presence of acyclovir or PAA might be due to lower expression levels of 
the viral protein kinases pUS3 and pUL13, or might reflect a more complex regulation of 
cellular kinases. To shed additional light on this observation, we extracted and compared 
highly abundant phosphorylation sequence motifs with and without inhibitors (Figure 3.4 
A) using motif-x29. For all three conditions, sequences containing the two residues ‘SP’ 
were found to be enriched. A higher number of common motifs were found for acyclovir 
and PAA compared to those detected in untreated cells. The ‘SP’ residues are reported 
as a putative minimal HSV2 pUL13 recognition motif (Figure 3.4 A)51. Since this motif is 
very short, it is difficult to infer whether protein phosphorylation was catalyzed by pUL13 
or other kinases. Untreated samples contained 39 peptides that were phosphorylated on 
a SP motif. Upon acyclovir and PAA treatment, this number decreased to only 21 and 14 
sites, respectively. Thus, the decrease in phosphorylated residues correlated with a 
reduced abundance of the viral kinase pUL13.  
Five of the phosphorylation sites harbour a motif similar to that of the viral kinase pUS352 
(Figure 3.4 B). Two sites were found on pUL46, one on pUS8, one on pUL54 and one on 
the kinase pUL13. Interestingly, this motif was detected less often after PAA or acyclovir 
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treatment, correlating with the lower expression level of pUS3 under these conditions. 
Overall, changes in phosphorylation of HSV1 substrates probably require a complex 
interplay of several cellular and viral kinases that might be regulated differentially when 
viral protein expression is altered following inhibitor treatment. 
 
 
Figure 3.4. Phosphorylation motifs. 
A: Phosphorylated motifs of HSV1 proteins detected in this study were clustered according to 
highly abundant amino acid sequences in contrast to the HSV1 proteome as a statistical 
background using motif-x. Heuristic scores from motif-x were calculated as the sum of the negative 
log of the binomial probabilities to generate the motifs. The size of the letter used to denote the 
amino acid located C-terminally (+) or N-terminally (-) of the phosphorylated S residue reflects 
how often this amino acid is found in phosphorylated motifs. B: Minimal amino acid sequences 
that function as phosphorylation motifs for the viral kinases pUS3 and pUL13 as published in 51, 
52. 
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3.6. Conclusions 
 
Our study represents a comprehensive analysis of the intracellular HSV1 proteome with 
and without DNA replication inhibitor treatment. While many viral proteins responded to 
DNA replication inhibition as expected for their respective kinetic class, some immediate 
early and early proteins displayed an unexpected sensitivity to this inhibition. Conversely, 
some late proteins remained surprisingly unaffected, suggesting that the current model 
of HSV1 protein expression regulation might not be entirely suited to explain the more 
subtle differences of viral protein expression. HSV1 proteome analyses at different times 
of infection should help to clarify this issue.  
We identified 10 ubiquitylation sites and 95 phosphorylation sites, most of which were 
previously unknown. Functional clustering indicated roles for modified proteins in viral 
protein transport regulation as well as regulation of viral protein expression. Knowledge 
of these modified residues opens the possibility for targeted mutagenesis of specific 
residues, and subsequent characterization of the functions of phosphorylation and 
ubiquitylation in the herpesviral life cycle. Future studies analysing certain fractions of 
infected cells at different times of infection should provide a better understanding on how 
HSV1 proteins are translocated through organelles to fullfill their functions, how this 
orchestrates the assembly of new viral particles, and to what extend these trafficking 
events are regulated by ubiquitylation and phosphorylation. 
Taken together, our dataset provides new insights into HSV1 protein expression 
regulation, and identified novel protein modification sites. We hope that it will serve as a 
valuable resource for future functional studies on HSV1 biology. 
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3.8. Abstract figure 
 
 
Figure 3.5. Abstract figure.  
Visual summary of the present study. 
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3.9. Supporting Information 
 
3.9.1. Supporting figures 
 
 
Figure 3.S1. Coverage of HSV1 structural proteins and proteins of different kinetic classes. 
HSV1 proteins detected with two or more peptides and a score of 25 or higher. Of the 82 
established HSV1 proteins, 67 were detected. Note that of the 15 undetected proteins, 7 are not 
detectable with this method since they are not contained in the database and/or are cleavage 
products of other proteins. The identified HSV1 proteins were grouped according to virus particle 
structure (A) or expression kinetics as published in reference4 (B).Data summarizes three 
independent experiments analyzed in three technical replicates. 
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3.9.2. Supporting tables 
 
 
Table III-S1: Summary of all HSV1 proteins that were identified in this study (under all 
experimental conditions) (CD-ROM).  
Table III-S2: Summary of detailed peptide identifications in HSV1 infected cells treated 
with DMSO, acyclovir or PAA (CD-ROM). 
Table III-S3: Statistics on peptides identified after DMSO, acyclovir and PAA treatment 
in replicate experiments (CD-ROM). 
Table III-S4: Organisation of HSV1 proteins in clusters according to sensitivity to 
acyclovir and PAA (CD-ROM). 
Table III-S5: Description of ubiquitylated peptides including links to spectra (CD-ROM). 
Table III-S6: Statistics on ubiquitylated residues detected in replicate experiments (CD-
ROM). 
Table III-S7: Description of phosphorylated peptides including links to spectra (CD-
ROM). 
Table III-S8: Statistics on phosphorylated residues detected in replicate experiments 
(CD-ROM). 
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4.2. Summary  
 
Herpes simplex virus 1 infection induces the formation of autophagosomes via a 
particular form of autophagy, referred to as nuclear envelope-derived autophagy (NEDA). 
The extent to which NEDA differs from macroautophagy and participates in the 
pathogenesis of HSV infection is still largely unknown. In the present study we showed 
that NEDA is an Atg5-independent pathway that participates in the capture of nuclear 
envelope-resident viral proteins and their processing and presentation on MHC class I 
molecules. Detailed proteomics characterization of autophagosomes revealed that 
NEDA leads to the specific targeting of nuclear envelope-resident proteins including gB 
to autophagosomes in an Atg5-independent manner. In contrast during macroautophagy 
mostly cytosolic proteins were transferred to the vacuolar compartment. These findings 
highlighted that various autophagic pathways can be induced to promote the capture of 
selective sets of viral proteins, thus actively shaping the nature of the immune response 
during infection.    
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4.3. Introduction 
 
The ability to capture, process and present proteins and antigens, either endogenous or 
exogenous, is essential to initiate a sustained immune response against infectious 
diseases and to eliminate aberrant cells that appear during carcinogenesis1, 2. The last 
decade highlighted important contributions of various membrane trafficking pathways to 
the processing and presentation of endogenous or exogenous proteins on MHC class I 
or class II molecules (for a review see 3). Cross-priming allows peptides from exogenous 
proteins to be presented on MHC class I molecules, enabling the production of reactive 
CD8+ T cells against a variety of intracellular pathogens4, 5. On the other hand, autophagy 
was shown to actively promote the capture and processing of endogenous proteins, 
including viral proteins, for presentation on MHC class II molecules6-8. These pathways 
take advantage of antigen processing machineries from the proteasome in the 
cytoplasm, and hydrolases within endocytic organelles to produce a wider diversity of 
peptides. Autophagy furthermore contributes to antimicrobial immunity both in direct 
ways as demonstrated by the xenophagic degradation of intracellular pathogens, and in 
indirect ways e.g. by modulating the activation of effector cells in adaptive immunity 
through the modulation of TLR signaling or antigen presentation9. 
Complex trafficking events, related to autophagy, have also been shown to be actively 
engaged during herpes simplex virus 1 (HSV1) infection10-13. Infection with Herpes 
viruses causes diseases that afflict a large number of people worldwide. Debilitating and 
sometimes severe symptoms can occur through the entire life of infected individuals14. 
This reflects the fact that the immune system is unable to eliminate and mount an efficient 
immune response against the virus, which can remain latent for years. A hallmark of the 
limitation of the immune response during HSV1 infection in mice is the strong CD8+ T 
cell immunodominant response against a single epitope (SSIEFARL) from the viral 
glycoprotein B (gB)15, 16. Although the molecular mechanisms associated with 
immunodominance are extremely complex, it has been proposed that antigen processing 
and presentation are key steps of this process17. We have shown recently that autophagy 
participates in the processing and presentation of viral peptides during HSV1 infection.13 
Remarkably, while this virus is able to inhibit macroautophagy11, it can induce a particular 
form of autophagy characterized by the formation of autophagosomes made of a 4-layers 
membrane, originating from the coiling of the inner and outer membrane of the nuclear 
envelope13. This process, referred to as nuclear envelope-derived autophagy (NEDA), 
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occurs around 6 hours after infection. NEDA can take place in different types of 
mammalian cells, including macrophages and neurons, and requires the synthesis of late 
viral proteins12. The role of NEDA in the pathogenesis of viral infection, the host immune 
response, and its distinctive mechanism compared to macroautophagy are still poorly 
understood. Furthermore, the extent to which NEDA is involved in the processing of viral 
proteins and presentation of antigenic peptides remains to be established. 
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4.4. Results 
 
4.4.1. Contribution of NEDA to viral antigen presentation 
 
Previous reports underscored the role of autophagy in adaptive immunity by increasing 
MHC class II presentation of cytoplasmic antigens, including self or viral antigens, or by 
affecting MHC class I presentation by competing with the proteasome for substrates or 
influencing the peptidome pools through the control of levels of components of microRNA 
(miRNA) machinery9. The significance of autophagy in mounting an appropriate immune 
response against viral antigens, mostly through MHC class II presentation was also 
highlighted in recent studies6, 7. Interestingly, autophagosomes originating from the 
nuclear envelope (NEDA), were found to be an important source of viral peptides for 
proteasomal degradation and presentation through the MHC class I pathway13. 
Accordingly, we sought to examine how NEDA and macroautophagy regulate antigen 
processing and presentation following HSV1 infection, and how they might influence the 
nature of the immune response in infected macrophages. Classical autophagy (referred 
from this point on as macroautophagy) is an Atg5-dependent process that can be 
efficiently inhibited by treating cells with Phosphoinositide-3 kinase (PI3K) inhibitors like 
3-methyl adenine (3-MA) and wortmannin and, more directly, by decreasing the 
expression of Atg518. Interestingly, these two drugs did not alter the recruitment of the 
protein LC3b to the nuclear membrane, a hallmark of NEDA, during HSV1 infection (Fig. 
4.1A). In contrast, the localization of LC3b to classical autophagosomes observed in the 
cytoplasm of uninfected cells after a mild heat shock is markedly decreased by these 
inhibitors. Furthermore, down-regulation of the expression of Atg5 by shRNA (Fig.4.S1) 
had no effect on the recruitment of a variant form of LC3, LC3a, a marker for NEDA, to 
the nuclear envelope (Fig. 4.1B), suggesting that NEDA is an Atg5-independent process. 
This was further confirmed using electron microscopy where the formation of 4-layers 
membrane autophagosomes on the nuclear envelope of HSV1-infected mouse 
embryonic fibroblasts (MEFs) was still observed in Atg5 -/- cells (Fig. 4.1C). Also, no 
significant changes in the distribution of LC3a on the nuclear rim was observed using 
immunofluorescence microscopy (Fig. 4.1D). These results clearly indicate that NEDA is 
an Atg5-independent process regulated by molecular mechanisms distinct from those of 
macroautophagy.  
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Figure 4.1. NEDA is regulated differently than macroautophagy and is Atg5-independent. 
A. Macrophages were treated with the PI3K inhibitors 3-methyl adenine (3-MA) or wortmannin, or 
with DMSO as a control. Additionally, they were either infected with HSV1 WT, or left uninfected 
and treated with a heatshock. Immunofluorescence analysis with a LC3b antibody showed that 
LC3b accumulation around the nucleus and thus NEDA took place in infected cells despite the 
inhibitors. Heatshock treatment confirmed the efficient inhibition of macroautophagosome 
formation with 3-MA and wortmannin, since the number of LC3b positive punctae (arrowheads) 
was markedly reduced by both drugs. B. Immunofluorescence analysis of macrophages stably 
expressing shRNA against Atg5 or scrambled shRNA showed that HSV1 WT infection induced 
LC3b accumulation around the nucleus and thus NEDA even when Atg5 was down regulated. C. 
Four-membrane hooks characteristic for NEDA formed at the nuclear envelopes of HSV1 WT 
infected MEF cells with and without Atg5, as observed by electron microscopy. D. Quantification 
of three representative immunofluorescence experiments with about 200 cells showed that LC3a 
accumulated in the nuclear envelopes of HSV1 WT infected MEF cells similarly with and without 
Atg5. Error bars: SD 
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To determine whether NEDA plays a role in the capture of viral antigens and their 
processing for presentation on MHC class I molecules, we infected BMA macrophages 
with the wild type (WT) HSV1 that induces NEDA, or the HSV1 mutant ΔPP1α that does 
not trigger NEDA12, and quantified gB presentation as described previously13. The 
ΔPP1α mutant contains point mutations in the ΔPP1α binding domain of ICP34.5, which 
interferes with PP1α binding. ICP34.5 via its PP1α binding domain binds both PP1α and 
eIF2α, thus facilitation eIF2α dephosphorylation and active translation, necessary for 
NEDA. Hence NEDA is not triggered anymore in the ΔPP1α mutant, while 
macroautophagy can still occur12. To determine if lytic vacuoles like autophagolysosomes 
are the primary sites of cytosolic antigen processing, we treated cells with the lysosomal 
acidification inhibitor Bafilomycin A1 (Baf). These experiments revealed that gB 
presentation was strongly reduced by Baf treatment in HSV1 WT, and to a much lesser 
extent in HSV1 ΔPP1α infected cells (Fig. 4.2A), suggesting that vacuolar processing 
contributes to HSV1 antigen presentation when NEDA occurs. It is noteworthy that 
changes in CD8+ T cell activation following Baf treatment of either WT or ΔPP1α infected 
macrophages were not due to variable levels of MHC I molecules at the cell surface (Fig. 
4.2B), or different expression levels of gB (Fig. 4.2C).  
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Figure 4.2. NEDA contributes to the presentation of gB to MHC class I molecules. A. 
Macrophages were infected with HSV1 WT that induces NEDA, or with HSV1 ΔPP1α that does 
not. MHC I presentation of the viral protein gB was determined 9h pi by assessing the activation 
of 2E2 T cell hybridoma. Bafilomycin A1 (Baf) was added at 4 h pi to inhibit the vacuolar 
contribution to antigen presentation. Error bars: SD. B. Infection with HSV1 WT or ΔPP1α and 
treatment with Bafilomycin A1 does not affect MHC I expression levels. C. Infection levels are 
comparable in macrophages infected with HSV1 WT and ΔPP1α as assessed by western blot for 
gB. Tubulin was used as a loading control. 
 
One of the remarkable features that distinguish NEDA from macroautophagy is the fact 
that the membrane required for autophagosome formation is recruited from the nuclear 
envelope, where several viral proteins, including gB, are highly enriched. To determine if 
gB present on the nuclear envelope can be captured for antigen presentation during 
NEDA, we expressed constructs where gB was linked to the ovalbumin peptide 
SIINFEKL (OVA) (Fig. 4.3A) and targeted either to the nuclear membrane or the lumen 
of the endoplasmic reticulum (ER) as a control (Fig. 4.3B). The addition of the SIINFEKL 
epitope allowed us to measure the level of antigen presentation using an OVA-specific 
CD8+ T cell hybridoma, rather than gB coming from the expression of the marker and 
the native viral protein during infection. In that context, HSV 1 infection is simply used to 
trigger NEDA (WT virus), or macroautophagy (ΔPP1α virus). Control experiments 
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indicated that NEDA was induced in cells expressing the gB/OVA constructs and infected 
with WT HSV 1 but not in cells infected with the ΔPP1α virus (data not shown). When 
BMA cells stably expressing these constructs were infected with WT HSV1, we observed 
that gB/OVA present on the nuclear envelope was effectively processed in a vacuolar 
compartment (Baf-sensitive) and presented to the OVA-specific CD8+ T cell hybridoma 
(Fig. 4.3C). In contrast, infection with the ΔPP1α virus led to a significant reduction 
presentation of gB/OVA by a mechanism largely unaffected by the Baf treatment. On the 
other hand, no change in CD8+T cell activation was observed when gB/OVA was 
expressed in the ER lumen of macrophage cells infected with the two distinct viruses and 
the ER luminal reporter antigen was presented mostly Bafilomycin A1 independently, 
suggesting that the ER itself can be recruited for the formation of autophagosomes during 
both NEDA (WT virus) and macroautophagy (ΔPP1α) (Fig. 4.3C). Control experiments 
indicated that the level of expression of the gB/OVA constructs was not affected by the 
viral infection since similar levels were observed in mock cells (Fig. 4.3D). To confirm 
that NEDA participates in the presentation of viral antigens, we also monitored changes 
in CD8+ T cell activation of macrophages infected with WT or ΔPP1α HSV 1 virus 
following pharmacological inhibition of the Atg5-dependent autophagic pathway or 
shRNA silencing of Atg5. Control experiments performed on WT HSV1-infected 
macrophages treated with Acyclovir, a drug that inactivates DNA polymerases and 
incorporates itself into viral DNA chain, confirmed the inhibition of the vacuolar pathway in 
gB/OVA presentation (Fig. 4.3E). In contrast, WT HSV1-infected macrophages with 
knock down Atg5 or grown in the presence of 3 methyl adenine (3-MA), which blocks the 
formation of autophagosome via the inhibition of phosphatidylinositol 3-kinases, showed 
no significant changes in antigen presentation (Fig. 4.3E). It is noteworthy that Baf 
treatment of macrophages infected with WT HSV 1 showed a significant reduction of 
gB/OVA presentation confirming the Atg5-independent pathway and the role of NEDA in 
antigen processing. These results were in stark contrast with those from macrophages 
infected with ΔPP1α virus where Baf treatment no longer affected the presentation of the 
full-length gB/OVA in either WT or Atg5 knock-down cells, thus validating that 
macroautophagy is an Atg5-dependent pathway. 
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Figure 4.3. NEDA contributes to MHC class I antigen presentation of a nuclear envelope-
resident viral antigen.  
A. Construction of macrophage cell lines that stably express a reporter antigen in the nuclear 
envelope or the ER lumen. RAW macrophages were stably transfected to express H2kb, and a 
vector coding either for HSV1 gB full length-SIINFEKL or a truncated version that lacks the 
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transmembrane domain (TM). B. Immunofluorescence analysis with a gB antibody confirmed the 
localization of these constructs to be either mainly in the nuclear envelope and vesicular structures 
that might represent Golgi (nuclear envelope), or diffusely spread out throughout the ER and most 
notably absent from the nuclear envelope (ER lumen). C. Macrophage cell lines stably expressing 
a reporter antigen (SIINFEKL) either at the nuclear envelope or in the ER lumen were infected 
with HSV1 WT or HSV1 ΔPP1α for 9h. Bafilomycin A1 (Baf) was added at 3h pi. The Bafilomycin 
A1-sensitive vacuolar antigen presentation of the nuclear envelope resident, but not the ER lumen 
resident reporter antigen was reduced strongly with HSV1 ΔPP1α that does not induce NEDA. 
Error bars: SD. D: HSV1 WT and ΔPP1α do not alter expression of the full length gB-OVA-myc 
construct. E. The autophagic contribution to antigen presentation on MHC I is partially insensitive 
to macroautophagy inhibition. Antigen presentation with macrophages expressing the nuclear 
envelope resident reporter antigen containing SIINFEKL and either scrambled shRNA or shRNA 
against Atg5 were infected with HSV1 WT or mock infected for 9h, and treated with acyclovir or 
3-MA at 2h pi. Bafilomycin A1 was added at 4h pi. Inhibition of NEDA with acyclovir strongly 
reduced the Bafilomycin A1-sensitive vacuolar contribution to antigen presentation. In contrast, 
inhibition of macroautophagy by 3-MA treatment or Atg5 knock down reduced the vacuolar 
contribution much less, indicating that NEDA could contribute to antigen presentation in the 
absence of macroautophagy. Bafilomycin A1 treatment no longer affected the presentation of the 
full-length gB/OVA construct in Atg5 knock-down cells infected with the ΔPP1α virus. Error bars: 
SD. (Figure 4.3. continued) 
 
4.4.2. Quantitative proteomics analyses of viral proteins in 
autophagolysosomes 
 
Thus far, our results highlight the fact that NEDA differs from macroautophagy, as an 
Atg5-independent process, and participates actively in the capture of viral antigens 
expressed in the nuclear envelope for antigen presentation during HSV1 infection. These 
features suggest that NEDA might provide an immunological advantage to the host 
during HSV1 infection by modulating the immune response via alternate antigen 
processing and presentation pathways.  To determine how NEDA could influence the 
immune response and pathogenesis infection, we analyzed enriched 
autophagolysosomes (APL) formed in HSV1-infected macrophages, using mass 
spectrometry (MS)-based quantitative proteomics. Procedures to isolate 
autophagosomes based on their intrinsic density have been used in the past to 
characterize the composition of these organelles19-21. However, the fact that a large 
repertoire of host proteins can be captured by autophagy and be present in 
autophagosomes renders the identification of contaminants very difficult (see 
discussion). Thus, to characterize the composition of APLs and identify their viral content, 
we developed a novel organelle isolation method that takes advantage of a well-
established flotation procedure shown to generate purified organelles with minimal 
contaminants22 (Fig.4.4A). Previous reports indicated that autophagosomes formed 
during autophagy fuse with late endosome/lysosome-like organelles to generate APL23. 
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In that context, we filled the late endosome/lysosome compartment by internalizing small 
latex beads (100 nm) prior to HSV1 infection and autophagosome formation. Upon HSV1 
infection, autophagosomes that fused with latex bead-containing compartments could be 
isolated by a simple flotation centrifugation. Latex bead-containing compartments (LB-C) 
isolated from uninfected cells were used as control to distinguish proteins associated with 
autophagosomes from those present on LBC. In addition to the 100 nm latex beads, we 
also used 800 nm beads for comparison. Electron microscopy experiments clearly 
indicated that 4-layered membrane autophagosomes containing viral capsids interact 
and fuse with LBC (Fig. 4.4B). Western blot analyses confirmed that the flotation method 
enabled the isolation of nuclear envelope-derived autophagosomes with the enrichment 
of the viral protein gB, the nuclear pore protein p62, and the autophagosome marker 
LC3b upon HSV1 infection of macrophage cells (Fig. 4.4C). The comparison of protein 
recovery yield from latex beads of different sizes indicated that beads of 800 nm generally 
provided higher recovery as indicated in Fig. 4.4C for the staining patterns of the different 
protein markers. These results demonstrated that this new cell fractionation approach is 
well suited to the rapid isolation of highly purified autophagosomes/APL for further 
characterization.  
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Figure 4.4. A novel autophagolysosome isolation method. 
A. The isolation method is based on the loading of the lysosomal compartment with latex beads. 
To isolate APL, we filled lysosomes/phagolysosomes with latex beads and induced NEDA through 
HSV1 WT infection to promote the fusion of autophagosomes with latex bead-containing 
lysosomal compartments. B. Macrophages were preloaded with either 100 nm or 800 nm latex 
beads to fill the lysosomal compartments, and infected cells with HSV-1 to induce the formation 
of the typical 4-membrane layered autophagosomes associated with NEDA. 4-membrane layered 
structures were either closely associated with the 100 and 800 nm latexbead-compartment (LB-
C) or fused with them. Electron microscopy also showed the presence of viral capsids within the 
lumen of LB-C, indicating that these compartments fused with autophagosomes to become APL. 
C. Western blotting showed that the nuclear membrane protein p62 nucleoporin was present in 
APL after infection, but absent from LB-C isolated from non-infected cells, confirming that the 
autophagosomes that fused with LB-C in infected cells were derived from the nuclear envelope.  
Since a higher enrichment of p62 was observed in APL formed with the 800 nm beads, these 
were used to perform subsequent experiments. 
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To determine whether NEDA selectively captures subsets of viral proteins, and study 
how this process could shape the nature of the immune response during HSV1 infection, 
we analyzed APL isolated from macrophages infected either with the WT or ΔPP1α 
mutant virus. We also analyzed total cell lysates (TCL) generated under the same 
conditions as controls for enrichment levels (Fig. 4.5A). Mass spectrometry analyses of 
APL protein extracts from macrophages infected with WT HSV1 enabled the 
identification of 54 viral proteins while a total of 60 viral proteins were identified for 
ΔPP1α HSV1 (Table IV-1 and Supplemental Table IV-S1). Analyses of TCL protein 
extracts from WT and ΔPP1α infected macrophages led to the identification of 63 and 
58 viral proteins, respectively (Table IV-1 and Supplemental Table IV-S1). Altogether 
these proteomics analyses identified a total of 68 HSV1 representing a 83% coverage of 
the HSV1 proteome (82 proteins).  
Table IV-1. Statistics of quantitative proteomics analysis of APL and TCL from HSV1 WT and 
HSV1 ΔPP1α infected macrophages (Protein identifications (>1 peptides/protein); HSV1 
proteome = 82 proteins). 
 HSV1 WT HSV1 ΔPP1α 
TCL APL TCL APL 
Distinct peptides 1207 972 978 1065 
HSV1 proteins 63 54 58 60 
% HSV1 proteome 77 66 71 73 
 
Quantitative analysis of protein abundance based on peptide spectral count revealed 4 
clusters of viral proteins (Fig. 4.5A). The first cluster consisted of 20 HSV1 proteins 
corresponding to peptides highly abundant in the TCL but under-represented in the APL. 
We were able to assign a subcellular localization to most HSV1 proteins expressed in 
cells during infection based on earlier reports24, 25. Interestingly, 65% of the proteins within 
this cluster are expressed in the nucleus, suggesting that intra-nuclear proteins are not 
efficiently captured during NEDA, and are prevented from being processed within 
vacuolar compartments for antigen presentation during infection. The second cluster 
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consisted of 15 viral proteins highly abundant and/or enriched in APL isolated from cells 
infected with the WT or mutant viruses. The majority of these proteins are captured from 
the cytoplasm and cellular membranes (TGN/plasma membrane). The third cluster 
consisted of 23 proteins enriched in APL isolated from WT HSV1-infected cells. The 
capture of these proteins is probably linked to NEDA. In that context, it is interesting to 
note that a significant part (26%) of these proteins is associated with the nuclear envelope 
membrane. Finally, the fourth cluster consisted of 10 proteins that are specifically 
enriched in APL formed during infection with the ΔPP1α virus where NEDA does not 
occur. Indeed, none of these proteins are predominantly localized to the nuclear 
membrane nor captured during NEDA. For the most part, these viral proteins are coming 
from other membrane compartments within the cell such as the Trans-Golgi network 
(TGN)/plasma membrane, suggesting that the autophagic process responsible for the 
capture of these proteins is not NEDA, but possibly macroautophagy. Further differences 
are observed in the type of viral proteins captured and transferred to APL during infection. 
Indeed, a significantly higher proportion of late viral proteins is captured by the 
autophagic processes occurring during HSV1 infection. How different subsets of viral 
proteins would be specifically targeted to the APL is still unknown. Selective autophagy 
is thought to involve the labelling of cargo with ubiquitin and an adaptor protein that binds 
both ubiquitin and LC326. Interestingly, we identified a number of ubiquitylated viral 
protein in our datasets suggesting a possible role for ubiquitin in the transfer of viral 
antigens to APL (Table IV-S2). Notably, we identified 28 ubiquitylation sites on 22 
proteins in APL extracts from macrophages infected with WT HSV1, while 34 
ubiquitylation sites on 24 proteins were detected upon ΔPP1α infection. However, 
mapping ubiquitylated proteins to specific clusters of proteins that are transferred to the 
APL (or not transferred) did not reveal any significant trend (Fig. 4.5) suggesting that 
ubiquitylation does not necessarily regulate the selective transfer of viral antigens to the 
APL during HSV1 infection. 
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Figure 4.5. Quantitative proteomics analysis of APL extracts.  
BMA macrophages were infected with HSV1 WT and ΔPP1α at MOI 5. Autophagolysosomes 
(APL) and total cell lysate (TCL) were isolated 8h pi. Mass spectrometry analysis of HSV1 proteins 
in TCL and APL revealed four distinct clusters. Viral proteins were assigned according to their 
predominant subcellular localization. Viral nuclear envelope-resident proteins were detected most 
frequently in APL of HSV1 WT infected cells. TGN: Trans-Golgi-network; PM: Plasma membrane. 
Mostly later viral proteins were transferred to the APL. Several proteins were found to be 
ubiquitylated (*) by mass spectrometry. 
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Several interesting observations can be highlighted from these data. We mentioned 
above that HSV1 infection is characterized by the induction of a CD8+ T cell response 
preferentially directed against the SSIEFARL peptide of gB. Interestingly, gB (UL27) is 
present within the third cluster of proteins, preferentially enriched in APL from WT-
infected cells where NEDA occurs (arrow in Fig. 4.5). When spectral peptide count was 
used to determine the relative abundance of the viral peptides present in APL and TCL 
from cells infected with WT or ΔPP1α virus, we observed that peptides from gB were 
more abundant in APL of WT-infected cells, while gB was only the third most abundant 
protein identified in the TCL. In contrast, gB peptides are more abundant in both APL and 
TCL extracts of ΔPP1α infected cells (Fig. 4.6A). However, gB is significantly enriched in 
the APL of macrophages infected with WT compared to ΔPP1α HSV1 virus (Fig. 4.6A). 
Western Blot analysis confirmed the preferential transfer of gB to the APL, and the 
appearance of small bands of lower molecular weight, suggesting its degradation and 
processing within APL (Fig. 4.6B). Interestingly, it has been known since more than a 
decade that the cytotoxic T cell response to HSV-1 infection in mice is almost entirely 
directed against a single gB immunodominant epitope (SSIEFARL)15. These observation 
suggest that NEDA might contribute to the immunodominance by promoting the transfer 
of gB to degradative compartments, such as APL, for antigen processing. 
Western blot analyses further indicated that Atg5KD does not affect the enrichment of gB 
in APL during WT infection (Fig. 4.6B), suggesting that the capture of this protein occurs 
independently of Atg5. Comparison of viral proteome data from the APL of WT and 
ΔPP1α infected cells showed that a higher sequence coverage of gB was observed in 
macrophages infected with WT (56%) compared to ΔPP1α HSV1 (48%) (Fig. 4.6C). We 
also noted that different gB sequences were identified in these extracts, possibly 
reflecting the different composition of lytic enzymes within APL of infected macrophages. 
This is also highlighted by the presence of different ubiquitylated residues on gB with 
different viruses. An extracted ion chromatogram (XIC) for a representative peptide of gB 
shows its preferential localization in APL isolated from WT HSV1-infected cells (Fig. 
4.6D).  
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Figure 4.6. NEDA leads to the enrichment of gB on the APL.  
A. Redundant peptide count of the five most abundant proteins in each sample. gB is significantly 
enriched in APL infected with HSV1 WT compared to ΔPP1α infection (p=value> 0.1). B. Western 
Blot analysis of APL extracts from BMA Scr and Atg5KD macrophages confirmed the preferential 
transfer of gB to the APL during HSV1 WT infection. This transfer is Atg5 independent. C: 
Comparison of gB sequence coverage in the APL from HSV1 WT and ΔPP1α infected 
macrophages, ub: ubiquitylation site detected by mass spectrometry. D. Extracted ion 
chromatogram (XIC) of a representative peptide of gB (RNQLHDLR) shows the stronger 
abundance in the APL of HSV1 WT infected macrophages. 
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Our proteomics analyses provide the first evidence that NEDA is functionally distinct from 
macroautophagy by the composition of viral proteins found in the corresponding APL 
compartments which on the other hand could impact the nature of the antigens presented 
on MHC molecules during infection. We also noted that viral proteins more abundant in 
APL of HSV1 ΔPP1α−infected macrophages corresponded mostly to cytosolic proteins, 
suggesting that classical macroautophagy could also be involved (Fig. 4.5 and 4.7A). 
The increase in abundance of UL17 in the APL of HSV1 ΔPP1α infected cells was also 
confirmed by comparing the extracted ion chromatograms of the corresponding peptides. 
A representative profile of a peptide from UL17 is shown in Figure 4.7B along with its 
MS/MS spectrum.  
The specific transfer of different viral proteins according to the type of autophagic 
pathway prompted us to further investigate the role of Atg5 in the transfer of specific 
antigens. The subset of the protein enriched in the APL during HSV1 ΔPP1α infection 
was probed by Western blotting. Accordingly we mainly detected UL1, UL17, UL51 and 
US4 in the APL extracts of macrophages infected with HSV1 ΔPP1α (Figure 4.7C). In 
Atg5 KD macrophages, these proteins were no longer detected in the corresponding 
extracts suggesting that the specific transfer of viral proteins to the APL during HSV1 
ΔPP1α infection is Atg5-dependent. In contrast proteins enriched on the APL of HSV1 
WT-infected macrophages revealed that proteins such as gB (Fig. 4.6B) and gH (Fig. 
4.7D) are preferentially transferred to the APL during viral infection. Importantly, these 
analyses also revealed that the transfer of these viral proteins is Atg5 independent as gB 
and gH and can still be detected on the APL even in Atg5 KD cells (Fig. 4.7D).  
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Figure 4.7. Atg5-dependent transfer of a specific subset of proteins to the APL during 
ΔPP1α infection.  
A. Cluster of proteins that are selectively transferred to the APL during HSV1 ΔPP1α infection. 
Atg5-dependent and independent antigen transfer to the APL. B. Mass Spectrometry analysis 
confirms the increase in abundance of UL17 in the APL of HSV1 ΔPP1α infected macrophages 
as shown by the XIC of a representative peptide of UL17 (AALQGGPR).C. Western Blot analysis 
for proteins selectively transferred to the APL during HSV1 ΔPP1α infection UL17, UL1, UL51and 
US4 in APL extracts reveals that the transfer of viral antigens to the APL during ΔPP1α infection 
is Atg5-dependent. D. Western Blot analysis for gH, enriched in the APL upon HSV1 WT infection, 
reveals that the transfer of viral antigens to the APL through NEDA is Atg5-independent.  
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4.5. Discussion 
 
It was only recently that autophagy was shown to play a role in the presentation of viral 
proteins on both MHC class I and class II molecules. The group of Münz initially showed 
that EBNA1, a viral protein expressed during Epstein-Barr virus (EBV) infection in EBV-
positive lymphoma cells6 was presented on MHC class II molecules. This important 
finding indicated that autophagy was a cellular process that could actively shape the 
CD4+ T cell immune response during infection. On the other hand, we were able to show 
that autophagy also contributes to the capture of endogenous viral proteins for 
processing in vacuolar compartments and presentation on MHC class I molecules during 
HSV1 infection13. This is of potential immunological interest as vacuolar processing of 
viral proteins by autophagy could lead to the generation of peptides not usually produced 
by proteasomal processing in the cytoplasm within the classical MHC class I presentation 
pathway. For example, it was shown that aminopeptidases present in the cytoplasm 
contributed to preferential amino acid cleavage, enhancing the presentation of certain 
peptides to cytotoxic T cells during HIV infection27. In the case of HSV1 infection, we 
have shown that a particular type of autophagic response was observed, characterized 
by the formation of 4-layers membrane autophagosomes generated from the coiling of 
the nuclear envelope. However, the contribution of this process, referred to as NEDA, to 
antigen presentation was not demonstrated. Also, it was not yet well understood how 
NEDA differs from macroautophagy. 
Our results clearly indicate that unlike macroautophagy, NEDA is an Atg5-independent 
process that contributes directly to the capture of viral antigens, their processing, and 
their presentation on MHC class I molecules (Fig.4.1 and Fig.4.2). While 
macroautophagy is inhibited by PI3K inhibitors such as 3-MA or by Atg5KD, NEDA is not 
affected (Fig. 4.1). Macroautophagy inhibition only partially reduce MHC class I antigen 
presentation, while inhibition of NEDA with acyclovir almost completely abolishes any 
vacuolar contribution to antigen presentation (Fig. 4.3E). This clearly shows that NEDA 
strongly contributes to MHC1 antigen presentation during HSV1 infection and also 
highlights functional differences between NEDA and macroautophagy. This could 
suggest that gB is processed differently in autophagosomes derived from NEDA and 
macroautophagy, hence resulting in the creation of more antigenic peptides during NEDA 
and thus more efficient antigen presentation on MHC class I molecules. 
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During macroautophagy bulk cytoplasm is engulfed and degraded in the APL23. NEDA is 
a more selective process and autophagosomes are functionally different as they originate 
from the nuclear envelope. To investigate the selectivity of viral antigen captured for 
antigen presentation during NEDA, we localized gB to the nuclear envelope (Fig. 4.3A 
and 4.3B) and monitored its presentation to CD8+ T cells using our novel antigen 
presentation system28. Our data indicated that NEDA specifically contributes to the 
presentation of a specific subset of viral antigens localized to the nuclear envelope, while 
it did not significantly contribute to the presentation of ER resident antigens to MHC class 
I molecules (Fig. 4.3C).  
To further understand how NEDA contributes to MHC class I antigen processing and 
presentation it is crucial to characterize the composition of autophagosomes formed 
during this process. To our knowledge no previous investigations reported the proteome 
of APL and only four previous studies described the use of mass spectrometry to identify 
autophagosomal proteins19-21, 29. While these approaches were mostly based on density 
gradient isolation19-21, they identified only a limited number of autophagosome proteins, 
as most proteins were associated to metabolic processes19 or had unknown functions. 
The conclusions from these studies were limited by the fact that autophagosomes were 
isolated by density gradient centrifugation30, an approach were contaminants can co-
migrate and can consequently hamper the identification of bona fide autophagosomal 
proteins. Furthermore, the overlap between all four autophagosomal proteomes is 
alarmingly low21, raising questions about co-purified contaminants or unselective capture 
during cytosolic bulk degradation. 
To characterize the proteome of the APL formed by NEDA, an efficient cell fractionation 
approach was developed to isolate these compartments. It is known that an APL is 
formed by the fusion of an autophagosome with a lysosome (or a phagolysosome)31. 
Thus, we reasoned that by filling the lysosomal compartment with latex beads prior to the 
stimulation of autophagy, it should be possible to isolate APL by a well-established 
flotation method (Fig. 4.4). The advantage of the flotation method is that it yields highly 
purified fractions devoid of cellular contaminants22. Here we show that this isolation 
technique yields pure APL extracts (Fig. 4.4) and the isolation method can be directly 
integrated into our well-established LC-MS/MS workflow. 
This new method for APL isolation is applicable to the investigation of several different 
types of autophagy and can be employed to investigate how different stimuli shape the 
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APL proteome. The availability of this technique for proteomics analyses of APL would 
be of immediate impact to the field of autophagy as it provides the ability to perform sub-
cellular fractionation and conduct large-scale study on APL under different experimental 
paradigms. The analysis of different types of selective autophagy pathways using our 
technique could provide important insights into cargo recognition, cargo receptors or 
even more on the origin of the phagophore membrane used to form the autophagosome. 
The selectivity of NEDA in preferentially capturing nuclear envelope derived proteins was 
confirmed by detailed proteomics analyses of the APL (Fig. 4.5). In contrast to 
macroautophagy, NEDA was found to be an Atg5-independent autophagy process. 
Interestingly, gB was found to be one of the most abundant viral proteins enriched on the 
nuclear envelope during infection with WT HSV1. This observation could partly explain 
the immunodominance of gB, where the cytotoxic T cell response to HSV-1 infection in 
mice is almost entirely directed against a single gB immunodominant epitope 
corresponding to the peptide SSIEFARL15. In fact, more than 50% of the CD8+ T cells 
present in infected mice are directed against this single epitope. The other reactive viral 
epitopes in mice are unknown16. A study examining the CD4+ T cell repertoire in HSV-1 
infected human patients also detected gB as the most abundantly presented protein, 
followed by gD, and ICP432. While the cellular processes responsible for gB 
immunodominance are poorly understood, our results suggest that NEDA could 
contribute to immunodominance by promoting the transfer of high amounts of gB to 
degradative compartments, such as APL, for antigen processing. Immunodominance 
leads to an inefficient immune response, and NEDA could be beneficial for the HSV1 
infection by limiting the immune response to a single epitope of the viral protein gB. NEDA 
inhibition by e.g. Acyclovir treatment could possibly represent a novel therapeutic avenue 
to reduce the damaging effects of immunodominance. Obviously, further studies will be 
required to validate this hypothesis. 
Comprehensive proteomics analyses revealed another striking finding where different 
viral proteins were transferred to the APL according to the type of autophagy. A subset 
of mostly cytosolic or trans-golgi network resident proteins was preferentially transferred 
to the APL during infection with the ΔPP1α virus (Fig. 4.5). Importantly, this transfer was 
Atg5-dependent, while most proteins transferred to the APL during HSV1 WT infection 
were trafficked in an Atg5-independent manner. The fact that many cytosolic proteins 
were transferred to the APL during ΔPP1α infection in an Atg5-dependent way, suggest 
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that macroautophagy contributes to this transfer. Our results clearly show that different 
types of autophagy can be induced to promote the capture of subsets of viral proteins for 
antigen processing and presentation. Our study represent the first contribution 
highlighting that the nature of the immune response can be shaped by modulating the 
autophagic process during infection. By stimulating distinct autophagic pathways, one 
could promote the recruitment of different organelles to the APL and hence capture 
specific sets of viral proteins for processing and antigen presentation. Taken together, 
our study highlights that harnessing the contribution of autophagy in antigen presentation 
has the potential to minimize the deleterious effects of immunodominance in viral 
infection, and to activate an immune response against disease epitopes less often 
detected. 
  
200     
 
4.6. Experimental Procedures 
 
4.6.1. Cells, viruses, and antibodies  
 
The BMA3.1A7 macrophage cell line was derived from C56/BL6 mice33. BMA3.1A7, 
RAW, MEF WT (kindly provided by Gilbert Arthur, University of Manitoba, Canada) and 
MEF atg5-/- (kindly provided by N. Mizushima (Medical and Dental University, Tokyo) 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% (vol/vol) 
fetal calf serum (FCS) and 2 mM glutamine. The gB HSV-specific CD8+ T cell hybridoma 
HSV-2.3.2E2 (kindly provided by G. Arthur, University of Manitoba, Canada, ) and the 
OVA-specific CD8+ B3Z T cell hybridoma (kindly provided by W. Heath, University of 
Melbourne) were cultivated in RPMI with 5% FBS. The HSV1 strains 17+ WT (kindly 
provided by Beate Sodeik, Medizinische Hochschule Hannover, Germany) and HSV1 
17+ ΔPP1α12 were propagated in BHK-21 cells (ATCC CCL-10), and titers were 
determined on Vero cells (ATCC CCL-81) as previously described34. 
The following primary antibodies against cellular proteins were used: rabbit polyclonal to 
cleaved LC3b (AP1806a; Abgent), rabbit polyclonal antibody to cleaved LC3a (AP1805a; 
Abgent), mouse monoclonal anti-tubulin antibody (GTU-88; Sigma), mouse monoclonal 
anti-nuclear pore complex/p62 antibody (610497, BD Transduction Laboratories), mouse 
monoclonal anti-GAPDH (MAB374, Millipore), a mouse monoclonal anti-atg5 antibody 
(NB110-74818, Novus Biologicals) for immuno blot, a rabbit polyclonal anti-atg5 antibody 
(PAB0712, Abnova) for immunofluorescence, and a rat polyclonal anti-lamp1 antibody 
that was contributed by J. Thomas August to the Developmental Studies Hybridoma 
Bank, University of Iowa. The rabbit polyclonal anti-myc antibody (ab9010; abcam) was 
used to detected myc-tagged proteins. Viral proteins were detected with mouse 
monoclonal antibodies against HSV1/2 gB (10-H44, Fitzgerald for immunofluorescence; 
clone 10B7, ab6506 Abcam for immuno blots), a mouse monoclonal antibody against 
HSV1 gE (H600, VirusSys),a mouse monoclonal against ICP0 (clone5H7, ab6515 , 
Abcam), a mouse monoclonal antibody against gH (BBH1, Abcam), a mouse-monoclonal 
antibody against gG (H1379, ab53471, Abcam) and mouse-monoclonal antibodies 
agains UL17, UL1 and UL51 (kindly provided by Roger Lippé , Université de Montréal). 
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4.6.2. Generation of pIRES-gB1-2715 Nuclear Envelope and pIRES-gB1-
2094 ER lumen vectors  
 
The HSV1 gB sequence was amplified from purified HSV1 F DNA as described 
previously28. The full length gene (coding for aa 1-2715) was transferred into pIRES-
EGFG without a localisation signal, and the C-terminally truncated gene that did not code 
for a transmembrane region (aa1-2094) was cloned into pIRES-EGFP-KDEL that 
contains the ER retention signal KDEL, both kindly provided by Claude Perreault 
(Université de Montréal). 
 
4.6.3. Generation of stable RAW gB-nuclear envelope & RAW gB-ER lumen 
cell lines  
 
RAW cells containing the MHC I isoform kb were described previously28. In order to 
generate the RAW gB-nuclear envelope and RAW gB-ER lumen cell lines, the RAW kb 
cells were transfected with the two pIRES-gB vectors described above. Stable clones 
were selected with 0.5 mg/ml G418 starting 24h after transfection. After 8 days individual 
cells expressing high levels of eGFP were selected and isolated using a BD FACS 
Vantage sorter. These cells were cultivated to derive at monoclonal stable cell lines.  
 
4.6.4. Infection and drug treatment  
 
Cells were inoculated at a multiplicity of infection (MOI) of 5-10 on a rocking platform at 
37°C for 30 min. The inoculum was removed and replaced with cell culture medium, and 
infected cells were incubated until 8 h postinfection (hpi) for APL isolations, 
immunofluorescence analysis and electron microscopy. For antigen presentation 
experiments, cells were incubated until 9 hpi. The PI3K inhibitors wortmannin (681675, 
Calbiochem) and 3-MA (011M4006, Sigma) were added at 2 hpi at final concentrations 
of 50 µM or 10 mM, respectively. Bafilomycin A1 (MT-800, KAMIYA Biomedical 
Company) was added at 3 h pi at a final concentration of 1 µM. For heatshock treatment, 
cells were incubated at 42C for 20 min. 
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4.6.5. Antigen presentation assays  
 
Infected macrophages were fixed for 10 min sharp with 1% (WT/vol) paraformadehyde 
at room temperature, followed by three washes with DMEM containing 10% FBS and 
1mM glycin (Sigma). The 2E2 or B3Z T cell hybridoma were added at a ratio of two T 
cells per macrophage to detect SSIEFARL (HSV1 gB) or SIINFEKL (ovalbumin) 
presentation, respectively. The T cells were incubated for 12 to 14h at 37C, and then 
collected and lysed  by treatment with 0.125 M Tris base, 0.01 M cyclohexane 
diaminotetraacetic acid, 50% (vol/vol) glycerol, 0.025% (vol/vol) Triton X-100 and 0.003 
M dithiothreitol, pH 7.8 for 10 min on a shaker. The beta-galactosidase substrate (0.15 
mM chlorophenol red b-D-galactopyranoside (10884308001, Roche) in 1 mM MgSO4 x 
7 H2O, 10 mM KCl, 0.39M NaH2PO4 _ H2O, 0.6 M Na2HPO4 x 7 H2O, pH 7.8) was 
added for 2–4 h at 37C. Cleavage of chlorophenol red-b-D-galactopyranoside was 
measured in a spectrophotometer at 595 nm. The SSIEFARL or SIINFEKL peptides were 
added together with the T cell hybridoma to control MHC I surface levels.  
 
4.6.6. Autophagolysosome isolation  
 
BMA3.1A7 macrophages were infected with HSV1 WT or ΔPP1α virus at a MOI of 10 for 
30 min. After a 15 min washing step with (DMEM) containing 10% (vol/vol) fetal calf 
serum (FCS) and 2 mM glutamine, macrophages were pulsed for 30min with latexbeads 
(0.8 μm, 1:100) followed by a chase until 10h post infection. Autophagolysosomes (APL) 
were isolated according to flotation on a sucrose gradient adapted from Desjardins et 
al.35. Total cell lysates were also obtained for controls of enrichment levels. All cell 
fractions were prepared in biological triplicates. 
 
4.6.7. Mass spectrometry analysis of APL  
 
Twenty micrograms of total cell lysate or isolated APL were separated on a 4−12% 
precast NuPAGE gel (NP0321, Invitrogen). After Coomassie staining, lanes were 
separated into 12 pieces using an in-house cutting device. The gel pieces were reduced 
with Dithiothreitol (DTT; D9163, Sigma Aldrich), alkylated by Chloroacetamide (C0267, 
Sigma-Aldrich).and digested with trypsin (ratio 1:25; V5111, Promega). After triple 
peptide extraction using 90% acetonitrile, extracts were combined, dried and 
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resuspended in 5% acetonitrile, 0.2% formic acid (FX0440-7, EMD). Peptides were 
separated on a 150 μm i.d., 15 cm reversed phase nano-LC column (Jupiter C18, 3 μm, 
300 Å; 04A-4263 Phenomenex) with 0.2% formic acid used for loading. Peptides were 
eluted with a gradient of 5−40% acetonitrile within 70 min on an Eksigent 2D-nanoLC 
(Dublin) operating at a flow-rate of 600 nL/min. The nano-LC was then coupled to an 
LTQ-Orbitrap Elite mass spectrometer (Thermo-Electron), and samples were injected in 
an interleaved manner. The apparatus was operated in a data-dependent acquisition 
mode with a 1 s survey scan at 120,000 resolution, followed by 12 product ion scans 
(MS/MS) of the most abundant precursors above a threshold of 10,000 counts in the  
LTQ-part of the instrument. CID was performed in the LTQ at 35% collision energy and 
an Activation Q of 0.25. 
The centroided MS/MS data were merged into single peak-list files (Distiller, v2.4.2.0) 
and analyzed with the Mascot search engine v2.3.01 (Matrix Science) against the forward 
and reversed HSV1 Uniprot release 2011 database. Mascot was searched with a parent 
ion tolerance of 10 ppm and a fragment ion mass tolerance of 0.5 Da. 
Carbamidomethylation of cysteine; oxidation of methionione; deamidation; 
phosphorylation of serine, threonine, and tyrosine residues were specified as variable 
modifications. The false discovery rate (FDR), was calculated as the percentage of 
positive hits in the decoy database versus the target database, and a FDR of 1% was 
considered for both proteins and peptides. Relative protein abundance was determined 
using a redundant peptide counting approach (spectral counts)36. The value of redundant 
peptide counts from 3 identification cycles (on 3 independent biological replicates) was 
used to generate heatmaps. Unsupervised clustering was performed using the Graphical 
Proteomics Data Explorer (GProX) software platform in default settings37. 
 
4.6.8. Immunofluorescence 
 
For immunofluorescence analysis, cells were fixed and permeabilized with 
Cytofix/Cytoperm according to manufacturer’s instructions (51-2091KZ, BD 
Biosciences). Proteins of interest were labeled with the primary antibodies listed above 
and the corresponding secondary antibodies coupled to Alexa 488 or Alexa 568 
(Invitrogen – Molecular Probes). Cells were then embedded with ProLong Gold antifade 
(Invitrogen) and analyzed with a confocal microscope (LSM510, Leica Microsystems). 
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Images were adapted with Adobe Photoshop CS3. Linear contrast adjustments were 
performed equally for all images within one experiment. 
 
4.6.9. SDS-PAGE & immunoblots  
 
Proteins in isolated APL and cell lysates were separated by SDS PAGE on 12% gels 
(Mini-PROTEAN TGX, 456-1043, Bio-Rad) and transferred onto nitrocellulose 
membrane (Pall Corporation). Proteins of interest were detected with the primary 
antibodies listed above, followed by appropriate secondary antibodies coupled to 
horseradish peroxidase (Jackson Immuno Research) for enhanced chemiluminescence 
detection (Western Lightning Plus, NEL105001EA, PerkinElmer). If required, 
membranes were stripped by incubation with 2% SDS, 100 mM beta-mercaptoethanol, 
and 50 mM Tris (pH 6.8) at 56°C for 15 min and re-probed with other antibodies. Images 
were analyzed and linearly contrast enhanced with Adobe Photoshop CS3. 
 
4.6.10. Electron microscopy  
 
For morphological analysis, infected cells were fixed in 2.5% (vol/vol) glutaraldehyde 
(Canemco), embedded in Epon (Mecalab), and thin sectioned as described previously38. 
Images were analyzed and contrast enhanced with Adobe Photoshop CS3. 
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4.8. Supplemental data 
 
4.8.1. Supplementary figures 
 
 
 
Figure 4.S1. Atg5 knockdown efficiency.  
The efficiency of Atg5 knockdown after shRNA treatment of RAW264.7 cells with scrambled 
shRNA (scr) or anti Atg5 shRNA was validated in immuno blot with an anti Atg5 antibody and an 
anti GAPDH antibody as a loading control. 
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4.8.2. Supplemental tables 
 
 
Table IV-S1: HSV1 protein identifications (under all experimental conditions) (CD-ROM). 
Table IV-S2: List of ubiquitylated peptides including links to spectra (CD-ROM). 
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Chapter 5 : Conclusion 
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5.1. Conclusion and Discussion 
 
Understanding the molecular mechanisms governing cell functions is essential to prevent 
diseases and develop therapeutic approaches. In that context, proteomics is a key 
enabling technology that continues to have a major impact on the understanding of how 
cells work, as proteins and their interacting complexes are the major actors performing 
and regulating cell functions. Proteomics has already led to several major discoveries 
and has provided direct insights into the understanding of the immune system1, 2. 
Autophagy is a highly conserved lysosomal degradation pathway that plays an essential 
role in cellular homeostasis. Although autophagy was first proposed to be a source of 
nutrients during stress, new data suggests that this process has implications in cancer, 
immune response, neurodegeneration, development and aging3. Recently, autophagy 
was shown to be involved in the presentation of endogenous proteins on MHC class II 
molecules4. Our lab has furthermore shown that autophagy contributes to the 
presentation of viral proteins on MHC class I molecules5. Protein degradation in vacuolar 
compartments is of particular interest for disease progressions like cancer and viral 
infections, as this process complements classical proteasome cleavage, providing a way 
to expose additional immunogenic epitopes. Autophagy is now recognized as a vacuolar 
pathway involved in antigen presentation and has also been linked in various other ways 
to processes in innate and adaptive immunity rendering autophagy an emerging 
immunological paradigm. Bulk degradation of proteins by autophagy causes major 
cellular remodeling and modulates the proteomics composition of a cell6. MS–based 
proteomics is hence an ideal approach to follow protein dynamics in autophagy 
pathways. However, proteomics analyses of protein dynamics during autophagy are still 
scarce and only very few studies have utilized proteomics techniques to investigate 
different aspects of autophagy. 
Consequently the main focus of this thesis was to develop an approach to define the 
molecular mechanisms governing the involvement of autophagy in innate and adaptive 
immunity using novel quantitative proteomics methods together with functional assays. 
This objective was successfully completed and documented in the preceding chapters of 
this thesis. An integrated proteomics research program was established to unravel the 
molecular machines associated with autophagy and to decipher the fine details of the 
molecular mechanisms governing the functions of the autophagosome in antigen 
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presentation using a systems biology approach. To study how autophagosome and 
antigen presentation are modulated in macrophages, we first conducted several 
comprehensive proteomics studies under different conditions known to stimulate 
autophagy. In this context, we employed cytokine activation as well as viral infections 
since both stimuli are known to modulate autophagy in various complex ways. 
 
5.1.1. An unexpected role for TNF-α in the induction of mitophagy 
 
While cytokines such as IFN-γ, TNF-α and IL-1β have been reported to induce 
autophagy, IL-4, IL-13 and IL-10 may antagonize this degradation process7. Cytokines 
are also crucial components of the immune system and play a central role in mounting 
an efficient immune response against pathogens. Classically, macrophages are 
activated by a priming stimulus by the proinflammatory cytokine IFN-γ followed by a 
microbial trigger. Following this activation macrophages release a variety of 
proinflammatory cytokines such as IL-1, IL-6 and TNF-α8. Interestingly, TNF-α is not only 
produced by macrophages, but can also act back on macrophages and synergize with 
IFN-γ to modulate the activity of macrophages through the induction of signaling 
cascades and changes in gene expression. Several pathways induced by TNF-α have 
been described in the literature including apoptosis9 or autophagy10-12, which may be cell 
type dependent. Relatively few studies have investigated the molecular mechanisms and 
signaling associated with the activation of macrophages by TNF-α. To date no 
comprehensive analysis has been performed.  
Our work, outlined in chapter 2 of this thesis, describes the first comprehensive analysis 
of TNF-α activation of macrophages by label-free quantitative proteomics and provided 
important insights on how TNF-α actively shapes the activity of macrophages. 
Quantitative proteomics analysis highlighted the consistent down regulation of 
mitochondrial proteins in response to TNF-α activation as well as the differential 
regulation of several proteins involved in protein degradation, vesicular trafficking, and 
immune response. Importantly, integration of our proteomics dataset with several 
bioinformatics tools as well as novel functional assays revealed an unsuspected role of 
TNF-α activation in macrophages leading to the selective degradation of mitochondrial 
proteins by mitophagy. Functional flow cytometry assays established the reduction of the 
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healthy mitochondria population upon TNF-α stimulation and confirmed that 
mitochondria are selectively degraded upon TNF-α stimulation by Atg5-dependent 
mitophagy. Fluorescence microscopy analysis revealed that mitochondria are indeed 
sequestered in autophagosome structures and confirmed the enhanced mitophagic 
activity in TNF-α activated macrophages. Complementary morphological analyses by 
electron microscopy showed the engulfment of mitochondria in double membrane 
structures during TNF-α stimulation. 
Our quantitative proteomics dataset also highlighted the upregulation of cPLA2, an 
enzyme known to modulate the induction of ROS, a well-established feature of the 
macrophage’s microbicidal activity to kill pathogenic invaders such as bacteria. Increased 
levels of ROS lead to the damage of mitochondria characterized by the depolarization of 
the mitochondrial membrane potential. Damaged mitochondria are eliminated as part of 
the mitochondrial quality control mechanism by mitophagic degradation13 . This suggests 
that TNF-α induced mitophagy involves the induction of ROS. Using a novel antigen 
presentation system we showed that the induction of mitophagy by TNF-α enabled the 
processing and presentation of mitochondrial antigens on MHC class I molecules in an 
Atg5 dependent manner, expanding the role of autophagy in the processing of 
intracellular antigens and their presentation by MHC class I molecules. Taken together, 
these findings highlight a novel, unsuspected role for TNF-α in mitophagy and in the 
processing and presentation of mitochondrial antigens by MHC class I molecules.  
 
5.1.2. Potential roles of TNF-α induced mitophagy 
 
Mitochondria execute several pivotal metabolic functions in the cell, including oxidative 
phosphorylation, and represent the main source of cellular energy. However 
mitochondria can also cause harm to the cell14. If damaged by, for example, oxidation of 
mitochondrial lipids or proteins, mitochondria release high levels of Ca2+ and cytochrome 
c, hence inducing apoptosis15. Mitophagy has evolved as a mitochondrial quality control 
mechanisms to prevent cellular damage by aiding in the removal of damaged or 
superfluous mitochondria and by preserving a population of healthy mitochondria13. The 
finding that TNF-α stimulation induces mitophagy might seem unsuspected at first, 
although it might be anticipated considering the association of ROS, mitochondrial 
damage and mitophagy. It can be hypothesized that TNF α induced ROS production can 
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damage mitochondria, which in turn could lead to the release of cytochrome c and the 
induction of apoptosis. Indeed, TNF-α is known to induce apoptosis in several cell types9. 
In macrophages, mitophagy may have evolved as a compensation mechanism to 
counteract the effects of mitochondrial damage caused by the microbicidal activity of 
macrophages via the selective degradation of impaired mitochondria. This ensures the 
survival of classically activated macrophages and hence the elucidation of an efficient 
immune response. 
Another functional hallmark of mitophagy is the selectivity for cargo selection. Mitophagy 
uses specific signals to recognize and remove damaged mitochondria. Loss of 
mitochondrial membrane potential leads to Pink1 accumulation on the outer membrane 
of dysfunctional mitochondria. This leads to the recruitment of Parkin, which tags 
mitochondrial proteins by ubiquitylation for subsequent degradation by mitophagy13. The 
regulation of Pink1 and Parkin upon TNF-α stimulation was not determined in our study. 
This is likely due to the time frame chosen for sample collection or due to the sample 
preparation used, which enriched for membrane proteins and might hence result in the 
loss of only weakly associated membrane proteins. Interestingly, we detected a number 
of ubiquitylated mitochondrial proteins which could mediate their recruitment to 
autophagosomes via binding to cargo receptors and LC3. Recently, it was found that 
Parkin also plays a role in the ubiquitin mediated xenophagic degradation of M. 
tuberculosis16. Parkin ubiquitylates phagosomes containing M. tuberculosis and targets 
the vesicles for lysosomal destruction. This finding is very exciting and provides an 
unexpected functional link between mitophagy and infectious diseases. In that context, it 
should be noted that TNF-α, as a proinflammatory cytokine, also executes a key function 
in the elimination of internalized bacteria. Furthermore, TNF-α also plays an important 
role in the protective immune response to M. tuberculosis. It is tempting to speculate that 
mitophagy in macrophages might have evolved from the xenophagic degradation 
pathway used to eradicate pathogenic invaders. These pathways seem distinct, however 
the evolutionary origin of mitochondria from a bacterial endosymbiont, suggests that 
perhaps autophagic mechanisms are shared between these pathways. Autophagy of 
mitochondria and bacteria share a lot of commonalities including specific recognition 
signals such as ubiquitylation, specific cargo receptors as well as a similar shaped 
autophagosome structures. It is reasonable to propose that the induction of mitophagy 
presented a survival advantage in TNF-α activated macrophages, which macrophages 
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might have been selected for during evolution and thus established mitophagy as a 
survival mechanism. Alternatively, recent research revealed that dysfunctional 
mitochondria may serve as a danger signal, resulting in the activation of several innate 
immune receptors such as the NLRP3-inflammasome17. Considering that several studies 
also indicated a modulation of host mitochondria dynamics18 during intracellular infection 
with several pathogens such as L. monocytogenes, it can be hypothesized that damaged 
mitochondria may serve as a signal for intracellular infection and activation of xenophagy, 
as speculated by Manzanillo et al.16. In that context, TNF-α induced mitophagy likely 
improves the pathogen killing abilities of macrophages, while simultaneously ensuring 
macrophage survival.  
Another scenario can be proposed, where TNF-α induced mitophagy might have 
developed as a proviral function. During viral infection, the virus relies on the host’s 
protein synthesis machinery to express all proteins needed for assembly of the virions 
and thus for its viral spread. If cells undergo apoptosis in the presence of high levels of 
TNF-α, the viral proliferative capacity is reduced. Keeping the cell alive by the induction 
of mitophagy and the removal of dysfunctional, harmful mitochondria allows the virus to 
continue to proliferate and propagate much more efficiently. Strikingly, our results 
showed that TNF-α not only induced mitophagy, but this process also contributed to MHC 
class I antigen presentation. The fact that TNF-α not only degraded mitochondrial 
proteins to prevent further damage to the cell, but also utilizes the mitochondrial antigens 
to promote a CD8+ T cell response, suggests an even more defined role of this process 
in the development of a specific immune response.  
 
5.1.3. TNF-α induced mitophagy contributes to antigen presentation: 
‘Shaping an efficient immune response’ 
 
Several studies have reported the contribution of autophagy to antigen presentation4, 5, 
19. Until now, studies only reported the contribution of bulk macroautophagy to both MHC 
class I and II processing and presentation. Our study represents the first report showing 
that selective autophagy, more specifically mitophagy, can also contribute to antigen 
presentation on MHC class I molecules. The notion that autophagic pathways can be 
modulated to promote the capture of specific sets of endogenous antigens for 
presentation on MHC molecules has fundamental implications for the immune response. 
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Previous studies have shown that antigens predominantly presented on MHC class I and 
II molecules derive from cytosolic or vacuolar origins (lysosome, endosome)20, 21. 
Mitochondrial proteins are usually not presented or presented in very low abundance. 
Interestingly, a recent study on the MHC class II immunopeptidome showed that 
autophagy promotes MHC class II presentation of peptides from intracellular source 
proteins. While proteins from the lysosome, nucleus or cytoskeleton were preferentially 
presented in cells undergoing autophagy, mitochondria proteins represented only 0.2% 
of all peptides presented22. These findings suggest that antigens localized in 
mitochondria can evade their detection by the immune system. This is important as there 
are several viruses known to localize parts of their proteome to mitochondria, hence 
evading immune detection. Examples include human immunodeficiency virus (HIV) 
protein Vpr, Hepatitis B virus (HBV) protein X, Hepatitis C virus (HCV) protein NS2 and 
Epstein barr virus (EBV) protein BHRF1, to mention a few23. HSV1 protein UL12.5 also 
localizes to mitochondria24. Interestingly, many viral proteins targeted to mitochondria 
control apoptosis23. This is in agreement with the complex interplay between apoptosis, 
autophagy and TNF-α activation, outlined above. The cell’s ability to increase the 
presentation of mitochondrial antigen by the stimulation of mitophagy with TNF-α could 
improve the immune detection of some viruses and thus limit viral spread. Inducing the 
selective degradation of mitochondrial proteins by TNF-α opens up important possibilities 
to shape the immunopeptidome presented to T cells. This could open up novel avenues 
to develop therapeutic approaches and vaccines against infectious diseases such as viral 
infection. 
 
5.1.4. HSV1 infection and autophagy 
 
After having investigated cytokines as potent stimulators or modulators of autophagy, we 
set out to investigate the complex interactions between viral infections and autophagy.  
HSV1 infection induces a novel form of autophagy, termed nuclear envelope derived 
autophagy (NEDA). NEDA results in the formation of autophagosomes that originate from 
the nuclear envelope. The role of NEDA in the pathogenesis of viral infection, whether it 
benefits the host or the virus, is poorly understood. NEDA is regulated differently than 
macroautophagy and is induced in response to ICP34.5 binding to PP1α25, hence 
depending on the production of late viral proteins. How this autophagic process differs 
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mechanistically from classical macroautophagy still needs to be elucidated. 
Macroautophagy was recently reported to contribute to efficient processing and 
presentation of a viral antigen in murine macrophages during HSV1 infection5. However, 
the extent to which NEDA is involved in the processing and presentation of viral proteins 
and peptides remains to be established. To further understand how NEDA and its 
involvement in antigen presentation is regulated, we first characterized our experimental 
system.  
 
5.1.5. A comprehensive characterization of viral protein expression in 
macrophages 
 
The definition of the viral proteome in infected cells is crucial for our understanding on 
how HSV1 executes its functions. In addition to protein expression levels, ubiquitylation 
and phosphorylation play an important role for HSV1 protein function, subcellular 
localization, or stability. No complete data exists of the expression of the whole viral 
proteome as well as of posttranslational modifications on HSV1 proteins. To address this, 
we performed a comprehensive quantitative analysis of the HSV1 proteome of infected 
cells by mass-spectrometry-based proteomics as described in chapter 3. 
LC-MS/MS analysis identified a total of 67 structural and non-structural viral proteins 
(82% of the proteome). Different kinetic classes of viral protein expression were 
investigated using two different inhibitors of DNA replication. Our data suggest that the 
classification into immediate early, early and late proteins might not totally reflect 
expression profiles in infected cells and protein expression might be controlled in a more 
complex manner in HSV1 infected cells. Our analysis also identified 90 novel 
phosphorylation sites and ten novel ubiquitylation sites on different viral proteins. 
Interestingly, all ubiquitylated proteins could either localize to the nucleus or participate 
in membrane fusion events suggesting that ubiquitylation might affect viral protein 
trafficking and localization. Taken together, our dataset provides new insights into HSV1 
protein expression regulation and generated comprehensive phosphorylation and 
ubiquitylation sites maps, which served as a resource for my third project outlined in 
chapter 4. 
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5.1.6. NEDA is Atg5-independent and contributes to MHC class I antigen 
presentation 
 
During HSV1 infection, viral proteins are degraded by the proteasome to generate 
peptides that are loaded on MHC class I molecules and presented at the cell surface to 
stimulate a CD8+ T cell response. Interest in NEDA stems from its potential ability to 
complement classical proteasome cleavage by the generation of non-traditional, 
immunogenic epitopes, distinct from those generated during classical autophagy. Our 
results outlined in chapter 4 clearly show that NEDA is an Atg5-independent pathway, 
different from macroautophagy, that contributes to the presentation of an epitope of gB 
to CD8+ T cells. During macroautophagy bulk cytoplasm is engulfed and degraded in the 
autophagolysosome26. NEDA is a more selective process and autophagosomes derive 
from the nuclear envelope. Indeed, our data, obtained using our novel antigen 
presentation assay, indicate that NEDA selectively captures antigens and specifically 
contributes to the presentation of a particular subset of viral antigens localized to the 
nuclear envelope. Clearly, NEDA exhibits functional differences to macroautophagy. To 
gain further insights into NEDA contribution to MHC class I antigen processing and 
presentation, we characterized the composition of autophagosomes formed during this 
process. 
 
5.1.7. A novel autophagosome isolation method 
 
To date, very little work has been done to decipher the proteome of autophagosomes 
and only few previous studies described the use of mass spectrometry to identify 
autophagosomal proteins27-30. To characterize the proteome of the autophagosome 
formed by NEDA, an efficient cell fractionation approach had to be developed to isolate 
these compartments. We developed a new isolation method based on the loading of the 
lysosomal compartment with latex beads, a unique tool to obtain very pure cell extracts, 
upon autophagy induction. We monitored the transfer of HSV1 antigens into 
autophagolysosomes (APL) using MS based proteomics. This isolation technique yields 
pure APL extracts and the isolation method can be directly integrated into our well-
established LC-MS/MS workflow. This new APL isolation method is amenable for the 
investigation of several different types of autophagy and can be used to investigate how 
different stimuli shape the autophagosome proteome. This new technique is expected to 
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have a great impact on the autophagy field since meaningful large-scale datasets for the 
different autophagy types can now be generated. This new method can potentially 
revolutionize the field of autophagy research. The analysis of different types of selective 
autophagy pathways using our technique could provide important insights into cargo 
recognition, cargo receptors or on the origin of the phagophore membrane used to form 
the autophagosome in a previously inaccessible and comprehensive manner. Based on 
hypothesis driven research, new concepts can be established from the large-scale 
proteomics datasets, which can be ultimately tested using our immunological follow-up 
screens. 
 
5.1.8. Selectivity of NEDA: beneficial for host or virus? 
 
Detailed proteomics analyses of the APL confirmed the selectivity of NEDA to favorably 
capture nuclear envelope derived proteins. Interestingly, gB, found to be enriched on the 
nuclear envelope during infection was also the most abundant protein in the APL during 
HSV1 WT infection, while it was significantly less abundant in NEDA-deficient systems. 
It has been established, that the cytotoxic T cell response to HSV-1 infection in mice is 
almost entirely directed against a single gB immunodominant epitope corresponding to 
the peptide SSIEFARL31. The cellular processes responsible for gB immunodominance 
are poorly understood. Our results support the hypothesis that NEDA contributes to 
immunodominance by promoting the transfer of high amounts of gB to degradative 
compartments, such as APL, for antigen processing. Immunodominance leads to an 
inefficient immune response. This would thus suggest that NEDA is an autophagic 
pathway that is beneficial for the virus by limiting the immune response to a single epitope 
of the viral protein gB. NEDA induction might represent a novel viral evasion mechanism 
and NEDA inhibition might hence represent a novel therapeutic avenue to reduce the 
damaging effects of immunodominance. However, further investigations are required to 
support this proposal. In contrast, previous studies argued that enhancing antigen 
presentation is an important means by which autophagy combats intracellular microbes 
and counteracts the effect of viral immune evasion32. The premise is that the host immune 
system retaliates by degrading proteins for presentation to MHC class I molecules that 
would generally not access the classical antigen presentation pathway. This research 
was conducted on macroautophagy, while our work focused specifically on NEDA. 
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Comprehensive proteomics analysis revealed another meaningful finding. Different viral 
protein subsets were transferred to the APL whether NEDA occurred or not. A subset of 
mostly cytosolic proteins was preferentially transferred to the APL during infection in a 
NEDA deficient system in an Atg5 dependent manner, while the transfer of most proteins 
transferred to the APL during HSV1 WT infection was Atg5 independent. Since many 
cytosolic proteins were transferred to the APL in NEDA deficient systems in an Atg5-
dependent manner, it is reasonable to propose that macroautophagy contributes to this 
transfer. 
 
5.1.9. Autophagy can shape the immune response by selectively targeting 
different protein subsets: a novel concept 
 
The integration of all results obtained during my PhD revealed an important new concept 
in immunology: different selective autophagy pathways can be induced to promote the 
capture of different subsets of proteins for antigen processing and presentation. While 
TNF-α induces the presentation of antigens localized in mitochondria, NEDA specifically 
targets proteins localized at the nuclear envelope. In contrast, macroautophagy samples 
cytosolic proteins and targets them to the autophagosome. The notion that autophagic 
pathways can be modulated to promote the capture of specific sets of endogenous 
antigens that are usually undetected for presentation on MHC molecules opens up novel 
avenues for therapeutic interventions. Indeed we are the first to demonstrate that the 
nature of the immune response can be actively shaped by modulating the autophagic 
process during infection. By stimulating distinct autophagic pathways, the recruitment of 
different organelles to autophagosomes and hence the capture of specific sets of viral 
proteins for processing and antigen presentation could be promoted. Modulating the 
autophagic response could be used to shape the repertoire of viral peptides presented 
by MHC I molecules during HSV-1 infection. 
The mechanism responsible for the selective transfer of various subsets of viral proteins 
by different autophagic conditions remains to be elucidated. NEDA and macroautophagy 
are two functionally distinct processes, which may account for their specificity or non- 
specificity in the sampling of antigens. While NEDA autophagosomes originate from the 
nuclear envelope, the origin of the phagophore membrane during macroautophagy is still 
under debate. The different origin of the membrane could contribute to the capture of 
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different antigen subsets. NEDA enriches for proteins localized at the nuclear envelope 
such as gB, since autophagosomes are derived from nuclear membranes. The different 
origins of autophagosomes formed during NEDA and macroautophagy can also influence 
the properties of these compartments. Different enzymes, proteases or lysosomal 
content might be recruited that can result in differential processing of the proteins in the 
vesicle. The improved presentation of antigens upon NEDA induction suggests that 
NEDA autophagosomes contain proteases and peptidases that cleave viral proteins to 
derive antigens that are preferentially presented on MHC class I molecules. 
Other factors may be responsible for the selectivity of NEDA as opposed to 
macroautophagy, which mostly recruits cytosolic proteins. Indeed, macroautophagy is 
Atg5-dependent, while NEDA is not. Recently, another Atg5-independent pathway has 
been characterized, where autophagosomes originate from the trans-golgi network33. 
Ubiquitylation of viral proteins might also play a role in the capture of specific subsets of 
viral proteins to the autophagosome. Different cargo receptors could be present in the 
autophagosomes that target different ubiquitylated motifs. It should be noted that we did 
not find modulation based on ubiquitylation patterns in our experiments. This could be 
attributed, in part, to the small number of ubiquitylation sites identified in this work. A 
large-scale analysis of ubiquitylation sites in the APL using affinity-enrichment would 
provide much needed information on this matter. Finally, NEDA is characterized by the 
presence of LC3a on the autophagosomal membrane, whereas during macroautophagy 
LC3b, a homologue of LC3a is enriched on the autophagosome. During selective 
autophagy the LIR motif34 is crucial for the selective targeting of cargo to the 
autophagosomal membrane. LC3a may act to recruit specific cargo containing a LC3a 
interacting motif, not yet identified to date.   
In conclusion, the application of quantitative proteomics methods allowed for the 
identification of alterations occurring in autophagosomes during disease and 
inflammatory conditions, including viral infections. Our established systems biology 
approach that combined mass spectrometry-based quantitative proteomics with novel 
antigen presentation assays revealed new immunological insights providing a greater 
understanding on autophagosome functions in antigen processing and presentation and 
their modulation. My PhD thesis research highlights the importance of autophagy in 
antigen presentation and its potential to shape an appropriate immune response against 
disease epitopes that are less often detected. 
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5.2. Future perspectives 
 
The finding that autophagic pathways can be modulated to promote the capture of 
specific sets of endogenous antigens for presentation on MHC molecules has 
implications well beyond the scope of this thesis. Indeed, the possibility to shape the 
composition of the peptides presented to T cells opens novel avenues to develop 
therapeutic approaches and vaccines against infectious diseases and cancer. In the 
context of the strong immunodominance often associated with these diseases, the ability 
to modify the immunopeptidome of antigen presenting cells has the potential to activate 
a T cell response against a broader set of microbial and cancer epitopes. 
 
5.2.1. Iterative proteomics: Autophagy and antigen presentation - ’network 
of influence’ 
 
The mechanisms by which NEDA or mitophagy mediate their contribution to antigen 
presentation remain to be elucidated. In order to be able to modulate and shape the 
immune response through the induction of different autophagy pathways, it is crucial to 
truly understand how these pathways are regulated and how they modulate and 
contribute to antigen presentation. The definition of the composition of the 
autophagosome isolated from different autophagic conditions will provide important 
insights into the distinct functional properties of these vesicles. In chapter 4 of this thesis, 
we performed a detailed characterization of the viral proteome transferred to the APL 
during NEDA and macroautophagy. In addition to the viral proteome data, this dataset 
contains important insights into the host proteome targeted to the  autophagosome. 
Indeed, preliminary analysis of our dataset show the modulation of protein interaction 
networks associated to lysosomal degradation as well as ion transport. This suggests, 
that different autophagic pathways might influence the degradative capabilities of the 
autophagosome and thus modulate the processing of antigens. Further analyses with 
regard to the autophagosome composition are currently ongoing. 
Importantly, the interaction of proteins into networks and molecular machines is at the 
base of most biological functions. To understand the molecular mechanisms regulating 
the functional properties of autophagosomes, and the role played by these organelles in 
antigen presentation, we developed a novel approach as a continuation of my PhD 
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research, where the links between proteins are identified by proteomics analyses and 
functional assays. This approach highlights a novel type of network that we call "networks 
of influence". The method to decipher these networks, called Iterative Proteomics, is 
based on proteomics analyses aimed to determine how a single autophagosome protein 
"influences" the overall proteome of this organelle. Hence, autophagosomes can be 
isolated from cells using the method described in this thesis, where a single protein is 
knockdown, and analyzed by quantitative mass spectrometry. The modulated proteins 
are further studied by generating corresponding knockdown cell lines where their 
functional properties are tested. The resolution of the networks expands as additional 
cycles of proteomic analyses/shRNA knock down/APL functional assays are performed. 
Iterative Proteomics is a novel approach to study how groups of proteins interact and 
"influence" each other. The networks identified by this approach are not necessarily 
representative of direct protein-protein interaction, but rather based on the fact that these 
proteins influence a given functional pathway by modulating the presence of each other. 
Preliminary results already show the strength of this method. Several proteins identified 
by mass spectrometry-based proteomics to be differentially regulated such as Irgm1 or 
Cxcl10 directly modulated antigen presentation, while other proteins such as Tmem176b 
modulated antigen presentation via the regulation of NEDA induction. This further 
highlights the potential of quantitative proteomics to investigate complex immunological 
paradigms in a comprehensive manner, which should become more common in future 
research. 
 
5.2.2. Quantitative proteomics approaches to investigate selectivity in 
autophagy pathways 
 
Understanding how selectivity is achieved in different autophagy processes is central to 
our capability to modulate these pathways. Concepts regarding selective autophagy are 
just starting to emerge. In recent years, it became clear that ubiquitylation not only plays 
a role in the UPS system, but is also essential for the selective targeting of cargo to 
autophagosomes35. Ubiquitylated proteins can be recognized by cargo receptors such 
as p62 which recruit them for autophagic degradation. In addition the LIR motif also plays 
an important role to recruit cargo for autophagosomal degradation34. 
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In order to get a more comprehensive view on the role of ubiquitylation in autophagy 
selectivity, it would be of key importance to obtain a large-scale repertoire of 
ubiquitylation sites in autophagosomes isolated under different autophagic conditions 
such as NEDA or mitophagy. Large-scale proteomics analysis of the ubiquitinome is now 
achievable36, 37. Antibody-based affinity approaches for the specific di-Gly fragment 
characteristic of ubiquitylation allows for the routine identification of up to 10 000 
ubiquitylation sites in mammalian cells37. The major shortcoming of the methods 
developed to date is the need for high protein quantities. Autophagosome isolation 
results in limited protein quantities (though it can be up-scaled), thus making the large 
scale analysis of ubiquitylation very challenging. Improvements in method development 
such as higher affinity antibodies in combination with higher sensitivity mass 
spectrometry instruments, such as the Orbitrap Fusion38, should make the 
comprehensive analysis of the autophagosome ubiquitinome possible in the near future. 
Comparative analysis of these sites should provide important insights on how this cargo 
selectivity is exerted and if it is indeed ubiquitin-dependent. The ubiquitinome together 
with the autophagosome proteome could also likely serve as a valuable resource for 
advanced bioinformatics analysis to define the LIR motif in more detail. Even more, this 
should aid in the identification of additional motifs. There are several homologs of LC3 in 
mammals, however the role of most of these homologs has not yet been established. 
Interestingly, LC3a is a specific marker for NEDA. Ubiquitylated and non-modified 
proteins present in the autophagosome in HSV1 WT infected cells could be 
computationally analyzed to define a LC3a interacting motif. This could provide a basis 
to predict which protein subsets will be preferentially transferred to the autophagosome 
under different conditions. 
 
5.2.3. Modulation of the Immunopeptidome by selective autophagy 
 
Promoting the transfer of different sets of viral proteins to APL, where they are actively 
processed, will influence the nature of the viral peptides presented on MHC class I 
molecules and shape the repertoire of CD8+ cytotoxic T cells. Thus, it would be 
interesting to investigate how various autophagic pathways affect the composition of the 
MHC class I peptides presented at the surface of HSV-1-infected cells. Our lab 
developed a mass-spectrometry platform to identify immunopeptides loaded on MHC 
class I molecules, which can be used to monitor the immunopeptidome in a high-
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throughput manner39-41. Integration of immunopeptidomics and autophagosome 
proteomics under different autophagy conditions can reveal, if the immunopeptidome 
reflects the autophagosomal composition or if it is rather shaped by the classical pathway 
of antigen processing. Furthermore, these results could be nicely complemented by the 
identification of the peptidome in autophagosomes. To this end, autophagosomes could 
be isolated and peptides extracted using molecular weight cutoffs. This would allow to 
determine peptide cleavage sites and the corresponding proteases and peptidase 
responsible for the cleavage, an important information usually lost in proteomics 
workflows following trypsin digestion. Peptides present in the autophagosome could then 
be correlated to the immunopeptidome to get a complete view on autophagy’s 
contribution to antigen processing and presentation. 
Remarkably, the ability to follow changes to the APL proteome during the activation of 
various autophagic pathways, and their effect on the nature of the viral 
immunopeptidome, will provide an opportunity to test whether the viral peptides produced 
by APL under various conditions are relevant to the immune response engaged in 
infected mice. The identity of the viral peptides recognized by T cells is unknown. 
Identifying these peptides is important to develop vaccination protocols, and/or methods 
to boost the immune response during infection by promoting the processing and 
presentation of viral epitopes proven to be reactive. The characterization of the viral 
immunopeptidome would provide the unique opportunity to test whether the identified 
peptides correspond to the ones recognized by reactive CD8+ T cells in infected animals. 
 
Taken together, the research performed during this PhD thesis as well as future research 
continues to deepen our understanding on how autophagy and its contribution to antigen 
presentation is actively modulated. 
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